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Bacteria of the Bacteroidetes phylum, dominant members within the gut microbiota, 
devote large genomic capacity towards nutrient acquisition via gene clusters termed 
polysaccharide utilization loci (PULs). The model organism, Bacteroides thetaiotaomicron (Bt) 
contains 88 PULs that target complex polysaccharides of host- microbial- or dietary origin. 
However, many PULs remain uncharacterized in terms of cognate substrate, enzyme 
functionality, and regulation. I have expanded the known substrates targeted through 
characterizing the ribose utilization system (rus) PUL in Bt. I created gene deletions based on 
predicted functionality within rus. Using these strains allowed for in vitro characterization of the 
substrates (e.g. ribose, nucleosides and RNA) that are catabolized through this PUL. The ability 
to access these nutrients confers a competitive advantage in vivo on a fiber-rich diet containing 
nucleosides. Additionally, through biochemical and in vivo studies I have connected the actions 
of a genomically unlinked nucleoside phosphorylase (BT4554) and the rus ribokinases 
(RusK1/K2). Determining that these two enzymes work together by BT4554 cleaving 
nucleosides which produces ribose-1-phosphate (R1P), which is subsequently phosphorylated by 
RusK1/K2 yielding ribose-1,5-bisphosphate (PRibP). Further, RusK2 accepts ribose-5-phosphate 
(R5P) as a substrate and synthesizes PRibP by phosphorylating the 1’C position. The functions 
displayed by RusK1 and RusK2 are the first described in eubacteria generating PRibP from R1P 
or R5P, and represents new metabolism in Bt. Further, the ability of Bt to sense ribose 
transcriptionally alter genes located within other PULs and loci.  
Contrastingly, to the rus PUL, mucin-O-glycan (MOG) PULs are strongly upregulated in 
vivo on a fiber-free diet (FF diet); a condition where Bt relies on host-derived glycans for growth. 
This FF diet resembles Westernized human diets that have been implicated in inflammatory 
bowel disorders (IBD) leading to colitis by bacteria eroding the host mucosa. By deleting MOG-
responsive, sulfatase-encoding PULs in Bt as single PUL deletions and sequentially, (up to a 
strain lacking 10 PULs), I abrogated growth of Bt on MOG. This approach has assisted in 
narrowing the gene-encoded functions responsible for disease. Additionally, using a transposon 




recognized in vivo during disease. The expression of this epitope is affected both by glucose and 
salt concentrations, demonstrating even more the interesting and largely unknown regulatory 
strategies employed by Bt. 
  The regulatory network in Bt is complicated, with each PUL encoding its own regulatory 
protein (ECF-σ/anti-σ proteins, hybrid two-component systems, etc.). Additionally, Bt encodes 
22 ECF-σ proteins as well as 4 LacI-type regulators not associated with known metabolic loci, 
making them orphan regulatory proteins. I have deleted most of these genes, resulting in 
discovery of a single ECF-σ gene, BT2492, which when deleted, reduces growth on 12 of the 
polysaccharides Bt degrades. Further, two LacI deletion strains result in drastically improved 
growth on normally low-priority monosaccharides. Lastly, as suggested by in vitro RNAseq data 
of ribose growth, the presence of ribose affects priority of other nutrients. This phenomenon 
extends to other simple sugars as arabinose and xylose RNAseq data reveal that they also exert 
changes in gene expression for loci not associated with their catabolism, including orphan ECF-σ 
factors. Together these data point to a complex regulatory cascade through a multi-faceted 
system involving PUL-encoded activators, trans-encoded proteins, and sugar-dependent 











  The importance of resident intestinal microbes to human health has been appreciated 
since the 1880s beginning with Theodor Escherich’s investigation of fecal bacteria, including 
Escherichia coli, and his hypothesis that these indigenous micoorganisms play roles in both 
digestion and intestinal diseases1. Since then, our understanding of the bacteria, viruses, archaea 
and eukaryotes that inhabit the gut has expanded alongside the rest of the field of microbiology 
and numerous fundamental roles have been established for this community, now termed the 
microbiome. As speculated by Escherich, these roles definitively include nutrient digestion2,3 and 
protection from invading pathogens4, but also extend to short- and long-term instruction of the 
immune system5-7 and production of a wide range of metabolites that could not be produced by 
human physiology. While the gut microbiome is typically described as being composed of non-
pathogenic, “commensal” organisms, it is now appreciated that both individual species8 or 
multiple community members acting together9,10 can exert pathogenic effects, which are often 
more subtle than those of classical pathogens. Indeed, the presence of common microorganisms 
with discrete virulence factors (e.g., enterotoxins, genotoxins) that may only manifest in diseases 
like colorectal cancer or inflammatory bowel disease (IBD) over long time periods or in certain 
host genetic backgrounds obscures the definition of pathogen. 
  Accelerated in the 2000’s by the “-omics” revolution, along with a recent resurgence of 
cultivation11-13, countless studies in the past two decades have implied or established connections 
between altered gut microbiomes and many diseases. These studies have demonstrated the 
malleability (or fragility) of the microbiome in the face of environmental and dietary 
perturbations encompassing antibiotic use14, geography15, immigration16, and dietary changes, 
including fiber deprivation17,18. While Escherich’s original ideas were logically predicted with 
respect to microbiome effects in the gut, less anticipated connections between gut microbes and 
health have extended to neurobiology19-21 and systemic immune responses that impact allergy22. 





mechanistic understanding of the relationships that connect host responses with microbiome-
derived metabolic functions. Here I look at recent examples that illustrate how the gut 
microbiome can augment or perturb host physiology through complementary or novel 
metabolism often changing the outcome of disease trajectories. The studies I highlight provide 
details that underscore the importance of gut microbes in human health, which Escherich 
postulated long ago. 
 
The impact of gut bacterial metabolites on host physiology  
  The collective diversity of microbial species that compose the gut microbiome harbor at 
least ~10 million unique, annotated genes23—probably many more24—that are not present in the 
human genome. Through our individual microbiomes, each of us has a personalized subset of 
this gene repertoire that substantially exceeds the genes in our human genome. Our microbiomes 
are equipped to produce an astonishing array of microbiome-produced products (MPPs), 
metabolites, and cellular products like polysaccharides and curli fibers that in many cases do not 
remain confined to the gut. The impacts of specific MPPs, and the presence/absence of 
individual species/strains that produce them, have been implicated in a wide-range of diseases 
both in and out of the gastrointestinal tract (Figure 1.1). Effects in the gut include preventing 
pathogen invasion through bile salt modifications25 and mucus layer erosion when the host lacks 
dietary fiber26. More surprisingly, studies have drawn connections to neurological conditions 
such as Parkinson’s Disease (PD)27, depression28,29, and autism spectrum disorders (ASD)30-32, 
showing that certain bacteria and their MPPs (e.g., curli fibers in PD and the metabolites, 4-
ethylphenylsulfate, p-cresol, taurine, and 5-aminovaleric acid in ASD) can contribute to these 
states (Figure 1.1).  
  A recent study using a forward chemical genetics culture-based screen showed that MPPs 
from several dozen bacteria promote direct interactions with G-Protein Coupled Receptors 
(GPCRs), a wide class of host receptors important in many aspects of physiology including 
mood regulation, immune function and the autonomic nervous system, such as peristalsis of the 
digestive tract33. This included a strain of Morganella morganii converting L-phenylalanine into 
phenethylamine, a psychoactive compound that can be fatal in individuals  







Figure 1.1 Effects of the gut microbiome on host health. 
A diagram highlighting many of the known effects of the gut microbiome within various organ systems. Each of the callout boxes 
highlights a different organ site and within each box several examples of diseases with an emerging connection to the gut 
microbiota is described. Abbreviations not defined in the figure in order of appearance are: GABA, gamma-aminobutyric acid, 
TMA/TMAO, Trimethylamine N-oxide, and IBD, inflammatory bowel disease, a collection of several intestinal disorders that 
includes Crohn’s disease and ulcerative colitis. References for each noted association: autism21,32, Parkinson’s34,35, depression28, 
multiple sclerosis36, drug metabolism37,38, non-alcoholic fatty liver disease39,40, asthma41, allergy42,43, heart disease44, Celiac 
disease45, IBD26, colorectal cancer46-49.   
convert tryptophan to tryptamine stimulate the colonic-restricted GPCR, 5HT4R, resulting in.  
increased intestinal transit time50. Additionally, bacterial production of N-acyl amides regulate 
glucose homeostasis and possibly appetite51. MPPs also interact with other receptors, such as the 
aryl-hydrocarbon receptor (AhR), for example by production of the Ahr ligand indole 3-aldehyde 
by Lactobacillus reuteri leading to increased IL-22 production and increased mucosal immune 
responses against Candida albicans52. Studies like the ones noted above often reveal beneficial 
and detrimental effects from variants of the same species, suggesting strain-level differences in 
the accessory genome mediate these effects. This is an important consideration when formulating 
potential probiotics or other bacterial-based treatments or therapies. A recent example of this is 
implication of L. reuteri (strain SP-C2-NAJ0070) as an exacerbator of systemic lupus 





  Another class of molecules, which have previously been well-studied in pathogenic 
bacteria, the cyclic di- and trinucleotides (CDNs/CTNs), are also emerging as molecules that 
interact with host sensors. The structural diversity of these compounds has expanded from 
purine-based to include pyrimidine-based examples54. While not definitively linked to aspects of 
host health, some of these CDNs which can be sensed by the host after bacteriolysis from 
antibiotics or host response can activate host immune pathways through pattern recognition 
receptors (PRRs), such as Stimulator of Interferon Genes (STING) and Reductase Controlling 
NF-ĸB (RECON) protein. Homologs of CDN synthesis operons are widespread in both 
commensal and pathogenic bacteria, including the prevalent Bacteroides genus. A recent study 
suggests that bacteria have evolved new ways of evading/enhancing host PRR recognition 
through synthesis of unique CTNs or modified CDNs not efficiently sensed by host PRRs54.  
  A final group of MPPs that is just beginning to be explored is bacterial capsular 
polysaccharides (CPS), which are enriched and highly diversified in several lineages of gut 
bacteria55. For example, just 14 sequenced strains of the common Gram-negative symbiont 
Bacteroides thetiotaomicron harbor 47 different configurations of gene clusters for producing 
CPS56. A subset of zwitterionic CPS, first discovered in Bacteroides fragilis but present in other 
species, has immunomodulatory properties, as do CPS and extracellular polysaccharides 
produced by members of different phyla, the Bifidobacteria57, Proteobacteria58 and  
Firmicutes59,60. These bacterial surface coatings are likely to be under intense pressure to 
diversify their glycan structures, perhaps to evade host immune responses, bacteriophages and 
microbe-mediated killing. In the process, they have fortuitously synthesized chemical structures 
that interact with the host epithelium and immune system (Figure 1.1), providing additional 
advantages during colonization and also opportunities for researchers to exploit these molecules 
for potential drug development61. 
  Collectively, the studies highlighted above illustrate how host cells have evolved to sense 
and interact with a variety of metabolites that are uniquely microbial, which is the basis of much 
innate immune recognition and of central importance in the tolerance of the dense human gut 
microbiome62. Better understanding these interactions may prove helpful in leveraging these 
existing chemical relationships to design new drugs that alter immune responses or other aspects 






Metabolism of drugs and other xenobiotics by gut microbes 
  Just as members of the microbiome produce novel molecules that interact with human 
physiology, they also have the capacity to modify exogenous chemicals (xenobiotics), many of 
which are the drugs used to treat diseases. Two of the most prominent examples are inactivation 
of the cardiac drug digoxin by Eggerthella lenta (E. lenta)63, and related plant-derived 
cardenolides64, and conversion of the common dietary compound choline to trimethylamine 
(TMA), which is subsequently converted by the host to harmful trimethylamine-N-oxide 
(TMAO) (Figure 1.1) that promotes cardiovascular disease44,65,66. Another process that has been 
characterized mechanistically is drug reactivation following -glucuronic acid conjugation in the 
liver and biliary secretion back into the gut. This process is catalyzed by gut bacterial β-
glucuronidases, which are widely present in gut bacteria37 and have broad substrate 
specificities38,67, which allow them to reactivate toxic drugs like the chemotherapeutic irinotecan. 
This process may be circumvented by drugs that, in turn block, β-glucuronidases to halt drug re-
toxification.  
  More recent examples highlight how the gut commensal Bacteroides thetaiotaomicron 
(Bt) and related Bacteroidetes metabolize a range of xenobiotics using previously undescribed 
mechanisms. One of these involves degradation of the nucleoside-based antiviral drugs brivudine 
and sorivudine to the hepatotoxic compound bromovinyluracil (BVU) through the action of a 
nucleoside phosphorylase68. Homologs of this gene are found in many members of the phylum, 
suggesting that toxic BVU could accumulate at faster rates based on which members of the 
microbiota are present. Another study expanded the repertoire of drugs that can be metabolized 
by Bt, identifying 18 drugs that are modified by an additional 17 unique enzymes69. Further 
highlighting that multiple bacteria can work synergistically in the gut, a recent study discovered 
a pathway for enzymatic conversion and inactivation of the Parkinson’s drug, levodopa (L-dopa). 
This step-wise mechanism involves Enterococcus faecalis, which first decarboxylates L-dopa to 
active dopamine, followed by an uncommon enzymatic dehydroxylase from E. lenta that 
inactivates L-dopa and produces m-tyramine70. These studies and several others like it point to 
variations in the gut microbiome as an often overlooked reason why therapy fails or patients 
have intolerable side-effects to treatments. Thus, the microbiota is another factor that needs 





culture/biochemistry-based approaches.  
  Beyond commensal bacteria altering the effects of therapeutic drugs, recent studies 
involving Clostridium difficile (Cd) have potentially uncovered an indirect link as to why 
patients taking common calcium supplements, NSAIDs, and proton-pump inhibitors may be 
predisposed to infection or have a more severe outcome once infected with Cd. The germination 
signal(s) for Cd is known to be intestinal bile salts, with co-germinates such as taurocholate and 
glycine. However, recent studies in vitro71 and in vivo72 have identified a role for both host-
derived (endogenous) and more importantly, dietary supplements or vitamins (exogenous) Ca2+ 
from the host. The presence of Ca2+ circumvents the requirement for glycine and suggests a 
plausible mechanism for why individuals with impaired Ca2+ absorption (high levels of intestinal 
Ca2+) are at greater risk of C. diff infection (CDI). Beyond predisposition to infection through 
calcium effects, NSAIDs were recently shown to alter the community structure of the microbiota 
potentially creating an environment where CDI is more severe73. Although the study only 
examined responses to the NSAID indomethacin, dysregulation of intestinal tight junctions was 
observed leading to more severe disease through translocation of Cd across the epithelium. 
Although no direct drug-Cd interaction was uncovered, the observation that the abundance of 
other strains is altered implies that they are affected by, or act on, this drug and in turn allow for 
invasion and infection by Cd. Findings such as the ones described above can be leveraged to 
design tools to guide drug selection and therapeutic interventions. A recent study detailed a new 
tool developed to model in silico interactions between drug classes and bacterial enzymes with 
activities against these drugs74.  This approach was used to successfully predict three previously 
unknown xenobiotic metabolic pathways by gut microbes that were confirmed through in vitro 
studies74. It is likely that in the future, personalized medicine approaches will utilize similar 
predictive tools coupled with in vitro and in vivo models to guide treatment regimes in a myriad 
of diseases and states of health. 
 
A way forward in the search for better therapeutics: detailed mechanistic studies 
  From the studies highlighted here, the picture of commensal and mutualistic bacteria 
always being “neutral” or “beneficial” to host biology is almost certainly wrong. Rather, 
commensals, and even mutualists, may also have potential to exhibit pathogenic activities, albeit 





damages cells, our non-pathogenic symbionts may not be as directly insidious. The means by 
which these commensal organisms exhibit pathogenic tendencies are highly context dependent 
on factors such as diet, drug intake and production of MPPs. Further, when considering if the 
presence of a species is beneficial or detrimental based on approaches like metagenomics or 16S 
approaches, the functional or accessory genome and not just phylogeny needs to be considered as 
strain level variations cause different outcomes. These pathogenic, condition-specific activities 
of commensal bacteria may have both transient (acute) and chronic (long term) health effects that 
likely influence disease states across organ systems. Moving forward, personalized medicine will 
need to consider these microbiome variations and incorporate deeper screening methodologies 
and functional studies. Leveraging the results of these approaches will hopefully generate new 
interventions that either prevent or cure the deleterious effects of the microbiome on diseases. In 
order to achieve these personalized medicine goals, engineering of the microbiome will need to 
be guided by in-depth mechanistic studies of the organisms that compose this community. A 
logical starting point is to examine the wealth of physiological knowledge available for 
prominent members such as the human gut Bacteroides, which target polysaccharides of diverse 
structure and origin. 
 
If you eat it, or secrete it, they will grow: The expanding cornucopia of nutrients that gut 
bacteria, especially Bacteroides utilize 
  Successful bacterial inhabitants within the gut, or any other ecosystem, need to be able to 
adapt to changing nutrient conditions if they are to persist. This means for the Bacteroides and 
members of other phyla, the requirement to encode many different metabolic loci that equip 
them to sense and respond to a variety of endogenous host-, dietary-, and bacteria-derived 
carbohydrate nutrients. Here, I focus mainly on the Bacteroides, describing recent advances in 
understanding polysaccharide utilization loci (PULs), the mechanisms of the multi-protein 
systems they encode, regulation, and expanding substrate diversity. I also briefly describe 
important studies involving marine Bacteroidetes, as some of the PULs found in these organisms 
have been naturally transferred to gut-dwelling Bacteroides. We highlight that previously under-
considered substrates such as monosaccharides and Maillard reaction products can also affect the 
gut microbiota. Since many invading pathogens preferentially utilize these nutrients, they may 





recent work on other important gut species and the strategies they employ to access nutrients in 
the gut. Finally, given constantly expanding examples of the importance of the gut microbiota to 
human health and disease, we showcase advances in the field of synthetic biology, engineering, 
and manipulation of key members of the gut microbiota. The tools and strategies reviewed here 
may one day help to construct synthetic, altered microbiota-based therapeutics for the promise of 
engineering the microbiome to modulate host health during infection and disease.   
  The importance of the gut microbiome of humans and animals has been realized in some 
capacity for several decades. New associations between disease states and microbiome 
alterations, which are most often characterized by changes in the abundance of certain microbes, 
are constantly emerging. While microbial abundance changes are not necessarily causal to 
disease, studies describing functional and mechanistic relationships are becoming increasingly 
more frequent26,44,53,61. A key theme underlying the persistence of many gut bacteria is their 
ability to utilize carbohydrate-based nutrients, with much of the focus to date on the prominent 
Bacteroidetes phylum and their ability to assimilate carbon from polysaccharides that often 
contain numerous covalently linked sugars and are complex in structure and linkage. This ability 
in Bacteroidetes is accomplished via the concerted actions of proteins encoded in Polysaccharide 
Utilization Loci (PULs). Previous studies have highlighted the broad abilities of bacteria in this 
phylum to catabolize diverse classes of polysaccharides from host mucosal glycans, dietary 
fibers, other microbes (capsules and exopolysaccharides), fungi and less traditionally consumed 
sources such as algal polysaccharides obtained from eating seaweed75-82. The ability of gut 
bacteria to utilize complex carbohydrates has been reviewed several times2,3,83. However, a 
number of recent studies have expanded the known repertoire of polysaccharides and other 
nutrients, such as simpler carbohydrates, that are targeted by gut bacteria and the enzymatic 
mechanisms responsible for their breakdown. Some of these, such as the effects of uncommon 
nutrients derived from Maillard reaction products or the ingestion of food preservatives may 
have unexpected consequences. While the regulation of individual loci by dedicated 
transcriptional factors has been studied for several systems, additional global regulation 
strategies controlling their prioritized expression in complex nutrient environments and potential 
co-regulation with other nutrient utilization systems have been described. One of the motivations 
for studying these nutrient systems is the possibility of engineering novel functions into bacteria 





livestock. Here we review recent findings of the mechanism and regulation of gut bacterial 
nutrient degradation capabilities, with a focus on newly identified substrates that Gram-positive 
and Gram-negative bacteria have adapted to forage and some emerging aspects of their cellular 
regulation. We approach this review with the idea that complex carbohydrates are of ubiquitous 
importance in shaping the ecology and physiology of gut microbes and, therefore, are a 
convenient lever to intentionally manipulate these communities.   
 
Mechanisms of Polysaccharide Utilization of Human Gut Microbes  
  Within the human gut microbiota (HGM), members of the Gram-negative Bacteroidetes 
phylum compose a substantial portion of all bacteria present, while members of the Bacteroides 
genus frequently make up the majority of this phylum84. As such, major work has concentrated 
on understanding the metabolic abilities of the Bacteroides who devote large portions of the 
genome to polysaccharide catabolism, a feat that is accomplished through regulated expression 
of PULs85. These gene clusters usually encode all of the functions required to sense, import, and 
degrade polysaccharide substrates or their products. These mechanisms can often be categorized 
as “selfish, sharing, or scavenging” depending on how much of the target substrate is primarily 
degraded by the producing bacterium or released for other bacteria to utilize (Figure 1.2). The 
first described system, the Starch Utilization System (Sus) has served as an archetype for 
characterizing and discovering new PULs86. The original definition of a PUL required at least 
one set of homologs of outer membrane (OM) TonB-dependent transporter (TBDT), susC, and 
OM glycan-binding protein, susD87. PULs also typically encode two—often many more—
Carbohydrate Active Enzymes (CAZymes)88, and additional carbohydrate binding proteins, 
regulators, and other enzymes (kinases, proteases, sulfatases and transporters)89,90. Degenerate or 
incomplete PULs also clearly exist, challenging the original definition to some degree.  
While I do not provide an in-depth description or catalog of specific PULs, which have already 
been reviewed2,83,91, recent studies on substrates and the bacterial mechanisms of glycan 
degradation are primarily considered. As an example, the well-studied B. thetaiotaomicron (Bt) 
Sus locus described over 30 years ago92, continues to provide new insight into the function of 
PUL-encoded proteins with recent mechanistic characterization of the role of the accessory 
binding protein SusE, which has distinct function compared to homologous SusF93. In vitro live-





with SusE being stationary94, while the hydrolytic enzyme, SusG, moves dynamically and 
rapidly around the length of the bacterium95. These studies provide important understanding into 
the assembly of PUL-encoded machinery on the cell surface and have further served as a 
reference for xyloglucan and cereal-derived beta-glucan degradation by related gut 
Bacteroides96,97. Previously known substrates that Bacteroides PULs target range from dietary 
plant-polysaccharides98-103 to host-derived polysaccharides such as the O-linked glycans attached 
to mucus and the N-linked glycans and glycosaminoglycans attached to other host proteins and 
glycoconjugates77,85,104-106. Expression of some of these PULs has been shown to cause colitis in 
a sulfatase-dependent manner8,26,107. Still other PULS have been shown to target human milk 
oligosaccharides, often overlapping with those that target similar structured O-glycans108. Other 
Figure 1.2 Selfish, Sharing, Scavenging: Different means to an end for carbohydrate utilization. 
Schematic highlighting several of the major mechanisms of carbohydrate utilization for prominent gut bacteria from the 
Gram-negative Bacteroidetes and Proteobacteria, and the Gram-positive Ruminococcus. In the left panel the Bacteroides 
PUL-encoded Sus-like systems are depicted (objects in figure: purple barrel is SusC-like outer membrane (OM) transporter, 
orange is SusD-like OM binding protein, enzymes are shown as Pacman-like ovals, green ovals are sulfatases, blue ovals 
are glycoside hydrolases. Bacteroides use several mechanisms to access nutrients including sharing, where one strain 
partially degrades a polysaccharide substrate and a related species can import and catabolize leftover, liberated 
oligosaccharides. Further, selfish mechanisms where the bacterium imports the entire substrate and breaks it down in the 
periplasm and cytoplasm. Lastly, Bacteroides produce outer membrane vesicles that target both host and fiber-derived 
glycans which can be both selfish and sharing in the mechanism of attack (lower, left panel). Although all of the bacteria 
shown can use a scavenging mechanism, whereby they import small mono- or disaccharides, the proteobacteria rely mainly 
on this method of obtaining nutrients and is shown in the middle panel with ABC transporters shown in blue. In the cytoplasm 
of the cell, common proteins such as kinases and isomerases are shown in black and yellow. In the lower section, a stealing 
or pirating mechanism is shown that was recently described in E. coli via a type III secretion system/injectisome where the 
bacterium delivers effector proteins or toxins into host cells, forcing nutrients into an adjacent tube that shuttles 
carbohydrates or amino acids back to the bacterium. In the right panel, a complex, multi-modular and sometimes 
extracellular complex produced by Gram-positive Ruminococcus and other related Gram-positive bacteria is shown. The 
cellulosome is composed of cohesins and dockerins which form the backbone of the complex and then each dockerin can pair 
with specific enzymes or carbohydrate-binding proteins that work in concert to degrade polysaccharides such as cellulose 
and hemicelluloses that are largely insoluble fibers found in the human gut, and these cleaved sugars are then imported 
through ABC transporters. In each panel, the small shapes depict the official glycobiology symbols for invidual 
monosaccharides (green circle, mannose; yellow, galactose; blue square, N-acetlyglucosamine; green star, xylose; green 
triangle, rhamnose; yellow and white diamond, Galacturonic acid; blue and white diamond, Glucuronic acid; red triangle, 






PUL-encoded abilities involve degradation of bacterial exopolysaccharides80, 109, the α-mannans 
of yeast75, and β-glucan of fungal cell walls76. This plethora continues to expand, with a recent 
study describing Bt degradation of the most complex dietary polysaccharide rhamnogalacturonan 
II79 through the action of three separate PULs encoding 26 different enzymes. Similar studies on 
the less complex pectin rhamnogalacturonan I and related galacturonic acid-containing pectins 
and pectic side chains in Bt and B. ovatus have demonstrated a cross-feeding degradation 
pathway between the two organisms and mapped the specific PULs and functions required for 
pectin catabolism65. Similar to these studies are those investigating the ability of Bt to breakdown 
complex host N-glycans such as high mannose N-glycans110 that decorate host glycoproteins, 
including those of mucosal immunoglobulin A, through degradation orchestrated by several, 
non-adjacent PULs110. Interestingly, Bacteroides hydrolytic enzymes are sometimes 
preferentially (almost entirely) packaged into outer membrane vesicles (OMVs), which could 
play important biological roles for these bacteria111. For example, the liberated glycans released 
by the OMVs of some species can serve as nutrients for the bacterium that produced the OMVs 
and as a communal resource among some but not all Bacteroides. (Figure 1.2)112.  
 
Marine Bacteroidetes use similar PUL-encoded mechanisms to utilize polysaccharides and 
may transfer these abilities to human gut Bacteroides 
  Beyond the degradative abilities directed towards plant- and host-derived 
polysaccharides, studies into seaweed-derived polysaccharides have shown some human gut 
Bacteroides have the ability to degrade seaweed-derived polysaccharides like porphyran, agarose 
and alginate81,82,113-116. In at least some cases, these abilities were transferred into gut Bacteroides 
from marine Bacteroidetes through the action of integrative chromosomal elements, and this 
ability is transferrable and can modulate gut composition117. The PULs found in marine 
Bacteroidetes often encode a larger gene content and an expanded repertoire of enzymatic 
functions than those present in gut Bacteroides and contain additional genes coding for adhesin 
proteins to help the producing bacterium remain anchored to the nutrient source118. This vast 
enzyme repertoire is likely due to the composition of the available substrates in the form of algal 
polysaccharides derived from cell walls of red, green, and brown algae as well as those from 
cyanobacteria and potential EPS structures that they produce119-121. The importance of encoding 





some of the most highly expressed products in the microbial ecosystem122,123, likely allowing for 
competitive advantages for strains able to utilize complex algae polysaccharides124,125. These 
blooms, along with metagenomics and predictive phenotyping by glycan arrays can be used to 
measure bacterial phyla present and to what extent they degrade diverse polysaccharides118,126,127. 
Beyond in silico modeling, detailed degradation capabilities for the algae polysaccharides 
laminarin128,129, alginate130, agarose131,132, ulvan133,134, and carrageenan135,136 have been 
described. Similarly, to human gut Bacteroides, marine Bacteroidetes also utilize α- and β-
mannans137. Like gut Bacteroidetes, the ways in which these marine bacteria utilize 
polysaccharides can also be characterized as selfish, sharing, or scavenging and may derived 
from the same substrate sequestration mechanisms (or lack thereof) (Figure 1.2)75,138,139.  Recent 
in-depth studies have highlighted the complex nature of PULs in marine bacteria. The genes 
responsible for utilization of ulvan, a highly-sulfated polysaccharide with a backbone of 
repeating rhamnose, xylose, glucuronic acid, and iduronic acid with sidechains consisting of 
rhamnose or glucuronic acid, have been described in Formosa agariphila, and requires 39 PUL-
encoded and 20 non-PUL encoded genes140. Additionally, the genes required for ulvan utilization 
are contained on a large plasmid in the gammaproteobacterial species, Alteromonas sp. 76-1, 
suggesting this locus may be transferrable141. Further, the largest PUL described to date is found 
in Paraglaciecola hydrolytica S66T, for the degradation of furcellaran, (a mixture of ĸ- and β-
carrageenan’s and agarose) and contained in a 167kb genomic region encoding 116 genes136.  
 
Gram-positive bacteria utilize polysaccharides via alternative multi-protein systems 
  In contrast to the Gram-negative, TonB-dependent transporter-dominated systems, 
polysaccharide degradation in the prominent Gram-positive Firmicutes phylum is built around 
different machinery and mechanistic studies are also beginning to emerge142-147. Similar to the 
mechanisms described above for marine Gammaproteobacteria, variant examples of multi-
protein-encoding genomic loci have been described in Gram-positive species, and termed Gram-
positive PULs (gpPULs)144.  These gpPULs lack homologs of the TonB-dependent transporter 
susC and binding protein susD, due to the lack of an OM, and instead rely on ABC-transporter 
dominated systems coupled with diverse hydrolytic enzymes and binding proteins133. Recently, a 
large gpPUL was characterized in the butyrate producer Roseburia intestinalis that assimilates 





(Figure 1.2). These multienzyme, modular complexes often target cellulose or plant-derived 
structures such as xylans and lignocellulose for degradation128. Additionally, recent work has 
shown that cellulosome-like structures, termed amylosomes, utilize a similar framework of 
proteins containing cohesin and dockerin domains to assemble the resistant-starch cleaving 
enzymes of Ruminococcus bromii, a keystone species of the rumen and HGM129-131. It is likely 
that strategies employed by Gram-positive members of the HGM will become clearer, and 
possibly new mechanisms added, as additional studies are undertaken in this very diverse 
phylum.  
 
Monosaccharides and other overlooked nutrients   
  While it is clear that gut Bacteroidetes, Firmicutes and other phyla are readily equipped 
to degrade complex host and dietary polysaccharides, the digestive fate and importance of 
monosaccharides have been less studied. Perhaps this negligence is due to a common thought 
that monosaccharides do not affect the microbiota due to host absorption in the small intestine, 
such that the microbiota does not access these in large quantities. However, it is increasingly 
clear that either from the cleavage of larger polysaccharides or from the diet directly, that 
monosaccharides can affect the composition and physiology of the gut microbiota. For instance, 
within the human gut, some of the initially investigated nutrient niches were those delineated by 
mono- and disaccharides148. Many studies have focused on the ability of invading pathogenic 
bacteria that preferentially utilize monosaccharides during infection. For instance, both 
enterohemorrhagic E. coli (EHEC) and Salmonella strains upregulate genes for the utilization of 
ribose and other sugars during infection of cows, chickens, and mice149-151 and EHEC displays 
preference for this sugar and several other available monosaccharides152. However, genes and 
mechanisms for the assimilation of ribose have been reported in non-pathogenic bacteria such as 
Bifidobacterium breve UCC200 and Lactobacillus sakei153,154. Further, related compounds such 
as deoxyribose and DNA can be utilized during pathogenic invasion by E. coli155,156.  
Additionally, the monosaccharides fucose and sialic acid are used by pathogens such as 
Clostridium difficile and Salmonella typhimurium by profiting off of the activity of gut 
commensals like Bt, which release these sugars with specific enzymes during breakdown of host-
derived mucosal polysaccharides157. Often these systems include a kinase, sugar import protein 





aldolases or isomerase, which are generally less complex than PUL-encoded mechanisms of the 
Gram-negative Bacteroides (Figure 1.2). However, in Bt there are at least two PULs that encode 
functions required for the utilization of monosaccharides along with the polysaccharides they are 
contained in. These include a system for 2,6-linked fructan utilization, which in addition to the 
fructose-containing polysaccharide levan, is also required for the utilization of fructose through 
actions of the PUL-encoded fructokinase and fructose permease99. Similarly, Bt encodes a PUL 
for the catabolism of ribose, nucleosides, and RNA (Chapter II). Interestingly, this ribose PUL is 
found throughout the phylum in many different genomic architectures, suggesting that individual 
species have evolved to access ribose from diverse sources. Additionally, Bt also catabolizes the 
monosaccharides L-fucose, L-rhamnose, and arabinose through loci that look similar to those 
found in Proteobacteria, encoding a sugar-specific kinase and dedicated transport machinery, 
with the exception that they all contain either novel regulatory protein or unique genetic 
arrangements158-160. This perhaps suggests that the fructan and ribose PUL have evolved from 
more common sugar utilization clusters, and that future studies may uncover PULs responsible 
for the catabolism of arabinose or rhamnose for instance, based on the acquisition of sus-like 
genes built around these core sugar assimilation systems. Lastly, emerging studies focusing on 
amino acids have demonstrated that these nutrients remodel the gut community composition and 
are important substrates for invading pathogens. For example, enteropathogenic E. coli (EPEC) 
employs a Type 3 secretion system (T3SS) injectisome to steal or “pirate” amino acids from host 
cells to gain an advantage over commensal bacteria161 (Figure 1.2). Similarly, dietary L-serine in 
an inflamed intestine provides Enterobactericea a competitive edge162. It is clear from these 
studies that both gut pathogens and commensals have found niches by catabolizing 
monosaccharides.  
 
To cook or not to cook, let’s ask the microbiota: cooking, food preservation, and ultra-
refined foods alter the gut microbiota 
  Produced through cooking and overlooked until recently, advanced glycation end-
products (AGEs) and Mailliard reaction products (MRPs) can also perturb the gut microbiota by 
feeding certain species163,164. MRPs are formed through the heat-induced crosslinking of 





bacteria with the right tools. For instance, the MRP of fructose-asparagine is metabolized almost 
exclusively by Salmonella enterica, which excludes other members of the microbiota by using 
high affinity systems for import of this nutrient165. This ability is not confined to pathogenic 
bacteria, as a recent study revealed that commensal Collinsella intestinalis and Collinsella 
aerofaciens are able to utilize the MRP, fructoselysine in vivo, via actions of a 
phosphotransferase system. Additionally, the AGE, N-ε-carboxymethyllysine is degraded by yet 
uncultured members of the gut microbiota166. These three studies along with others examining 
the effects of MRPs and AGEs on the microbiota indicate that this area requires further study as 
microbiota composition can be affected by these nutrients and in-turn aspects of host health. 
Lastly, MRPs and AGEs are not the only substances generated or modified by actions of 
cooking. Resistant starch (RS) is categorized into types: raw or uncooked, cooked starch that has 
been cooled and retrograded, chemical modification, or physically inaccessible167. Each of these 
types is accessible to varying degrees by gut microbes such as Ruminococcus bromii, while 
cooking RS yields soluble starch accessible to many gut bacterial species168.  In light of these 
studies of MRPs, AGEs, and resistant starch, the need to recognize the importance of these 
compounds as well as other compounds such as food emulsfiers169, artificial sweeteners170, and 
inadvertently consumed plastic-byproducts171 is clear due to the capacity to alter the gut 
microbiota. These substances, although perhaps not commonly considered as nutrients could be 
targeted for degradation and catabolized as nutrients through actions of gut bacteria.   
 
The central bank, how Bacteroides regulate their carbohydrate metabolism 
  With their plethora of carbohydrate degrading systems, Bacteroides require a finely-
tuned series of local and global regulatory networks to optimally detect when specific nutrients 
are available and manage responses from multiple nutrient utilization systems that are activated 
in parallel so that they can optimize energy expenditure while also staying primed for the next 
meal. Previous studies and reviews have focused on this topic172-174; however, new studies 
examining the phenomenon of Bacteroides nutrient prioritization in complex mixtures (nutrient 
hierarchies) and global regulation mechanisms warrant discussion. Within the Bacteroides there 
is a clear nutrient utilization hierarchy during growth in a complex mixture of polysaccharides, 
the PUL-encoded machinery is transcriptionally upregulated in a specific order, similar to carbon 





species and can be slightly different between Bacteroides species175. This indicates that the co-
existence of many strains could be aided by this differential hierarchy of polysaccharide 
utilization.  
  One mechanism that is implicated in the ability of Bacteroides to rapidly switch between 
targeting different polysaccharides is the relatively restricted, but not absolute, transcriptional 
control such that PULs are highly expressed only when their cognate substrate is detected. For 
instance, within Bt there is a sensory state of low-level transcript production and protein 
translation of PUL machinery for the starch utilization system (Sus) and other systems. This can 
be seen through immunofluorescent imaging of the outer-membrane Sus proteins in the presence 
of glucose, but absence of the cognate signaling molecule, maltose176. Upon exposure to starch 
or maltose, the sus PUL is activated and the outer membrane of the cell is flooded with Sus 
proteins. The regulatory protein within the sus PUL is SusR, a transcriptional activator, and is 
one of three recognized broad classes of regulatory proteins in Bacteroides. SusR-type regulators 
are thought to mainly affect glucose polysaccharides (although approximately 1/3 of these are 
unknown)177. The second type, ECF-σ/anti-σ pairs are seen primarily in systems responsible for 
the breakdown of host-derived mucin polysaccharides, these regulators function similar to other 
described sigma factor pairs77. Lastly, Bacteroides uniquely combine the normal two-component 
regulatory system domain of sensor and DNA-binding activator into a single protein termed a 
hybrid two-component system (HTCS), and these are found primarily in PULs involved in 
degrading fiber polysaccharides, although several are found in PULs associated with host mucin 
degradation99 (Figure 1.3).  
  The local, positive acting feedback loops described above are PUL-encoded regulatory 
mechanisms and are on the front lines of regulation, interacting directly with cognate substrates. 
However, this is not the only level of regulation that is required to establish more complex, 
nutrient hierarchies which require some form of catabolite repression. Recently, antisense small-
RNAs (sRNAs) have been described within B. fragilis and Bt found directly upstream of PULs 
involved in catabolism of both N- and O-linked mucus-derived polysaccharides in PULs 
regulated by ECF-σ/anti-σ pairs, suggesting that this sRNA is substrate restricted primarily to 
host glycans178. These sRNAs repress the transcription of the PULs leading to less breakdown 
and catabolism of host-derived polysaccharides, likely for more favored metabolism of dietary 





uncovered in two separate studies trying to determine if Bacteroides utilize a mechanism similar 
to catabolite repressor protein (CRP) in E. coli. One such homolog within Bt was found to be 
encoded by BT4338 which was previously named MalR (maltose regulator) for its requirement 
 
Figure 1.3 Known regulatory control mechanisms in Bacteroides. 
Diagram of common regulatory mechanisms based on the types of substrates that the systems sense and degrade. At the bottom of 
the figure, a generic schematic of a polysaccharide utilization loci (PUL) is shown in the cytoplasm displaying the susC/D-like 
genes that denote PULs, a generic upstream regulatory gene, a carbohydrate active enzyme (CAZyme), and accessory genes, green 
boxes. Also shown in the cytoplasm for all three panels: SusC- and SusD-like proteins in the outer membrane as they are required 
for import and binding/stabilization of the complex regardless of the type or origin of the polysaccharide. Also shown, is the TonB-
dependent energization mechanism, thought to be required for transportation through SusC-like proteins.  Additional regulators 
known to operate in Bt are shown in the cytoplasm including, a CRP-like protein and a blue boxed area calling attention to 
regulators responsible for monosaccharide catabolism that do not fall in the three types shown in the panels. Also, in the cytoplasm, 
small RNAs and post-translational modifications such as acetylation or elongation termination are shown. The left panel shows 
ECF-σ/anti-σ factor based regulators which are mainly found in PULs responsible for host-polysaccharide breakdown. These types 
of systems have the anti-σ spanning the inner membrane (IM) and periplasmic space, while keeping the soluble, activating ECF-σ 
factor bound until an inducer is sensed in the periplasmic space, when it is then released and can help in recruiting RNA pol for 
transcript initiation. Additionally, several genomically unlinked, orphaned ECF-σ factors without adjacent encoded anti-σ factors 
are present within Bt and related Bacteroides genomes, suggesting an unknown role for these regulators. Also, one hybrid two-
component system (HTCS) regulator, BT3172 (also known as the regulatory of colonization, Roc) is shown. This is one of the only 
known HTCS found in a host-responsive PUL and affects persistence in the gut in a diet-dependent manner. Mainly HTCS 
regulators are associated with fiber-responsive PULs (middle panel). Unlike classical two-component systems composed of two 
separate response regulator and histidine kinase-encoding genes, these functions have been fused into one, multi-domain 
containing protein. In the right panel, the SusR family of regulatory proteins is shown. Normally these regulators are in PULs 
targeting glucose-based polysaccharides for degradation. The mechanism of signal transduction is unknown for this family of 
regulators, but in the Bt starch system, the inducing molecule is maltose, which when sensed by SusR causes a large transcriptional 





in maltose catabolism in the absence of SusR179. In a more recent study, the authors found that a 
deletion strain lacking BT4338 either lost or had diminished growth on several substrates, many 
of which were monosaccharides, rather than polysaccharides180. It is possible then that BT4338 
acts at the level of the monosaccharide utilization, whereby PULs are still upregulated, but 
metabolism genes required for growth on these substrates are not functionally expressed. Further, 
a recent study demonstrated that BT3172, a PUL-associated HTCS that is likely responsible for 
upregulating the adjacent PUL genes BT3173-3180 in response to mucosal glycans is highly 
repressed at the post-transcriptional level by glucose and a few other monosaccharides. This is 
interesting, as it suggests that the dietary monosaccharides fructose and glucose affect the 
activity of Roc, preventing it from upregulating the adjacent genes, which are clearly important 
in vivo while Roc (“regulator of colonization”) is not required for catabolism of these 
monosaccharides. Further, the suppressive effect of glucose/fructose was localized to an 
upstream mRNA leader sequence, that when deleted, alleviated Roc repression from glucose or 
fructose. Taken together, these studies into the regulatory networks underpinning carbohydrate 
metabolism in Bt show that there is still much to discovery in this field (and model organism). 
These studies also provide insight into the hierarchical or global regulation that has many 
different layers (Figure 1.3). Lastly, I want to highlight that within Bt’s genome there are at least 
20 separate ECF-σ factors that are “orphans” throughout the genome, meaning that they are not 
apparently adjacent to known PUL genes181. It is possible that these orphan regulators function in 
the assimilation of non-carbohydrate nutrients such as cofactors, amino acids, vitamins, or in a 
manner previously unknown for PUL-encoded functions. Uncovering the function(s) of these 
regulators will likely add important knowledge to the overall understanding of the regulatory 
mechanisms within Bacteroides species.   
 
Synthetic engineering of gut bacteria and generation of synthetic communities 
  With the above mentioned examples, it should come as no surprise that strides in the area 
of synthetic biology and engineering of the HGM have been made in the past several years. One 
impetus for this renewed interest in generating genetic toolkits has been the realization that the 
majority of species and isolates within the gut microbiota are genetically intractable. Although 
new genetic tools have been generated for some strains, many of the prominent members of 





discuss how systems developed for use elsewhere in non-HGM isolates may be relevant to the 
HGM. Although proteobacteria are often less prominent or more transient members of the gut 
microbiota, they are still commonly found182,183 and several important pathogens such as E. coli, 
V. cholera, S. enterica and others have numerous genetic tools. However, even within this 
phylum, new tools have been developed with broad-host range to target strains inhabiting the bee 
gut microbiome that can be used in Alpha-, Beta-, and Gammaproteobacteria184. It is 
conceivable that these tools could also be used in proteobacteria of the HGM. In sticking with 
proteobacteria, an elegant example of synthetic biology that used 12-independent, inducible 
sensors in a single strain of E. coli185, demonstrated some of the types of tools required for HGM 
isolates to assay aspects of bacteria-host interactions. These techniques will allow for 
identification of genes coding for important, direct effectors of disease such as the proteins 
required for host polysaccharide degradation.  
For strains that are not tractable, an interesting and useful technique being used to isolate and 
transfer DNA is metaparental mating186. However, this strategy is limited to strains that are not 
multi-antibiotic resistant, and is more often used to identify genetically manipulatable strains 
rather than to transfer or edit DNA for experimental or engineering purposes. Antibiotic 
resistance is a common reason why strains are hard to genetically manipulate and is likely to 
only get worse as strains become multi- and pan-drug resistant187. However, a new set of 
plasmids have been created for a large range of Bacteroidetes isolates188. This new system is 
based off of a Gain-of-Function phenotype for the ability to utilize inulin, a polysaccharide that 
only a small percentage of strains can normally utilize99,188,189. Presumably this strategy can be 
adapted to different substrates for recipient strains already able to grow on inulin. Further, the 
novel counter-selection strategy bypasses the need for antibiotics by using a toxin encoded from 
a T6SS gene in the Bacteroides fragilis genome. Most of the Bacteroides plasmids are 
constructed off of a NBU2 integration plasmid backbone190, that has previously been adapted for 
use in up to 8 different channels of in vivo fluorescence imaging of Bacteroides191, tunable 
expression of genes in vivo192, and ability to respond to endogenous signals and record these 
exposures via a CRISPR-Cas9 system193. Although all of these tools represent a nice toolkit, to 
fully take advantage of engineering strains for health in the HGM, the transfer of PULs, which 
are often several kb in length, require new approaches to transfer functional, intact PULs into 





piece-wise, the components of larger PULs into a bacterial artificial chromosome has been 
described117. Applications of new techniques such as the transfer of entire PULs, allows for 
creative, niche engineering approaches to modulate individual species of the HGM and may one 
day lead to better precision editing of the HGM in disease states. These built niches may also 
guide the formulation of synthetic microbial communities that can be introduced by consumption 
of prebiotics or probiotics or in the event of advanced disease states, fecal microbiota transfer.  
 
Prospectus  
   Given the central importance of complex carbohydrate-based nutrients in the human gut 
and other environments, more in-depth mechanistic studies are needed to understand the 
metabolism of these nutrients. One of the most exciting areas that can guide these studies involve 
the capability of using recombinant or whole cell lysates of Bacteroidetes SusD-like proteins in 
glycan binding arrays in an effort to determine substrate and growth preferences of either 
uncultivated strains or PULs with unknown substrates126. Importantly, within the gut microbiota 
there are likely additional nutrients such as microbial capsular polysaccharides that can serve as 
carbohydrate nutrients. This mechanism could essentially be described as predation of other 
bacteria or their products but it might also be the basis of enforcing species-species interactions. 
This avenue is one that requires much more in-depth study, as it is likely that capsules represent 
a massive nutrient pool in the gut. For example, within individual strains there can be several 
different capsules (Bt encodes 8 separate capsular biosynthesis loci for instance)56 and within the 
umbrella of E. coli there are at least 80 different capsule structures or K antigens194. Relatedly, 
certain exopolysaccharides from Lactobacillus and Bifidobacteria are degraded and used for 
growth by Bt and B. fragilis80,109, and this is yet another possible nutrient source in the gut. I 
therefore speculate based on the diversity of origin, structure, and linkage of substrates 
catabolized by the gut microbiota, that it is highly likely that inhabitants and invaders of the gut 
ecosystem have developed the collective capacity to target many, tens or hundreds of additional, 
unknown nutrients. Lastly, I believe that a significant aspect of future work in the gut microbiota 
and nutrient utilization will be to connect these functions to host health and disease states. In 
order to do that we both need to continue developing synthetic biology and genetic tools and 
increase efforts aimed at mapping phenotype to genotype to better understand niche partitioning 





of interdisciplinary approaches involving enzymology, metabolic modeling, informatics, 
microbial growth and phenotype assays, and the use of omics-based approaches.  
 
Chapter outline 
  The carbohydrate nutrients present in the human gastrointestinal tract often define niches 
based on the degrading or catabolizing abilities of certain species. This phenomenon can often 
influence human health and disease states. Members of the prominent Bacteroidetes have 
evolved and developed the ability to degrade and grow on a broad range of dietary-, host-, 
microbial-, and fungal-derived polysaccharides, monosaccharides, and additional carbohydrate-
containing nutrients. Although significant work has been performed examining the genetic loci 
(polysaccharide utilization loci, PUL) and protein functions (Sus-like systems) that they encode, 
there are still critical details lacking. The cognate substrates for many of these systems as well as 
the regulatory mechanisms used to distinguish and respond to available nutrients are unknown. 
Building on previous knowledge, molecular mechanisms of carbohydrate degradation and 
recognition in the model system Bacteroides thetaiotaomicron (Bt) are explored here. The major 
focus of this dissertation is to elucidate the molecular mechanisms by which a ribose utilization 
system (rus) encoded by a PUL degrades ribose-containing compounds, and the impact this has 
in vivo. Additional work has focused on host-polysaccharide degradation through the 
identification and study of 12 related PULs that work in concert to break down mucin 
polysaccharides (host mucosal-derived). Lastly, global regulatory mechanisms were examined.  
  In Chapter II, I describe the essential in vitro and in vivo functions encoded in the rus 
locus for the catabolism of ribose and nucleosides. Demonstrating, that rus-encoded ribokinases 
perform a previously unidentified (in eubacteria) mechanism of ribose phosphorylation in 
cooperation of an upstream, unlinked nucleoside phosphorylase. This mechanism was found to 
be important in vivo on a high fiber diet containing a nucleoside or nucleoside-like substrate. 
This work also expands the known substrate diversity of PULs to include nucleosides and the 
monosaccharide ribose, as well as demonstrating that ribose utilization is penetrant across the 
phylum in at least 70 different genomic configurations.  
  In Chapter III, I examine a Bt-specific, in vivo T cell clone by confirming the epitope 
recognized by these T cells and identify the exact amino acids recognized. The protein epitope, 





cell stimulation due to reduced transcription of the epitope. Additionally, BT4295 is found in a 
PUL responsive to growth in host mucosal polysaccharides, and additional proteins of this locus 
also served as weaker T cell epitopes. Further, in identifying the epitope, a transposon screen 
implicated functions of the pentose phosphate pathway as serving as potential epitopes.  
  In Chapter IV, I highlight regulatory mechanisms in Bt. This work uncovered a 
previously unknown, potentially global regulator of polysaccharide utilization, BT2492. BT2492 
is one of many orphan ECF-σ factors without functional knowledge. Additionally, 3 LacI family 
transcriptional regulators where investigated. They display regulation towards uronic acids or 
uronic acid-containing polysaccharides. Further, in Chapter II, I observed that ribose altered the 
expression of other PULs and metabolic loci, this was followed up with experiments in arabinose 
and xylose, yielding similar results and suggesting this cross-metabolism phenomenon may be an 
additional layer of regulation in Bt. Interestingly, one of the PULs identified during arabinose 
growth was the one containing the epitope, BT4295 from Chapter III, providing a potential 
reason why pentose phosphate metabolism genes were found during that study.  
  Finally, in Chapter V, I expand upon previous work examining host mucosal 
polysaccharide utilization via PUL-encoded mechanisms. Within this chapter is the 
characterization of a complex genetic deletion in Bt, lacking 11 different PULs associated with 
host polysaccharide degradation. This study revealed some of the PULs and genes required for 
mucosal polysaccharide utilization including sulfatases and fucosidases which have proved 
valuable in guiding additional in vivo studies in attempts to decrease colitogenic responses of Bt 
in fiber free dietary conditions.  
 
Notes 
  Portions of this chapter have been adapted from review articles in preparation with 
permission from Glowacki, R.W. and Martens, E.C. The first half of this chapter is from an 
invited, “Pearls” mini-review for PloS Pathogens, with a working title of “In sickness and health: 
effects of gut microbial metabolites on human physiology”. The second half of this chapter is 
being prepared for an invited review to Journal of Bacteriology. 
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A Genetically Adaptable Strategy for Ribose and Nucleoside Scavenging in a Human Gut 
Symbiont Plays A Diet-Dependent Role in Colon Colonization  
 
Abstract 
  Efficient nutrient acquisition in the competitive human gut is essential for microbial 
persistence. While polysaccharides have been well-studied nutrients for the gut microbiome, 
other resources such as nucleic acids and nucleosides are less studied. We describe a series of 
ribose utilization systems (RUSs) that are broadly represented in Bacteroidetes and appear to 
have diversified to allow access to ribose from a variety of substrates. One Bacteroides 
thetaiotaomicron RUS variant is critical for competitive gut colonization in a diet-specific 
fashion. We used molecular genetics to probe the required functions and nature of the nutrient 
source(s) underlying this phenotype. Two RUS-encoded ribokinases were the only components 
required for this effect, presumably because they generate ribose-phosphate derivatives from 
products of an unlinked, but essential nucleoside phosphorylase. Our results underscore the 
extensive mechanisms that gut symbionts have evolved to access nutrients and the potential for 
unexpected dependencies between systems that mediate colonization and persistence.   
 
Introduction  
  Symbiotic microorganisms that inhabit the human intestine complement digestive 
capacity in numerous ways, with the most mechanistically understood examples involving 
degradation of diverse dietary polysaccharides1. In contrast, the digestive fates of nucleic acids 
(from diet, host or microbial origin) and their component ribo- and deoxyribonucleosides are less 
understood, as are their contributions to gut microbiota community structure and physiology. 
Mutualistic Lactobacillus2 and Bifidobacterium3 as well as pathogenic and non-pathogenic 
Escherichia coli4 and Salmonella enterica5 have characterized ribose degrading systems. 
Additional systems containing nucleoside-cleaving enzymes have been defined in E. coli and 





the action of competence genes and exonucleases8,9. Mechanisms for assimilating exogenous 
RNA have not been explored.  
  Members of the phylum Bacteroidetes constitute a major portion of bacteria in the human 
gut, with individual species devoting large portions of their genomes towards carbohydrate 
utilization via coordinately regulated polysaccharide utilization loci (PULs). A number of these 
PULs targeting dietary polysaccharides from plant cell walls or fermented foods have been 
thoroughly characterized10-14. Other characterized PULs degrade infrequent dietary substrates 
such as agarose and porphyran in edible seaweed15,16 or host-derived glycans such as those in 
mucus17,18. Despite variations in the substrates they target, the cellular “Sus-like systems” 
encoded by Bacteroidetes PULs are similarly patterned—each containing one or more TonB-
dependent receptors (SusC homologs) and corresponding substrate binding lipoproteins (SusD 
homologs). These two proteins form a complex19 and work in concert with a variable repertoire 
of carbohydrate-degrading enzymes, substrate binding proteins and regulators to bind, degrade 
and import substrates. Despite these studies, many identified PULs within genomes of gut and 
environmental Bacteroidetes lack existing knowledge of their target substrates20, suggesting that 
they have evolved to target a broader range of nutrients beyond the common plant and host 
polysaccharides that have been evaluated21,22. 
  Here we describe a ribose-responsive PUL in the human gut symbiont Bacteroides 
thetaiotaomicron (Bt). Variants of this PUL exist in a diverse range of human gut and 
environmental Bacteroidetes, but based on enzymatic diversity have likely evolved to target a 
variety of different ribose-containing nutrients. Using Bt as a model, we investigated the 
functions of this PUL in vivo in multiple diet conditions and in vitro in defined media. We show 
that this PUL is essential for utilization of ribose through the activity of two ribokinases, 
enzymes that catalyze formation of ribose-5-phosphate from ribose or ribose-1,5-bisphosphate 
from the product of a genomically unlinked nucleoside phosphorylase that is required for growth 
on nucleosides. The ability to catabolize ribose through PUL-encoded functions and the unlinked 
nucleoside phosphorylase confers a strong, diet-specific competitive advantage to Bt in vivo. 
This suggests a model in which a diet-specific nucleoside-scavenging pathway has become 
dependent on cellular ribokinases, which are critical for creating phosphorylated ribose 
intermediates and are persistently activated in the gut by an unknown signal. Our results reveal 





ribose and nucleosides that are important for colonization. The common regulation of a family of 
highly diversified PULs by ribose, which occurs in nucleic acids, co-factors, modifications 
(ADP- and poly-ADP-ribose), bacteriocins, and bacterial capsules, suggests that these systems 
have adapted at the level of encoded enzymes to release ribose from varied sources, diversifying 
the nutrient niches available to these bacteria. However, the results of our in vivo studies 
highlight that underlying mechanisms for observed colonization advantages are context specific 




A ribose-inducible gene cluster is highly active in vivo and required for fitness in a diet-
dependent fashion 
  Members of the human gut Bacteroidetes typically encode coordinated degradative 
functions within discrete polysaccharide utilization loci (PULs), facilitating identification of 
components that work together to access particular nutrients23. Previous work using gnotobiotic 
mice colonized with only B. thetaiotaomicron (Bt) identified one such locus (BT2803-2809) for 
which all individual genes are upregulated between 10- and 139-fold in mice fed high or low 
fiber diets (Figure 2.1A). During low fiber, Bt’s physiology shifts to expression of genes 
involved in host glycan foraging17,24,25. Thus, expression of BT2803-09 in the absence of dietary 
fiber suggested that it may also target endogenous nutrients.  
  Typically, PULs involved in host glycan foraging encode enzymes required for liberating 
sugars from mucins and other glycoconjugates (fucosidases, sulfatases, etc.), but the content of 
the BT2803-09 PUL was different in several ways (Figure 2.1B). Three predicted enzymes (one 
nucleoside hydrolase, two ribokinases) suggested a role in assimilating ribose from substrate(s) 
such as nucleosides. A previous study determined that Bt grows on ribose21, but the genes 
involved, relevant source(s) of ribose, and whether enzymatic liberation is required from 
complex substrates were not explored. The immediate upstream gene (BT2802) is predicted to 
have DNA-binding motifs and may act as a regulator, but shares no homology to regulators 
previously associated with PULs. In addition to the enzymes noted above, other PUL genes 
encode homologs of the Bacteroides SusC and SusD outer-membrane proteins (BT2805, 






Figure 2.1 Bt upregulates a PUL for ribose metabolism in vivo and in vitro in response to ribose. 
(A) In vivo Genechip data showing fold-change relative to in vitro growth MM, plus glucose for BT2803-09 in mice fed high fiber 
(dark and light green bars) or low fiber diets, including pre-weaned, suckling mice (red and purple bars, respectively). (B) 
Organization of the rus locus with locus tag numbers, names and predicted functions. (C) In vitro transcriptional response of Bt 
rus genes in MM-ribose compared to MM-glucose reference (n=3, error bars are SD of the mean). (D) Growth in MM-ribose (5 
mg/ml) for wild-type Bt (black) or a strain lacking rus (red) (minimum of n=5 separate replicates). 
 
nucleoside hydrolase (BT2808), and a sugar permease (BT2809).  
  The enzymes encoded in this PUL suggested the hypothesis that it is responsible for Bt’s 
ability to catabolize ribose and possibly liberate it from more complex sources such as 
nucleosides. To test if this gene cluster is transcriptionally responsive to growth on ribose, we 
performed in vitro growth in minimal-medium (MM) containing ribose as the sole carbon source 
and measured expression of BT2803-09. All genes were activated 142-240 fold by ribose 
compared to a MM-glucose reference (Figure 2.1C). Other mono- and disaccharides did not 
activate this PUL as sole carbon sources (Figure 2.2A). We next examined the requirement for 
this locus by deleting BT2802-09. Loss of the PUL eliminated growth on free ribose (Figure 
2.1D) but did not affect growth on non-ribose substrates (Table 2.1, shown in Methods). Based 
on these findings, we classified this PUL as the Bt ribose utilization system, rus, with gene  





Figure 2.2 In vitro rus activation specificity and supplemental in vivo competitions. 
Data is related to Figures 2.1 and 2.3 demonstrating the in vitro activation specificity of the rus locus and further in vivo 
competition or monocolonization experiments. (A) rusC (BT2805) expression during mid-log phase growth in MM containing a 
sole carbon source from either mono-, di-, or trisaccharide’s compared to growth on MM-glucose, the dashed orange line 
represents a 2-fold upregulation, while the dotted black line is a 5-fold upregulation, error bars represent the SD of n=3 replicates. 
(B-F), in vivo competitions all performed in germfree Swiss Webster mice and fed a fiber rich (FR) diet. Relative abundance was 
enumerated by qRT-PCR of unique chromosomally encoded barcodes for wild type (black line) vs. Δrus strain (red line) in FR diet 
in (B) 12 week old female mice or (C) 6-8 week old male mice. (D) 6-8 week old female mice mono-associated with either wild-





samples to obtain CFU/g feces. Error bars show SEM of the biological average of n=3 mice. (E) As in (D), but enumerating 
absolute cecal abundance in mono-associated mice. (F) Wild type rus expression from cecal contents from experiments in Fig. 2A-
B and Fig. S2A-B, with SEM of each sample. P-values were calculated for B-F by Student’s t test, specifically in B-E,  the relative 
abundance of each strain is tested with an (*) indicates a statistically significant difference of (P<0.05), while (**) represents 
(P<0.01), and (***) indicates (P<0.001) and (****) is used to express (P<0.0001) or no significant (ns). In (F) the values used 
for t test compare all other samples to rus expression in 6-8 week old females on FR diet shown as lines above the bars.  
Based on these findings, we classified this PUL as the Bt ribose utilization system, rus, with gene  
annotations listed in (Figure 2.1B). 
  Because rus exhibits high transcriptional activity in the gnotobiotic mouse gut and is 
elevated in fiber starved mice, we next hypothesized that the ability to utilize endogenous 
sources of ribose is advantageous in vivo during fiber-deficient diets. To test this, we inoculated 
6-8 week old germfree (GF) female Swiss-Webster mice with an equal mixture of wild-type and 
Δrus Bt strains and maintained mice on either a fiber-rich (FR) diet containing several 
unprocessed plant-derived fiber polysaccharides or an accessible fiber-free (FF) diet consisting 
mainly of glucose, protein, lipids, and cellulose26. We measured the relative abundance by qPCR 
of each strain for 42 days in DNA extracted from feces. Opposite to our initial hypothesis, the 
Δrus strain was strongly outcompeted (~100-fold) in mice fed the FR diet (Figure 2.3A). In 
contrast, in mice fed the FF diet, Δrus exhibited similar abundance to wild-type Bt (Figure 2.3B). 
A similar competitive defect of the Δrus strain in mice fed the FR diet was observed in separate 
experiments with 12-week-old female and 6-8 week old male mice (Figure 2.2B-C), suggesting 
the effect is not influenced by sex or age within the range tested. The FR diet-associated defect 
was not due to lack of colonization or persistence, as the levels of each strain were similar over 
time in mice colonized with either strain alone (Figure 2.2D-E). Additionally, the defect in the 
FR diet could not be attributed to the wild-type strain exhibiting different expression of the rus 
PUL, as wild-type Bt exhibited similarly high levels of rus expression in mice fed either diet 
when present alone or in competition with the rus mutant (Figure 2.2F).  
  Gas chromatography-mass spectrometry (GC-MS) analysis of the diets revealed ribose 
present only in the FR diet, in levels similar to other common monosaccharides, in an acid-
hydrolyzable (i.e., covalently linked) but not free form. This suggested the presence of a ribose-
containing molecule(s), such as RNA, nucleosides or cofactors (Figure 2.4A). In cecal contents 
of FR diet-fed mice mono-colonized with wild-type Bt or rus strains, ribose was not detectable 
above our limit of detection (LOD) (Figure 2.4B). However, the LOD for ribose in the cecal 





Figure 2.3 The Bt rus locus confers a competitive advantage in vivo in a diet-dependent context. 
(A-E) Log-scale relative abundance of wild type (black line) and Δrus (red line) strains enumerated by qRT-PCR from feces of 6-
8 week old germfree Swiss-Webster mice. (A) Mice fed a high fiber diet (green arrow; n = 4 mice). (B) Mice pre-fed a fiber-free 
(FF) diet for one week prior to colonization and maintained for 42d (pink arrow). (C-E) Same diet and strain competition as in 
(B), but mice were given water containing 1% w/v ribose (C), 1% w/v RNA from type IV Torula yeast tRNAs (D), or a 1% w/v 
mixture of nucleosides (0.25% each of uridine, cytidine, thymidine, and 5-methyl uridine) (E). The period of water supplementation 





E. For all panels, the mean ± SEM is shown at each time point. In panels A-E, asterisks indicate significant differences (*P<0.05, 
**P<0.01, ***P<0.001, and ****P<0.0001) calculated by Student’s t test between strains at the same day. 
amounts reach the cecum but are obscured. This ambiguity about the amount of diet-derived 
ribose in vivo prompted us to test if different sources of dietary ribose impact Bt in the gut. We 
colonized three separate groups of GF mice with a mixture of wild-type and Δrus strains and 
maintained them on the FF diet. After 14 days of stable competition between strains, water was 
supplemented with either 1% ribose, 1% RNA, or 1% pyrimidine nucleosides (purines were not 
tested due to insolubility). The results clearly show that free ribose in the water exerts an effect 
against the Δrus strain similar in magnitude to the defect in mice fed the FR diet (Figure 2.3C). 
Little or no defect was observed in mice provided water containing RNA or nucleosides (Figure 
2.3D-E) despite increased acid-hydrolyzable ribose being detectable in the cecum (Figure 2.4C). 
There was comparable expression of the rus locus in all conditions, suggesting rus expression 
differences did not account for different fitness outcomes (Figure 2.3F).  
 
A subset of ribose-utilization functions is required for competitive colonization in mice  
  The experiments described so far used a mutant lacking all 8 rus genes, but only a subset 
of the functions may be important for competition. We therefore took a molecular genetic 
approach to more precisely probe the required functions and get a clearer idea of the nature of 
the important nutrient(s) in the FR diet. We constructed single and double gene deletions based 
on predicted functionality (Figure 2.1B) and performed additional competitive colonization 
experiments in FR diet-fed mice. Each individual mouse group was inoculated with wild-type Bt 
and one of the following competing strains: ΔrusK1/2, ΔrusC/D, ΔrusGH/NH, ΔrusT, or ΔrusR, 
to test the predicted contributions of phosphorylation, outer membrane transport, hydrolase 
activity, inner membrane transport and regulation, respectively. Surprisingly, only the 
ΔrusK1/K2 strain which lacks both predicted ribokinases, exhibited a competitive fitness defect 
similar to the full Δrus mutant (Figure 2.5A). In contrast, the other deletion strains exhibited 
equal or better competition compared to wild-type (Figure 2.5B and Figure 2.4D-F). These 
results show that the required functions underlying the competitive defect in the Δrus strain are 
encoded by the rusK1 or rusK2 genes, while other functions provide no advantage and perhaps a 
fitness disadvantage on the FR diet. We speculate that the advantages exhibited by the other 






Figure 2.4 Monosaccharide content of diets and cecal contents, additional in vivo experiments and in vivo complementation.  
Data is related to Figures 2.3 and 2.5. (A-C) GC/MS analysis of free and linked (acid hydrolyzed) monosaccharides from fiber-
rich (FR) or fiber-free (FF) diets (B) cecal contents of wild type or Δrus mono-associated 6-8 week old, female Swiss Webster mice 
on the FR diet or (C) ribose content only analysis from mice maintained on the FF diet provided water containing ribose, 
nucleosides, or RNA. Data is presented as mg of sugar per gram of diet or cecal contents. (A) Blue and green bars represent the 
FR diet linked or free respectively, while the red or purple bars represent the FF diet linked or free respectively. (B) The pink and 
olive green bars represent wild type linked and free respectively, while the orange and green represent linked or free for the Δrus 
colonized mice. In figures A-C error bars show the SEM of n=3 biological replicates. N.D. indicates that the sugar was not 
detectable above our limit of detection (L.O.D.) which is shown as a dotted line above the ribose bars only in (B), or as a dotted 
line in (C). (D-G) In vivo competition with 6-8 week old Swiss Webster mice inoculated with both wild-type Bt (black line) against 
one other mutant or complemented strain (red line) with fecal relative abundance shown as enumerated by qRT-PCR with error 
bars showing the SEM. (D) Wild-type Bt and ΔrusR strain, (E) wild-type Bt and ΔrusC/D strain, (F) wild-type Bt and ΔrusT strain; 
all deletion strains in D-F displayed slight, but significant competitive advantages over wild-type Bt with n=4 biological replicates. 
(G) Competition of wild-type Bt against the complementation of the ΔrusK1/K2 strain (ΔBT2803-04::BT2803-04) n=5 biological 
replicates. (H) in vivo rus transcript measured by qRT-PCR from cecal contents where the gene deleted in the mutant strain was 
probed to assay rus transcript levels, thus transcript is representative of the wild-type strain only, in the case of Δrus and ΔrusR, 





difference of (P<0.05), while (**) represents (P<0.01), and (***) indicates (P<0.001) and (****) is used to express (P<0.0001) 
in the relative abundance of each strain compared to the other at each separate time point. 
do not participate in acquiring nutrients, a phenomenon observed with Bt fungal mannan 
utilization11. To test if one ribokinase is most important in vivo, we repeated the above  
competition with single ΔrusK1 and ΔrusK2 deletion strains. Each of these single kinase mutants 
also competed better than wild-type, suggesting functional redundancy in this context (Figure 
2.5C-D). Genetic complementation of the ΔrusK1/K2 strain restored the competitive ability of 
the defective mutant strain, allowing equal competition against wild-type (Figure 2.4G). Finally, 
variations in competitive behavior were not attributable to significant differences in rus 
expression in wild-type Bt for any of the in vivo competitions (Figure 2.4H).  
Figure 2.5 Ribokinases are required for competitive advantage in vivo. 
(A-D) In vivo competition between wild-type Bt (black line) and individual mutant strains indicated (red line) in 6-8 week old, 
germfree Swiss-Webster mice fed the FR diet. Relative abundance is displayed as in Fig. 2. In all panels, the mean of n=4 biological 
replicates ± SEM is shown. Asterisks indicate significant differences (*P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001) 
calculated by Student’s t test between strains at the same day. 
Rus functions are required for sensing and utilization of RNA, nucleosides and other nutrients in 
vitro 
  The results described above indicate a diet-specific advantage for Bt strains containing 





mutants in a variety of growth conditions, including free ribose, nucleosides, RNA, and other 
sources of ribose. Consistent with in vivo data, a mutant lacking both rusK1 and rusK2 could not 
grow on free ribose (Figure 2.6A). Arguing against purely redundant functions, the mutant 
lacking just rusK2 displayed a complete loss of growth phenotype, while a mutant lacking only 
rusK1 reproducibly displayed a substantial growth lag, but eventually grew with slightly slower 
rate than wild-type (Figure 2.6B-C). The delayed growth of this mutant may be due to a genetic 
suppressor mutation since cells that eventually grew were able to grow quickly on ribose after 
being isolated and passaged in rich media (Figure 2.7A). Deletion of the flanking gene rusR, a 
candidate transcriptional regulator, also failed to grow on ribose. Suggesting that although it is 
not transcriptionally activated in response to ribose, it plays an essential role in ribose catabolism 
(Figure 2.6D). The ΔrusT strain exhibited increased lag, slower growth rate, and lower overall 
growth compared to wild-type (Figure 2.6E).  
Figure 2.6 The Bt rus PUL encodes functions required for growth and transcript activation on ribose containing nutrients. 
(A-E) Growth curves of the individual rus deletion strains indicated (red lines) with growth on glucose (black line) as a control. 
(F) Growth of genetically complemented ΔrusR (blue line) and ΔrusK1/K2 (green line) on ribose, showing restored growth 
compared to wild-type (black line) and corresponding deletions (purple and orange lines). (G,H) Wild-type or Δrus growth on 





substrates tested. (I,J) Wild-type Bt and rus deletion strains grown in MM, plus 5 mg/ml yeast RNA with RNase A and IAP. 
Mutants with similar growth phenotypes as wild-type (I), are compared to mutants with reductions in growth (J). (K) Bt rusC 
transcript activation measured by qRT-PCR after mid-log phase cells grown in MM-glucose were washed in carbon-free medium 
and transferred to MM-ribose. For all strains, samples were taken every 5 minutes for 30 minutes, then every 15 minutes until 
120 minutes. Strains are tinted according to the key provided. Data shown are the mean of n=3 separate experiments ± SEM.  
Unlike the rusK1 mutant this mutant did not exhibit increased growth after passage (not 
shown), suggesting that suppressor mutations are not involved, but perhaps a lower-affinity sugar 
permease imports ribose less efficiently. All of the other single or double deletion mutants 
(ΔrusC, ΔrusD, ΔrusC/D, ΔrusGH, ΔrusNH, ΔrusGH/NH), exhibited no measurable differences 
in growth on ribose compared to wild-type Bt (Figure 2.7B-G and Table 2.1). The growth defects 
associated with rusK1/K2 and rusR were fully repaired by a single, complementing copy of 
each gene in trans (Figure 2.6F, rusT was not attempted).  
  Owing to their larger and more complex structure, we hypothesized that utilization of 
covalently linked ribose sources would require the additional rus-encoded outer membrane 
transport and hydrolase functions. To test this, we assayed growth of our rus mutants and wild-
type Bt on nucleosides and RNA. Wild-type Bt displayed no or poor growth on all nucleosides 
tested as well as on RNA (Figure 2.7H-I and Table 2.1). We hypothesized that free ribose may 
be required to activate transcription of the rus locus, generating proteins necessary for catabolism 
of these substrates. We determined a concentration (0.5 mg/ml) at which ribose elicited strong 
rus expression but little measurable growth based on absorption measurement (Figure 2.7J-K). 
We then re-evaluated the ability of wild-type Bt to grow on nucleosides, observing considerably 
higher levels of growth on pyrimidine nucleosides (Figure 2.6G). Growth was comparatively 
poor relative to growth on ribose, increased growth was not observed by doubling nucleoside 
concentrations, suggesting that something else related to nucleoside catabolism limits growth 
(Figure 2.7L).  
  Importantly, growth on nucleosides was eliminated in mutants lacking the full rus locus 
(Figure 2.6H), either or both ribokinases, the candidate regulator (rusR) or the putative 
transporter (rusT) (Figure 2.7M-Q). Growth on RNA was not observed after addition of ribose, 
suggesting that Bt does not produce sufficient extracellular RNAse and phosphatase enzymes 
required to liberate nucleosides. Therefore, we tested if exogenously added RNase A and 
intestinal alkaline phosphatase (IAP), both present in the gut from pancreatic secretions (RNAse) 
or the enterocyte brush boarder (IAP), could enhance growth on RNA at physiologically relevant 





not attributable to Bt growing on the exogenous enzymes themselves (Figure 2.7R). As with 
individual nucleosides, reductions or eliminations in growth on enzyme-degraded RNA were 
observed in mutants lacking the entire rus locus, rusK1, rusK2, rusK1/K2, rusT, and rusR  
Figure 2.7 Detailed growth of rus mutants on ribose, nucleosides, and RNA. 
Data is related to Fig. 2.6 (A) Wild-type (maize, solid line) or ΔrusK1 (blue, solid line) strains grown in MM-ribose or wild-type 
and ΔrusK1 strains that had been previously grown on MM-ribose, struck on BHI-blood plates, two separate colonies picked into 





check if the delayed growth phenotype associated with the ΔrusK1 strain was the product of a genetic suppressor mutation or 
similar epigenetic/reprogramming for MM-ribose growth, all strains were grown for 72 hours. (B-G) Growth of rus deletion strains 
exhibiting similar growth as wild-type on MM-ribose (red line) with no obvious growth defects, growth on MM-glucose (black line) 
is also shown for comparison: ΔrusC (B), ΔrusD (C), ΔrusGH (D), ΔrusNH (E), ΔrusGH/NH (F), ΔrusC/D (G). For panel (H) 
wild-type Bt was grown in MM containing 5 mg/ml of one of the following nucleosides (uridine, blue line; cytidine, pink line; 5-
methyl uridine, green line; or thymidine, purple line) without any ribose added. (I)Wild-type Bt growth on MM containing 5 mg/ml 
of yeast RNA without any exogenous enzymes. (J) rusC transcriptional response when wild-type Bt was exposed to titrated amounts 
of ribose (mg/ml) where each data point represents a different 10-fold dilution of ribose. The red dot represents 0.5 mg/ml ribose 
which induces rus activation to comparable levels as 5 mg/ml ribose compared to growth in MM-glucose. (K) Wild-type growth 
on different concentrations of MM containing ribose at the following concentrations (mg/ml): 5, black line; 2.5, purple; 1.25, 
green; 0.625, orange; 0.5, red; or 0.15, blue. Growth was not detectable at levels ≤0.5 mg/ml. (L) Wild-type growth on MM 
containing nucleosides at concentrations of 5 mg/ml (solid lines) or 10 mg/ml (dashed lines) in the presence of 0.5 mg/ml ribose. 
Individual nucleoside growths are colored same as (G). rus deletion strains exhibiting a complete lack of growth phenotype on all 
nucleosides tested are shown in (M-Q) as follows with lines colored same as (H): ΔrusK1/2 (M), ΔrusK1 (N), ΔrusK2 (O), ΔrusR 
(P), and ΔrusT (Q). (R) Wild-type growth curves on enzyme only controls for media supplemented with 1 mg/ml RNase A (teal 
line), 100 U calf Intestinal Alkaline Phosphatase (IAP) (plum line), or 1 mg/ml RNase A and 100 U IAP (green line), demonstrating 
that without a carbon source, these enzymes do not support growth of Bt. (S-X) Growth of deletion strains on nucleosides with 0.5 
mg/ml ribose added where growth was similar to wild type levels: ΔrusC (S), ΔrusD (T), ΔrusC/D (U), ΔrusGH (V), ΔrusNH (W), 
or ΔrusGH/NH (X). For (B-I) and (K-X), growth is plotted over 96 hours  with dashes denoting 24 hour increments.  
(Figure 2.6J). Further, mutants lacking predicted transport and hydrolytic functions grew 
similarly to wild-type on both nucleosides and degraded RNA (Figure 2.6I and Figure 2.7S-X). 
In addition, we determined that Bt utilizes deoxyribose and lyxose, as well as ADP-ribose, UDP-
galactose and UDP--glucose. All of these required the presence of a low amount of ribose and 
the rus locus, while 21 other substrates did not support Bt growth under any conditions tested 
(Table 2.1).  
  Based on our mutant growth phenotypes, we sought to determine if the genes required for 
ribose growth were also required for activating expression of rus. We examined the kinetics of 
rus transcriptional responses when Bt was exposed to ribose, an assay that allows us to measure 
response independent of ability to grow on ribose. Interestingly, the ΔrusK2 strain, which cannot 
grow on ribose, generated transcript at a similar rate/level to wild-type up to 2h (Figure 2.6K). In 
contrast, the ΔrusK1 mutant, which exhibits an extensive lag before growth on ribose, was 
unable to quickly generate transcript within 2h, but eventually achieves near wild-type rus 
expression once actively growing on ribose due to its suspected suppressor (Figure 2.6K and 
Figure 2.8D). As expected, the ΔrusK1/K2 double mutant did not generate transcript. The ΔrusR 
mutant achieved partial (~10%) activation, supporting the hypothesis that RusR is a positive-
acting regulator. The ΔrusT strain only has a slight defect, suggesting that another, non-specific 
permease can transport ribose. We also measured rus expression dynamics in our ΔrusC and 
ΔrusD strains, but failed to detect any differences compared to wild type, consistent with the lack 
of their requirement for ribose growth (Figure 2.8E). Finally, the nucleosides uridine and inosine 






Non Rus-encoded functions are required for nucleoside utilization 
  The lack of a requirement for the rus hydrolase functions in nucleoside catabolism is 
noteworthy as we confirmed through biochemical experiments with recombinant enzyme that  
Figure 2.8 Potential crosstalk between ribose and other metabolism genes and PULs 
Data is related to Fig. 2.9 (A-C) Growth of NSSs deletion strains or wild-type Bt on thymidine (A), ribose (B), or RNA (C) (with 
added enzymes) out to 96 hours. Strains are color coded (wild-type, black; ΔBT0184, red; ΔBT1881, green; ΔBT4330, purple; or 
ΔBT4554, orange). (D) rusK2 (left bars) or rusC (right bars) transcript expression of wild-type Bt (purple) or ΔrusK1 strains when 
grown to mid-log phase in MM-ribose compared to growth in MM-glucose, error bars represent the SD of n=3 replicates. (E) rus 
transcript during a time course experiment where cells were shifted from growth on MM-glucose to MM-ribose, and transcript 
probed over time with points every 5 minutes for the first 30 minutes and every 15 minutes after out to the conclusion at 120 minutes 
post-ribose exposure. For the wild-type (black line) and ΔrusD (dark yellow line) strains, the rusC gene was probed, while for the 
ΔrusC strain (red line), the rusD gene was probed (similar kinetics were seen in the wild-type strain when the rusD gene was used 
to assay rus activation, data not shown). Error bars represent the SEM of n=3 replicates performed on separate days. (F) Similar 
to the experiment in (E) but using nucleosides (inosine, black line or uridine, green line) and probing rusC expression to address 
if nucleosides could stimulate rus activation, with no response detected compared to growth in MM-glucose. (G) in vivo competition 
of a strain lacking the entire fructan PUL, BT1754-1765 (Δfruc, blue line) against a strain lacking both the fructan PUL and the 
rus PUL (Δfruc/Δrus, orange line) in 6-8 week old Swiss-Webster female mice on the FR diet. The relative fecal abundance is 
shown on a log scale as assayed by qRT-PCR over the course of the experiment, error bars show the SEM of n=4 mice. (H) in vivo 
rus expression from cecal contents of the mice from (G) probing the rusC gene, error bar shows the SEM of n=4 mice. P-values 
for (G) were calculated using Student’s t test for the relative abundance of each strain (*) indicates a statistically significant 






RusNH is a genuine, albeit weak, nucleoside hydrolase (Table 2.2A) and that RusGH can cleave 
p-nitrophenyl--D-riboside (Table 2.2B-C). The lack of a phenotype associated with loss of 
RusNH, suggested that other functions in Bt are responsible for cleavage of free pyrimidine 
nucleosides or those liberated from RNA. To identify alternative enzymes, we searched the Bt 
genome for functions from known nucleoside scavenging systems (NSSs) and identified several 
candidates. We made deletions of 4 genes predicted to encode nucleoside phosphorylase 
(BT1881, BT4554), uridine kinase (BT0184) and nucleoside permease (BT4330) activities and 
tested growth of these mutants on pyrimidine nucleosides (Figure 2.9A-C and Figure 2.8A).  
Table 2.2A Detailed cleavage activities of the RusNH (BT2808)   




Parkin et al. 1991 Nucleoside 
Hydrolase from C. fasciculata 
Enzyme: BT2808 (RusNH) Kcat/km (s-1/M-1) Kcat/km (s-1/M-1) 
Substrate Average Standard deviation Average Standard deviation 
Adenosine 15.06 10.75 9800 NR 
Cytidine 16.75 8.96 4500 NR 
Thymidine 9.63 1.10 NT NT 
5-methyl Uridine 9.91 0.88 NT NT 
Uridine 5.64 0.11 120000 NR 
Inosine 9.42 1.91 76000 NR 
Xanthosine 10.05 0.89 NT NT 
Guanosine 5.54 0.98 3400 NR 
DeoxyUridine 8.80 2.26 NT NT 
DeoxyInosine 9.73 0.78 NT NT 
DeoxyAdenosine 15.51 8.03 NT NT 
DeoxyCytidine 5.01 0.60 NT NT 
Footnotes: NT = Not Tested, NR = Not Reported 
One strain (ΔBT4554) displayed loss of growth on all nucleosides tested, suggesting that it 
encodes an essential enzyme for cleaving nucleosides and might work upstream of the rus 
functions, which are also required. The ΔBT4330 mutant exhibited reductions in growth on 
uridine, cytidine, and 5-methyl uridine (Figure 2.9A-C), with only a slight defect on thymidine 
(Figure 2.8A). The ΔBT0184 mutant displayed enhanced growth that began quicker than wild 
type and reached a higher total growth level on all nucleosides, except thymidine. This 
phenotype could be due to its role in 5’- phosphorylating scavenged nucleosides and shunting 
them towards anabolic pathways, such that its loss favors catabolism. ΔBT1881 did not display 
any detectable growth defects compared to wild-type, suggesting that the product of this gene is 
not essential for pyrimidine catabolism.  
  To understand how these NSS functions may impact gut colonization, we tested the 
ΔBT4554 mutant in our in vivo competition assay. In mice fed the FR diet, this mutant exhibited 





strains (Figure 2.9D). This finding helps connect the role of rus functions, which in all of the 
conditions assayed have been ubiquitously expressed in vivo, and the FR diet-specific fitness 
advantage experienced by wild-type Bt in vivo. We cannot definitively determine that  
  
Table 2.2B pNP-assays for RusGH (BT2807)                       Table 2.2C TLC reactions for RusGH (BT2807)  
Footnotes: *This activity was calcium dependent 
nucleosides are the nutrients scavenged in vivo that drive this competitive advantage. However, 
i) similarity of the rus, rusK1/K2 and BT4554 phenotypes and ii) the dependence on both a 
small amount of ribose (i.e., to induce rus) and a functional rus system for in vitro growth on 
nucleosides via BT4554, supports a model in which ribose-induced Rus kinases are essential for 
the in vivo scavenging of nucleosides processed by BT4554. Although growth on nucleosides in 
some NSS mutants was reduced or eliminated this phenotype did not extend to growth on RNA 
or ribose, as the mutant strains exhibited similar levels of growth as wild-type (Figure 2.8B-C). 
This suggests that, while Rus functions are required to use RNA, the NSS functions interrogated 
here are not individually essential for catabolism of RNA-derived nucleosides or oligos.  
 
Rus kinases are active towards ribose and nucleoside-derived ribose-1-phosphate 
  To scrutinize the activities of the rus-encoded kinases in detail, we produced recombinant 
forms and performed in vitro phosphorylation assays against pentose sugars and other 
monosaccharides (E. coli RbsK was a positive control). RusK2 has a preferred specificity 
towards ribose and deoxyribose, while exhibiting weaker activity on arabinose and xylose (Table 
 
Enzyme: BT2807 (RusGH), Substrate 
Active 
 (Y/N) 








p-nitrophenyl β-D-ribofuranoside* Y  Deoxycytidine N ADP-ribose N 
4-nitrophenyl N-acetyl-α-D-galactosamide N  Thymidine N UDP N 
4-nitrophenyl N-acetyl-β-D-glucosaminide N  Cytidine N UDP-N-acetyl-
D-glucosamine 
N 
4-nitrophenyl α-D-galactopyranoside N  5-Methyl uridine N AICAR N 
4-nitrophenyl α-D-glucopyranoside N  Deoxyuridine N D-lyxose N 
4-nitrophenyl α-D-mannopyranoside N  Uridine N D-psicose N 
4-nitrophenyl α-D-xylopyranoside N  Inosine N Ribostimycin N 
4-nitrophenyl α-L-arabinofuranoside N  Deoxyinosine N Myo-inositol N 
4-nitrophenyl α-L-arabinopyranoside N  Deoxyadenosine N Neomycin N 
4-nitrophenyl α-L-fucopyranoside N  Adenosine N Rebaudioside-
A 
N 
4-nitrophenyl α-L-rhamnopyranoside N  Xanthosine N Ribitol N 
4-nitrophenyl β-D-galactopyranoside N  Deoxyguanosine N Amygdalin N 
4-nitrophenyl β-D-glucopyranoside N  Guanosine N   
4-nitrophenyl β-D-glucuronide N  UDP-α-D-Glucose N   
4-nitrophenyl β-D-mannopyranoside N  UDP-β-D-Glucose N   
4-nitrophenyl β-D-xylopyranoside N  UDP-α-D-Galactose N   





2.2D). RusK1 displayed nearly 10-fold weaker activity on ribose and deoxyribose compared to 
RusK2 and weak activity towards other sugars tested (Table 2.2D). The initial assay used to 
measure activity from RusK1 and K2 did not determine positional phosphorylation specificity. 
We hypothesized that an important difference in these kinases might be their positional  

























D-Ribose 10 mM 13.797 1.920 336.263 32.437 2273.630 504.526 
Deoxyribose 10 mM 13.956 1.156 44.245 6.795 141.407 59.810 
D-Arabinose 200 mM 0.670 0.023 0.585 0.098 4.471 0.888 
D-Xylose 200 mM 0.677 0.053 0.597 0.199 6.382 0.304 
D-Fructose 200 mM 0.653 0.067 ND NA ND NA 
D-Glucose 200 mM + + ND NA ND NA 
D-Galactose 200 mM + + ND NA ND NA 
L-Fucose 200 mM + + ND NA ND NA 
D-Mannose 200 mM + + ND NA ND NA 
L-Rhamnose 200 mM + + ND NA ND NA 
D-Sucrose 200 mM + + ND NA ND NA 
phosphorylation at either the 1 or 5 carbon of ribose. When RusK1 and RusK2 enzymes were 
incubated with ribose and analyzed by LC/MS/MS, both generated ribose-5-phosphate (R5P) as 
the major detectable product (Figure 2.9E). We did not detect formation of ribose-1-phosphate 
(R1P) from ribose despite being able to reliably distinguish this compound as a standard (Table 
2.2E). We next performed reactions using R1P as the substrate to test if this product, which we 
expect to be generated by BT4554 phosphorolysis of nucleosides, could be a substrate for the 
Rus kinases. Interestingly, our results show that ribose-1,5-bisphosphate (PRibP) is generated 
from R1P by both RusK1 and RusK2 (Figure 2.9F). In addition, RusK2 could generate a product 
with the same predicted mass as PRibP when given R5P as a substrate, despite RusK2 not 
forming R1P from ribose (Figure 2.9F). These are both novel findings as either mechanism 
involved in generating PRibP, or ribokinases capable of phosphorylation in the 1 position, have 
yet been identified in eubacteria. Rather, generation of PRibP by a different family of kinases has 
been described in archaea and plants as part of the RuBISCO pathway29. Our results help connect 
the function of Rus-encoded kinases with BT4554-mediated nucleoside scavenging via 
generation of intermediate PRibP. The route that PRibP takes after it is produced is still 
uncertain, since Bt lacks a clear homolog of the E. coli ribose 1,5-bisphosphokinase (phnN) that 
consumes PRibP to generate phosphoribosyl pyrophosphate (PRPP), which can be used both in 





suggest that the similar in vivo defects associated with loss of either RusK1/K2 or BT4554 are 
due to the requirement of both systems for utilization of exogenous nucleosides.  
 
Global responses to ribose catabolism 
  We hypothesized that growth on ribose may affect expression of a global regulon. To test 
this, we performed RNAseq-based whole-genome transcriptional profiling on wild-type Bt  
Figure 2.9 Requirements for Bt nucleoside scavenging genes, ribokinase positional phosphorylation & global response to ribose.  
(A-C) Growth curves of nucleoside scavenging gene deletion strains (colored according to key) versus wild type Bt (black) on 
uridine (A), cytidine (B), or 5-methyl uridine (C). (D) In vivo competition between wild-type Bt (black) and ΔBT4554 strains (red) 
showing the relative abundance on the FR diet with mean ± SEM of n=4 biological replicates. (E-F) Positional ribose 
phosphorylation by RusK1 or RusK2 measured by LC/MS/MS for ribose 5-phosphate (E) or ribose-1,5-bisphosphate (F), for each 
bar the mean of n=3 biological replicates ± SD is shown. The y-axis minimum of 103 was determined from negative control 
reactions that included control enzyme or buffer only (Table 2.2E). Detection of PRibP was based off of a PRPP standard 





grown on MM-ribose compared to MM-glucose. Same bar color indicates genes in the same locus. Genes with gray bars are not 
physically linked in the genome. For each bar, the mean of n=3 replicates are shown ± SD. In (E), asterisks indicate significant 
differences (*P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001) calculated by Student’s t test. 
grown on ribose or glucose. Indeed, the data revealed a global response in which 81 genes were 
differentially expressed based on the parameters and thresholds used. Many of the genes (46%) 
belong to other PULs or metabolic pathways. (Table 2.3, shown below in Methods).  Notable 
changes included upregulation of a previously defined PUL for fructose and 2,6-linked fructan 
metabolism (BT1757-1765; average upregulation of 15-fold), which interestingly liberates 
fructose that initiates the PPP30 and suppresses rus expression (Figure 2.2A). At the same time, 
two other PULs of unknown specificity were repressed (BT3024-3027, BT3344-3347). Further, 
several genes encoding TCA cycle enzymes leading to generation of succinate and propionate, of 
which Bt has a partial pathway31, were upregulated. In contrast, genes predicted to participate in 
sugar-phosphate isomerization and metabolism were strongly repressed (BT2156-2159; average 
of 24-fold) (Figure 2.9G). An experiment to test if cross-regulation between ribose metabolism 
and the fructan PUL contributes to the FR-diet specific competitive defect failed to support this 
model (Figure 2.8G-H).  
Table 2.2E LC/MS/MS results for ribokinase reactions and controls showing raw data for area under the curve 
measured as ion counts 
Starting Compound Detection Ribose Ribose-1P Ribose-5P Ribose-1,5-bisphosphate 
Transition 149.0->89.0  229.0 ->210.9  229.0 ->97.0   309.0 -> 211.0  
1mM Ribose Standard Area 268,210 2,270 3,726 24 
1mM Ribose-1P Standard Area 910 24,518,553 3,777 108 
1mM Ribose-5P Standard Area 916 6,353 17,002,705 44 
BT 2803 (RusK1) Enzyme Only Area 173 524 420 205 
BT 2804 (RusK2) Enzyme Only Area 175 249 66 108 
BT2803+Ribose n=1 Area 759,589 936 2,178,751 1,735 
BT2803+Ribose n=2 Area 805,800 627 2,620,909 1,528 
BT2803+Ribose n=3 Area 897,783 1,048 2,407,413 1,735 
BT2803+Ribose-1P n=1 Area 104 7,706,247 3,078 135,812 
BT2803+Ribose-1P n=2 Area 101 8,684,800 5,001 122,344 
BT2803+Ribose-1P n=3 Area 78 8,117,289 1,438 137,551 
BT2803+Ribose-5P n=1 Area 332 720 32,223,656 1,828 
BT2803+Ribose-5P n=2 Area 278 323 28,552,913 1,036 
BT2803+Ribose-5P n=3 Area 297 531 24,072,099 1,230 
BT2804+Ribose n=1 Area 139,132 734 10,376,139 172 
BT2804+Ribose n=2 Area     452,072            858  12,367,333                           2,986  
BT2804+Ribose n=3 Area    364,124             936   14,799,917                      227 
BT2804+Ribose-1P n=1 Area         133      7,654,273           8,161                    161,399  
BT2804+Ribose-1P n=2 Area         109     8,195,257          5,517                   202,726  
BT2804+Ribose-1P n=3 Area        145     8,085,939         5,825                       223,148  
BT2804+Ribose-5P n=1 Area         270               595   27,915,015                     184,873  
BT2804+Ribose-5P n=2 Area           250               201  21,565,887                      156,384  
BT2804+Ribose-5P n=3 Area           254               366   26,182,891                     165,367  
ATP Area        175                423        221                              74  
Buffer Blank1 Area        1,565                 17               5                            12  





Buffer Blank3 Area        526               21             372                               46  
Buffer Blank4 Area        507               5              149                            50  
Buffer Blank5 Area          363             2,141          3,327                            20  
Buffer Blank6 Area          306            1,733          3,015                             39  
Buffer Blank7 Area            454            1,415           2,578                           37  
Internal QC Standard 1 Area       4,667          11,244          587                     15,350  
Internal QC Standard 2 Area      3,637          11,303           694                       15,071  
Internal QC Standard 3 Area        5,026          11,303           724                        14,705  
Internal QC Standard 4 Area        4,851         11,310           881                        14,970  
Internal QC Standard 5 Area        4,791           11,296              888                        14,531  
Internal QC Standard 6 Area       5,337          11,384           1,012                        14,702  
Internal QC Standard 7 Area      4,523          11,855         1,107                        14,806  
Internal QC Standard 8 Area        3,245          13,122           8,026                      10,401  
Internal QC Standard 9 Area      3,353        14,722       6,436                        11,239  
Internal QC Standard 10 Area        4,618          10,454          6,329                        10,682  
An enzyme-diversified family of Rus systems exists throughout the Bacteroidetes  
  The data described above support the idea that the Bt rus PUL is necessary, but not 
always sufficient, for metabolizing ribose and nucleosides. Since it is strongly activated in 
response to the simple sugar ribose and not an oligosaccharide cue, rus is relatively unique and 
only the second PUL after the Bt fructan PUL shown to be activated in response to a 
monosaccharide30. The architecture of this system suggests that it is equipped to liberate ribose 
from additional unknown sources via its hydrolases. Therefore, we hypothesized that rus-like 
systems may be found in other gut isolates and perhaps more broadly across the Bacteroidetes. 
To test this, we measured the growth ability of 354 different human and animal gut Bacteroidetes 
in MM-ribose, revealing that ribose utilization is widely but variably present in different species 
(Figure 2.10A, Figure 2.11A, and shown in the Methods section Table 2.4). To determine if 
sequenced representatives of the species/strains that grow on ribose contain a homolog of the 
experimentally validated Bt rus, we used comparative genomics to search for homologs of this 
PUL within these gut isolates. This revealed that all of the sequenced strains that grow on ribose 
possess a candidate rus-like PUL, while none of the strains unable to grow on ribose had a 
homologous gene cluster. Interestingly, our analysis revealed very similar homologs of some rus 
genes in sequenced gut isolates (e.g., Prevotella) beyond those present in our initial survey. 
When we expanded the search to include Bacteroidetes isolates found in other body sites and in 
the environment, we detected rus-like systems across the phylum, with systems found in the 
genus Bacteroides being most similar to the prototype from Bt. Remarkably, we identified a total 
of 70 different rus configurations, ranging from simple two gene units (permease and kinase), to 





like systems, the following genes were present: rusC and rusD, an upstream rusR (or to a lesser 
extent different regulator types) either one or two rusK genes, and a rusT homolog. 
Figure 2.10 Ribose utilization is present across the Bacteroidetes phylum with many configurations of corresponding rus PULs.  
(A) Genus-level phylogeny constructed from sequenced isolates showing the presence of ribose utilization. Outer black circles are 
sized to represent the number of strains tested for each species. Inner red circles indicate the number of tested strains that grow 
on ribose. (B) Comparisons of several variants of rus PULs throughout the Bacteroidetes. Identical background color indicates 
the same predicted function(s), which are defined according to the key. The number of sequenced isolates that harbor each PUL 





name indicate that the PUL type shown is upregulated by ribose as the sole carbon source in at least one strain tested. Genes are 
sized to scale and all species represented here are human gut isolates. A broader representation of rus diversity is shown in Figure 
2.11 and includes PULs from environmental and oral Bacteroidetes. Abbreviations not previously defined in the text are: (GH*, 
Glycoside hydrolase of unknown family/function; BACON, Bacteroidetes-Associated Carbohydrate-binding Often N-terminal 
domain; DHDPS, dihydrodipicolinate synthase; LacI, predicted lacI-type transcriptional regulator; MFS, Major-facilitator 
superfamily of transporters; ADP-RGH, ADP-ribosyl glycoside hydrolase; DNAH, DNA helicase; PBS, Polysaccharide 
Biosynthesis and export of O-antigen and techoic acids; DPP7, Dipeptidyl-Peptidase 7 (serine peptidase); GT, Glycosyl 
Transferase). (C) Fold change of rusC-like transcript from the indicated species/strain showing that several additional rus PULs 
are activated during growth on ribose compared to glucose. Error bars show the SEM of n=3 biological replicates. 
Perhaps most intriguingly, the predicted enzymes found in different rus-like systems are 
exceptionally variable, with at least 22 different predicted glycoside hydrolase families, ADP-
ribosylglycohydrolases, carbohydrate esterases, and nucleoside hydrolases among others. This 
plethora of enzymatic potential encoded in rus homologs across the Bacteroidetes suggests 
individual species or strains target different ribose-containing nutrients. To further connect these 
predicted rus-like systems with ribose utilization, we probed the transcriptional response of 8 
different systems during growth on MM-ribose, finding that all strains tested exhibited ~100-
1000 fold upregulation relative to a MM-glucose reference (Figure 2.10C).  
 
Discussion 
  Diet impacts the gut microbiota in many ways and members of the prominent 
Bacteroidetes phylum have developed sophisticated strategies to liberate sugars from very 
complex dietary fiber polysaccharides such as pectins13,14. Such abilities equip these bacteria to 
compete for dietary and endogenous nutrients to sustain their populations. Diet-, microbiome- 
and host-derived RNA, nucleosides, cofactors and other sources of ribose have been largely 
unexplored as potential nutrients scavenged by members of the gut microbiota. Our findings 
demonstrate that Bt utilizes free- and covalently-linked sources of ribose and this metabolic 
capability contributes to competitive fitness in vivo in a diet-dependent fashion—likely through a 
more complicated metabolic mechanism that interconnects ribose sensing and nucleoside 
scavenging (Figure 2.12). It is also clear from comparative genomics that the ability to access 
ribose from diverse sources, extends across the Bacteroidetes phylum and is present in many 
animal gut, oral, and environmental isolates.  
  Although we have not yet uncovered a more complex ribose containing polymer 
requiring Rus transport and hydrolase functions, a key aspect of our ribose utilization model is 
that Rus-encoded kinases are required for growth on free and RNA-derived nucleosides, the 





nucleoside assimilation, the roles of periplasmic RusNH and cell surface RusGH remain 
enigmatic. Given the weak activities of these enzymes towards the substrates tested, it is 
Figure 2.11 An expanded repertoire of rus architectures across the Bacteroidetes phylum. 
A comparative genomics approach across the Bacteroidetes phylum revealed many different types and subtypes of the rus locus. 
This figure displays almost all of the additional types found in both the human gut isolates as an expansion from Figure 2.10B, and 
those found in aquatic, soil, and human oral cavity isolates. Not shown are subtypes, where the same genes are present, but 
arranged differently, as well as types 21, 30, 33, 36, 39, 44, 48, 46, and 61, all of these types only had one isolate and were of 





background color is kept constant for genes predicted to encode the same or very similar functions. Gene abbreviations are as 
follows in order of appearance: (DeoR, DeoR-like family of transcriptional regulator; MFS, Major Facilitator Superfamily of 
transporters; FADOR, Flavin (FAD) Oxidoreductase; NAD, NAD Binding Protein; CK, Carbohydrate Kinase, unknown family; 
GDPDE, Glycerophosphoryl Diester Phosphodiesterase; NH, Nucleoside Hydrolase; GH, Glycoside hydrolase; HAD, Haloacid 
Dehydrogenase; LacI, LacI-type transcriptional regulator; FrcK, fructokinase; FGE, Formylglycine-Generating Enzyme, required 
for sulfatase activity; NADP-DH, NADP-Dependent aldehyde Dehydrogenase; ALT-DH, Altronate Dehydrogenase; kdxD, 2-
dehydro-3-deoxy-D-arabinonate dehydratase; AraC, AraC-like transcriptional regulator; Rib Iso, Ribose-5-Phosphate Isomerase; 
Tn-ase, transposase; BACON, Bacteroidetes-Associated Carbohydrate-binding Often N-terminal domain; cpdA, 3’.5’-cyclic AMP 
phosphodiesterase; EEPase, Endo-Exo Nucleoside-Phosphatase; TAT, Twin-Arginine Translocase; BNR, BNR repeat-like 
domain; SIAE, Sialate O-acetylesterase; DPP IV, Dipeptidyl-peptidase IV; ***, RNA polymerase sigma factor ECF subfamily; 
FecR, FecR-like transcriptional regulator; SusE, Bacteroides SusE-like outer membrane binding protein; GntR, GntR-like 
transcriptional regulator; FBA, Fructose Bisphosphate Aldolase; Xyl Iso, Xylose Isomerase; ROK, Repressor/ORF/Kinase domain 
containing protein; ADH, Alcohol Dehydrogenase; LmbE, N-acetylglucosaminyl deacetylase LmbE-like family; E/L/P, 
Esterase/Lipase/Peptidase-like domain containing protein; RhaA, Regulator of RNaseE activity; Acid Pase, Acid Phosphotase-like 
protein). We have included a color-coded legend on the figure with the abbreviations listed next to them to help clarify the 
relationship between the colored genes.  
probable that they are optimized to cleave substrates that we have not yet been able to test and 
which are the bona fide nutrient targets of the Bt Rus system. At least for the pyrimidine 
nucleosides tested in vitro, the BT4554 phosphorylase, which generates a cleaved base plus R1P, 
is the primary component required. A novel aspect of the model we have determined for Bt, is 
that Rus-encoded ribokinases are required for conversion of R1P to PRibP, and this conversion 
requires ribose induction of Rus to activate production of the ribokinases. This interconnection 
may stem from the dual function of the ribokinases, phosphorylating both ribose to R5P and R1P 
to PRibP. Based on our growth and positional phosphorylation data, it is unlikely that R5P is 
being shunted directly into catabolism as canonically represented in KEGG maps of the PPP. 
This is largely based on the observation that either Rus kinase can generate R5P, so if direct 
assimilatory pathways exist through D-ribulose-5-P or D-sedoheptulose-7-P, both single kinase 
mutants should grow normally as they would be redundant in this function. Rather the generation 
of PRibP from R1P or R5P, whose ultimate path(s) are uncertain is more likely the relevant 
molecule being generated for use in catabolism. The lack of a detectable phosphopentomutase in 
Bt that isomerizes R5P to R1P, (having only a phosphoglucomutase, BT1548) may have driven 
the evolution of co-dependence on the ribokinases and nucleoside phosphorylase (BT4554) to 
generate PRibP. Although the full catabolic pathway for PRibP in Bt is still unclear, our findings 
hold important implications for how predicted metabolic maps may be incomplete in some 
instances and should be interpreted with caution. By investigating this pathway more deeply, our 
results demonstrate the first known bacterial ATP-dependent ribokinases able to generate PRibP 





  Similar to only one other previously characterized Bacteroides PUL for fructan 
utilization30, the rus PUL is activated in response to a monosaccharide, (fructose and ribose 
respectively) (Figure 2.1C) and also contains a dedicated permease and kinase revealing that 
Figure 2.12 Model of ribose utilization by Bt and connection to nucleoside scavenging. 
The model shown represents a proposed mechanism of ribose and nucleoside metabolism via rus-encoded functions and nucleoside 
scavenging systems based on the data in this study and predicted KEGG metabolic maps. Ribose is depicted as a pink star, 
phosphate groups are represented as yellow circles, while nucleoside bases are shown as colored circles (blue: uridine, green: 5-
methyl uridine, dark pink: cytidine, red: guanosine). Some cellular locations of protein products were experimentally determined 
(e.g., (Figure 2.13) for localization data for RusGH and RusNH). Proteins for which no functional requirement could be assigned 
are shaded in gray (RusC, RusD, RusGH). Abbreviations: intestinal alkaline phosphatase, IAP, rus-encoded nucleoside hydrolase, 
RusNH, ribokinases, RusK1/K2, nucleoside phosphorylase, np, uridine kinase, udk. Our cytosolic metabolic model depicts our 
interpretation of the PPP of Bt based on our results. Dashed arrows with red “x” indicate that homologs of the enzymes normally 
catalyzing these steps are not detectable by homology searching in Bt. Black arrows are steps of the PPP that likely occur in Bt 
and we have results indicating the importance of BT0184, BT4330, and BT4554 in nucleoside catabolism.  
these two systems are similarly patterned around a core monosaccharide utilization pathway. 
Although the activation signal for rus is derived from extracellular ribose, we are unable to 





results, the kinases and the putative regulator RusR are required for generation of transcript. 
Often, the enzyme content encoded in Bacteroidetes PULs provides a window into the nutrient 
linkages that any given system has evolved to target10,11,32. Ribose is present in many diverse 
sources with different linkages, including RNA and nucleosides, bacterial capsules, cofactors 
such as NAD, cellular modification like (poly) ADP-ribose, and more exotic molecules such as 
microcins33. The breadth of enzymatic diversity emphasized by the presence of at least 22 
different glycoside hydrolase families plus others, and 70 different configurations of ribose 
utilization systems across the phylum supports a hypothesis whereby species have adapted to 
liberate ribose from different and diverse sources. We initially hypothesized that the nutrient 
mediating the competitive advantage in vivo for Bt rus would be endogenous nucleosides or 
RNA from bacteria or host cells in a fiber-free diet (FF-diet). However, our results suggest that 
in the FR-diet, nucleosides are the nutrients targeted by the combined actions of BT4554 and the 
rus kinases. While pyrimidine nucleoside addition to water in mice fed the FF diet did not reveal  
Figure 2.13 Localization of RusGH and sequence alignment of conserved residues of RusNH. 
Data is in support of Fig. 2.12 (A) Immunofluorescent microscopy of Bt grown in MM-ribose media staining with anti-BT2807 
(RusGH) antibody, indicating that the protein is localized to the outer membrane as the secondary antibody has clearly labeled 
nearly all of the cells seen in the brightfield image (left), a green color in the fluorescent image at (right). (B) Multiple sequence 
alignment of BT2808 (RusNH) and other RusNH-like proteins from Bacteroidetes (red boxed region) compared to previously 
validated nucleoside hydrolases isolated from bacteria (E. coli, RihA,B,C and P. fluorescens), archaea (S. solfataricus), parasitic 
eukaryotes (T. vivax, L. major, and C. fasciculata), moss (P. patens), maize (Zea mays), and yeast (S. pombe), indicating that the 
predicted nucleoside hydrolase of BT2808 shares the universally conserved N-terminal DXDXXXDD motif responsible for Ca2+ 
coordination (2nd and 4th yellow-highlighted aspartic acid residues) and ribose binding (3rd yellow-highlighted aspartic acid), as 
well as the nearly conserved canonical 1st aspartic acid residue denoting the motif (yellow or green highlighted position). Specific 
to the Bacteroidetes nucleoside hydrolases, there are two residues, an asparagine and an additional aspartic acid within the motif 
(highlighted in teal) not found IUNH family nucleoside hydrolases outside of the Bacteroidetes.  
a competitive defect, it is possible that purine nucleosides, which were not tested due to low 





  The results described here highlight how survival of bacteria in the human gut and other 
ecosystems has driven adaptations to sense and scavenge the ubiquitous sugar ribose. Since 
enterohemorrhagic E. coli (EHEC) and other pathogenic E. coli preferentially utilize ribose in 
vivo4,34, or upregulate genes for the catabolism of this nutrient in the environment35 these 
substrates may represent unexplored nutrient niches competed for by commensal and pathogenic 
microorganisms and may therefore help mediate colonization resistance against pathogens. The 
evolution of diverse enzyme functions throughout the Bacteroidetes may be analogous to a 
molecular “Swiss-army knife”, in which the core function is utilization of ribose but the various 
blades and other implements represent the enzymes equipping the system to sense, import or 
harvest ribose from diverse sources. This molecular adaptability is particularly important in the 
context of the nutrient niche hypothesis of gut bacterial survival. While some nutrients may be 
scarce compared to abundant dietary fiber polysaccharides, competition for these lower 
abundance nutrients may be less intense and organisms capable of accessing them could thereby 
occupy a stable niche. While a number of gut bacteria, including pathogens, are capable of 
utilizing free ribose, the Bacteroides may have developed a more sophisticated ability to 
scavenge multiple sources by cleaving it from covalently linked forms. From this perspective, 
understanding the struggle to access this “simple” sugar may reveal additional layers 




Gnotobiotic mouse experiments 
  All experiments involving animals, including euthanasia via carbon dioxide asphyxiation, 
were approved by the University Committee on Use and Care of Animals at the University of 
Michigan (NIH Office of Laboratory Animal Welfare number A3114-01) and overseen by a 
veterinarian. Six to eight-week-old, germfree female Swiss-Webster mice were initially 
maintained on the standard, fiber-rich lab diet (LabDiet 5010, LabDiet, St. Louis, MO), where 
appropriate, mice were switched to a fiber-free diet (Envigo-Teklad TD 130343) and maintained 
for one week prior to colonization with Bt strains. After stable colonization had been observed, at 
day 14 some groups of mice were provided water ab libitum containing one of the following: 1% 





0.25% cytidine) or Type VI torula yeast RNA. DNA was extracted from fecal pellets throughout 
the experiment and strain abundance was quantified as described previously26. Relative 
abundance of each strain was normalized to the original abundance on day of gavage (day 0). 
Post-sacrifice, cecal contents were collected, flash frozen and stored at -80°C. RNA was 
extracted as described previously1, briefly, RNA was phenol-chloroform treated and ethanol 
precipitated, DNA removed by treatment with TURBOTM DNaseI (Ambion), followed by 
purification using RNeasy mini kit (Qiagen) according to manufactures instructions.  
 
Bacterial strains, culturing conditions, and molecular genetics.  
  B. thetaiotaomicron ATCC 29148 (VPI-5482) and its genetic variants, as well as other 
Bacteroides strains used in this study, were routinely grown in tryptone-yeast extract-glucose 
(TYG) broth medium36, in minimal medium (MM), plus a defined carbon source17, or on brain 
heart infusion agar with 10% defibrinated horse blood (Colorado Serum Co.). Unless otherwise 
noted, carbon sources used in MM were added to a final concentration of 5 mg/ml. Cultures were 
grown at 37°C in an anaerobic chamber (10% H2, 5% CO2, and 85% N2; Coy Manufacturing, 
Grass Lake, MI). Genetic deletions and mutations were performed by counter-selectable allelic 
exchange as previously described37. Complementation of deletion strains was performed using 
pNBU2 vectors as described previously17, containing 314 bp upstream of BT2802, predicted to 
contain the promoter sequence for the ΔrusR strain or 186 bp upstream of BT2803-04 containing 
the entire intergenic region for the ΔrusK1/K2 strain. Primers used in this study are listed in 
(Table 2.5, located at the end of Methods). To quantify growth on carbon sources and examine 
mutant phenotypes, increase in culture absorbance (600 nm) in 200µl cultures in 96-well plates 
was measured at 10 minute intervals for at least 96 hours on an automated plate reader as 
previously described21. To achieve consistent and robust growth on nucleosides and other 
covalently linked sources of ribose, free ribose was added at a final concentration of 0.5 mg/ml 
to MM containing 5 mg/ml of carbon source. Growth on 5mg/ml of MM containing Type IV 
Torula yeast RNA (Sigma) was obtained by adding 100 units of calf-intestinal alkaline 
phosphatase (CIP) (New England Biolabs) and 2mg/ml RNase A (Sigma). Growth parameters 
and conditions for all substrates are summarized in (Table 2.1).  
Table 2.1 Growth characteristics of B. thetaiotaomicron strains on ribose and other ribose-containing molecules 










Glucose Δtdk (isogenic parent strain) 0.1655 8.068 NA 1.301 
Glucose ΔBT2802-2809 (rus) 0.1565 7.065 NA 1.269 
Glucose ΔBT2802 (rusR) 0.1504 7.650 NA 1.258 
Glucose ΔBT2803 (rusK1) 0.1452 7.608 NA 1.292 
Glucose ΔBT2804 (rusK2) 0.1392 7.984 NA 1.263 
Glucose ΔBT2803-2804 (rusK1/K2) 0.1476 7.023 NA 1.283 
Glucose ΔBT2805 (rusC) 0.1461 6.981 NA 1.270 
Glucose ΔBT2806 (rusD) 0.1411 7.316 NA 1.280 
Glucose ΔBT2805-2806 (rusC/D) 0.0911 6.424 NA 0.946 
Glucose ΔBT2807 (rusGH) 0.1379 6.856 NA 1.267 
Glucose ΔBT2808 (rusNH) 0.1344 7.441 NA 1.224 
Glucose ΔBT2807-2808 (rusGH/NH) 0.1345 8.402 NA 1.263 
Glucose ΔBT2809 (rusT) 0.1596 7.024 NA 1.288 
Glucose ΔBT0184 0.1109 3.951 NA 0.877 
Glucose ΔBT1881 0.1053 4.939 NA 0.937 
Glucose ΔBT4330 0.1161 4.447 NA 0.976 
Glucose ΔBT4554 0.0986 8.401 NA 1.025 
Ribose wild-type BT (Δtdk) 0.0802 31.437 23.367 1.101 
Ribose ΔBT2802-2809 (rus) NG NA NA NG 
Ribose ΔBT2802 (rusR) NG NA NA NG 
Ribose ΔBT2803 (rusK1) 0.0768 62.582 54.972 1.123 
Ribose ΔBT2804 (rusK2) NG NA NA NG 
Ribose ΔBT2803-2804 (rusK1/K2) NG NA NA NG 
Ribose ΔBT2805 (rusC) 0.0579 28.385 21.405 1.123 
Ribose ΔBT2806 (rusD) 0.0577 32.189 24.869 1.128 
Ribose ΔBT2805-2806 (rusC/D) 0.0449 51.992 45.568 1.071 
Ribose ΔBT2807 (rusGH) 0.0741 30.015 23.155 1.126 
Ribose ΔBT2808 (rusNH) 0.0762 31.771 24.331 1.129 
Ribose ΔBT2807-2808 (rusGH/NH) 0.0786 32.774 24.374 1.107 
Ribose ΔBT2809 (rusT) 0.0225 40.550 33.530 0.829 
Ribose ΔBT0184 0.0539 46.531 42.580 1.125 
Ribose ΔBT1881 0.0544 44.053 39.114 1.079 
Ribose ΔBT4330 0.0560 43.554 39.107 1.111 
Ribose ΔBT4554 0.0538 46.037 37.636 1.122 
Thymidine wild-type BT (Δtdk) NC 66.977 49.434 0.224 
Thymidine wild-type BT (Δtdk) NC 42.127 38.623 0.318 
Thymidine ΔBT2802-2809 (rus) NG NA NA NG 
Thymidine ΔBT2802 (rusR) NG NA NA NG 
Thymidine ΔBT2803 (rusK1) NG NA NA NG 
Thymidine ΔBT2804 (rusK2) NG NA NA NG 
Thymidine ΔBT2803-2804 (rusK1/K2) NG NA NA NG 
Thymidine ΔBT2805 (rusC) NC 66.393 52.427 0.248 
Thymidine ΔBT2806 (rusD) NC 74.866 60.977 0.177 
Thymidine ΔBT2805-2806 (rusC/D) NC 46.531 42.084 0.182 
Thymidine ΔBT2807 (rusGH) NC 63.984 55.847 0.167 
Thymidine ΔBT2808 (rusNH) NC 50.850 42.568 0.260 
Thymidine ΔBT2807-2808 (rusGH/NH) NC 67.270 59.932 0.177 
Thymidine ΔBT2809 (rusT) NC 116.377 105.406 0.036 
Thymidine ΔBT0184 NC 33.148 29.198 0.284 
Thymidine ΔBT1881 NC 40.580 35.641 0.271 
Thymidine ΔBT4330 NC 41.078 36.631 0.255 
Thymidine ΔBT4554 NG NA NA NG 
Uridine wild-type BT (Δtdk) NC 70.321 52.778 0.200 
Uridine (10 mg/ml) wild-type BT (Δtdk) NC 42.069 38.613 0.198 
Uridine ΔBT2802-2809 (rus) NG NA NA NG 
Uridine ΔBT2802 (rusR) NG NA NA NG 
Uridine ΔBT2803 (rusK1) NG NA NA NG 





Uridine ΔBT2803-2804 (rusK1/K2) NG NA NA NG 
Uridine ΔBT2805 (rusC) NC 73.697 59.730 0.252 
Uridine ΔBT2806 (rusD) NC 76.327 62.438 0.207 
Uridine ΔBT2805-2806 (rusC/D) NC 64.405 59.958 0.134 
Uridine ΔBT2807 (rusGH) NC 59.897 51.760 0.227 
Uridine ΔBT2808 (rusNH) NC 60.991 52.709 0.242 
Uridine ΔBT2807-2808 (rusGH/NH) NC 62.743 55.405 0.220 
Uridine ΔBT2809 (rusT) NG NA NA NG 
Uridine ΔBT0184 NC 31.659 27.709 0.261 
Uridine ΔBT1881 NC 54.472 49.533 0.199 
Uridine ΔBT4330 NC NC NC 0.056 
Uridine ΔBT4554 NG NA NA NG 
Cytidine wild-type BT (Δtdk) NC 101.248 83.705 0.048 
Cytidine (10 mg/ml) wild-type BT (Δtdk) NC 66.393 62.937 0.107 
Cytidine ΔBT2802-2809 (rus) NG NA NA NG 
Cytidine ΔBT2802 (rusR) NG NA NA NG 
Cytidine ΔBT2803 (rusK1) NG NA NA NG 
Cytidine ΔBT2804 (rusK2) NG NA NA NG 
Cytidine ΔBT2803-2804 (rusK1/K2) NG NA NA NG 
Cytidine ΔBT2805 (rusC) NC 108.557 94.591 0.034 
Cytidine ΔBT2806 (rusD) NC NC NC 0.011 
Cytidine ΔBT2805-2806 (rusC/D) NC 74.844 70.397 0.081 
Cytidine ΔBT2807 (rusGH) NC 83.345 75.208 0.052 
Cytidine ΔBT2808 (rusNH) NC 86.526 78.243 0.088 
Cytidine ΔBT2807-2808 (rusGH/NH) NC 90.912 83.574 0.072 
Cytidine ΔBT2809 (rusT) NG NA NA NG 
Cytidine ΔBT0184 NC 39.59 35.64 0.20 
Cytidine ΔBT1881 NC 66.89 61.95 0.10 
Cytidine ΔBT4330 NC NC NC 0.02 
Cytidine ΔBT4554 NG NA NA NG 
5-methyl uridine wild-type BT (Δtdk) NC 82.356 64.812 0.151 
5-methyl uridine (10 mg/ml) wild-type BT (Δtdk) NC 49.014 45.558 0.203 
5-methyl uridine ΔBT2802-2809 (rus) NG NA NA NG 
5-methyl uridine ΔBT2802 (rusR) NG NA NA NG 
5-methyl uridine ΔBT2803 (rusK1) NG NA NA NG 
5-methyl uridine ΔBT2804 (rusK2) NG NA NA NG 
5-methyl uridine ΔBT2803-2804 (rusK1/K2) NG NA NA NG 
5-methyl uridine ΔBT2805 (rusC) NC 77.423 63.456 0.187 
5-methyl uridine ΔBT2806 (rusD) NC 64.451 50.562 0.258 
5-methyl uridine ΔBT2805-2806 (rusC/D) NC 58.943 54.496 0.131 
5-methyl uridine ΔBT2807 (rusGH) NC 50.004 41.867 0.255 
5-methyl uridine ΔBT2808 (rusNH) NC 65.765 57.483 0.192 
5-methyl uridine ΔBT2807-2808 (rusGH/NH) NC 51.929 44.591 0.262 
5-methyl uridine ΔBT2809 (rusT) NG NA NA NG 
5-methyl uridine ΔBT0184 NC 38.104 34.153 0.223 
5-methyl uridine ΔBT1881 NC 48.516 43.577 0.197 
5-methyl uridine ΔBT4330 NC 58.943 54.496 0.159 
5-methyl uridine ΔBT4554 NG NA NA NG 
RNA w/enzyme wild-type BT (Δtdk) NC 28.468 20.398 0.199 
RNA w/enzyme ΔBT2802-2809 (rus) NC NC NC 0.067 
RNA w/enzyme ΔBT2802 (rusR) NC NC NC 0.059 
RNA w/enzyme ΔBT2803 (rusK1) NC NC NC 0.090 
RNA w/enzyme ΔBT2804 (rusK2) NC NC NC 0.057 
RNA w/enzyme ΔBT2803-2804 (rusK1/K2) NC NC NC 0.082 
RNA w/enzyme ΔBT2805 (rusC) NC 43.693 36.713 0.237 
RNA w/enzyme ΔBT2806 (rusD) NC 46.313 38.993 0.221 
RNA w/enzyme ΔBT2805-2806 (rusC/D) NC 40.997 32.927 0.207 





RNA w/enzyme ΔBT2808 (rusNH) NC 45.828 38.388 0.247 
RNA w/enzyme ΔBT2807-2808 (rusGH/NH) NC 38.357 29.957 0.260 
RNA w/enzyme ΔBT2809 (rusT) NC NC NC 0.087 
RNA w/enzyme ΔBT0184 NC 39.278 31.208 0.169 
RNA w/enzyme ΔBT1881 NC 20.630 12.564 0.292 
RNA w/enzyme ΔBT4330 NC 23.634 15.490 0.200 
RNA w/enzyme ΔBT4554 NC 34.020 25.950 0.173 
Deoxyribose wild-type BT (Δtdk) NC 72.979 64.909 0.142 
Deoxyribose ΔBT2802-2809 (rus) NG NA NA NG 
AMP wild-type BT (Δtdk) NG NA NA NG 
AMP ΔBT2802-2809 (rus) NG NA NA NG 
Tagatose wild-type BT (Δtdk) NG NA NA NG 
Inosine wild-type BT (Δtdk) NG NA NA NG 
Adenosine wild-type BT (Δtdk) NG NA NA NG 
Xanthosine wild-type BT (Δtdk) NG NA NA NG 
Rebauside A wild-type BT (Δtdk) NG NA NA NG 
Amygdalin wild-type BT (Δtdk) NG NA NA NG 
Ribostymycin wild-type BT (Δtdk) NG NA NA NG 
N-acetylmuramic acid wild-type BT (Δtdk) NG NA NA NG 
Neomycin wild-type BT (Δtdk) NG NA NA NG 
Myo-Inositol wild-type BT (Δtdk) NG NA NA NG 
UDP-Galactose wild-type BT (Δtdk) NC 88.198 80.128 0.391 
UDP-β-Glucose wild-type BT (Δtdk) NC NC NC 0.300 
UDP-α-Glucose wild-type BT (Δtdk) NC 98.458 90.390 0.23 
UDP wild-type BT (Δtdk) NC NA NA NG 
Salmon Sperm DNA wild-type BT (Δtdk) NG NA NA NG 
ADP-Ribose wild-type BT (Δtdk) NC 82.048 73.978 0.076 
Lyxose wild-type BT (Δtdk) NC 66.256 58.186 0.116 
Psicose wild-type BT (Δtdk) NG NA NA NG 
Melezitose wild-type BT (Δtdk) NG NA NA NG 
UDP-N-acetylglucosamine wild-type BT (Δtdk) NG NA NA NG 
UDP-β-Glucose ΔBT2802-2809 (rus) NG NA NA NG 
UDP-α-Glucose ΔBT2802-2809 (rus) NG NA NA NG 
UDP ΔBT2802-2809 (rus) NG NA NA NG 
ADP-Ribose ΔBT2802-2809 (rus) NG NA NA NG 
UDP-glucuronic acid wild-type BT (Δtdk) NG NA NA NG 
UDP-glucosamine wild-type BT (Δtdk) NG NA NA NG 
NADH wild-type BT (Δtdk) NG NA NA NG 
Ribitol (adonitol) wild-type BT (Δtdk) NG NA NA NG 
Palatinose Δtdk (isogenic parent strain) 0.0812 48.495 39.632 0.937 
Palatinose ΔBT2802-2809 (rus) 0.0621 46.823 37.291 0.872 
Turanose  Δtdk (isogenic parent strain) 0.0878 24.080 15.217 1.013 
Turanose  ΔBT2802-2809 (rus) 0.0876 22.241 12.709 0.982 
Trehalose  Δtdk (isogenic parent strain) 0.0930 42.141 33.277 0.995 
Trehalose  ΔBT2802-2809 (rus) 0.0641 43.813 34.281 0.879 
Maltose  Δtdk (isogenic parent strain) 0.0979 11.539 2.676 1.014 
Maltose  ΔBT2802-2809 (rus) 0.0851 11.371 1.839 1.039 
Sucrose  Δtdk (isogenic parent strain) 0.0969 8.027 -0.836 1.053 
Sucrose  ΔBT2802-2809 (rus) 0.1086 8.361 -1.171 1.035 
Lactose  Δtdk (isogenic parent strain) 0.1106 8.696 -0.168 1.036 
Lactose  ΔBT2802-2809 (rus) 0.1033 9.365 -0.168 0.968 
Galactose  Δtdk (isogenic parent strain) 0.1133 11.539 2.676 0.928 
Galactose  ΔBT2802-2809 (rus) 0.1109 11.371 1.839 0.871 
Glucose  Δtdk (isogenic parent strain) 0.1075 8.863 0.000 1.042 
Glucose  ΔBT2802-2809 (rus) 0.1129 9.532 0.000 1.019 
Fructose  Δtdk (isogenic parent strain) 0.1070 8.863 0.000 0.895 
Fructose  ΔBT2802-2809 (rus) 0.1109 9.030 -0.502 0.853 





L-Fucose  ΔBT2802-2809 (rus) 0.0194 40.970 31.438 0.341 
Rhamnose  Δtdk (isogenic parent strain) 0.0503 38.796 29.933 0.538 
Rhamnose  ΔBT2802-2809 (rus) 0.0511 37.626 28.094 0.496 
Galacturonic Acid  Δtdk (isogenic parent strain) 0.0255 50.000 41.137 0.511 
Galacturonic Acid  ΔBT2802-2809 (rus) 0.0155 49.164 39.632 0.486 
Glucuronic Acid Δtdk (isogenic parent strain) 0.0342 46.488 37.625 0.561 
Glucuronic Acid ΔBT2802-2809 (rus) 0.0358 48.328 38.796 0.539 
N-acetylgalactosamine  Δtdk (isogenic parent strain) 0.0552 20.067 11.204 0.850 
N-acetylgalactosamine  ΔBT2802-2809 (rus) 0.0536 21.572 12.040 0.816 
N-acetylglucosamine  Δtdk (isogenic parent strain) 0.0827 10.368 1.505 0.926 
N-acetylglucosamine  ΔBT2802-2809 (rus) 0.0788 11.873 2.341 0.856 
Xylose  Δtdk (isogenic parent strain) 0.1074 20.569 11.706 1.131 
Xylose  ΔBT2802-2809 (rus) 0.1074 19.566 10.033 1.096 
Mannose  Δtdk (isogenic parent strain) 0.1278 7.526 -1.338 1.047 
Mannose  ΔBT2802-2809 (rus) 0.1310 8.194 -1.338 1.029 
L-Arabinose Δtdk (isogenic parent strain) 0.1171 16.054 7.190 0.999 
L-Arabinose  ΔBT2802-2809 (rus) 0.1017 16.388 6.856 0.919 
D-Arabinose  Δtdk (isogenic parent strain) 0.1034 20.234 11.371 0.934 
D-Arabinose  ΔBT2802-2809 (rus) 0.0949 19.900 10.368 0.920 
Glucosamine  Δtdk (isogenic parent strain) 0.0189 31.271 22.408 0.590 
Glucosamine  ΔBT2802-2809 (rus) 0.0202 28.930 19.398 0.589 
Raffinose  Δtdk (isogenic parent strain) 0.0245 17.559 8.696 0.732 
Raffinose  ΔBT2802-2809 (rus) 0.0175 30.603 21.070 0.660 
Erlose  Δtdk (isogenic parent strain) 0.0474 16.054 7.190 0.904 
Erlose  ΔBT2802-2809 (rus) 0.0505 16.221 6.689 0.879 
Chondroitin Sulfate Δtdk (isogenic parent strain) 0.1042 10.536 1.672 0.592 
Chondroitin Sulfate ΔBT2802-2809 (rus) 0.1190 10.368 0.836 0.557 
Heparin Sulfate Δtdk (isogenic parent strain) 0.0028 144.520 135.657 0.144 
Heparin Sulfate ΔBT2802-2809 (rus) 0.0051 67.391 57.859 0.141 
α-mannan Δtdk (isogenic parent strain) 0.0674 8.529 -0.334 0.541 
α-mannan ΔBT2802-2809 (rus) 0.0595 8.529 -1.003 0.497 
Mucin-O-glycans Δtdk (isogenic parent strain) 0.0074 8.863 0.000 0.848 
Mucin-O-glycans ΔBT2802-2809 (rus) 0.0074 7.693 -1.840 0.813 
Dextran  Δtdk (isogenic parent strain) 0.1019 18.897 10.033 0.920 
Dextran  ΔBT2802-2809 (rus) 0.1086 18.060 8.528 0.926 
Arabinan  Δtdk (isogenic parent strain) 0.0366 10.870 2.007 0.754 
Arabinan  ΔBT2802-2809 (rus) 0.0391 9.030 -0.502 0.725 
Arabinogalactan  Δtdk (isogenic parent strain) 0.0642 23.244 14.381 0.817 
Arabinogalactan  ΔBT2802-2809 (rus) 0.0581 16.890 7.358 0.748 
Pectic galactan (potato) Δtdk (isogenic parent strain) 0.1273 6.689 -2.174 0.809 
Pectic galactan (potato) ΔBT2802-2809 (rus) 0.1265 6.355 -3.178 0.740 
Pectic galactan (lupin) Δtdk (isogenic parent strain) 
 
5.853 -3.010 0.961 
Pectic galactan (lupin) ΔBT2802-2809 (rus) 0.0954 7.024 -2.509 0.798 
Polygalacturonate Δtdk (isogenic parent strain) 0.0858 8.863 0.000 0.660 
Polygalacturonate ΔBT2802-2809 (rus) 0.1078 10.870 1.338 0.595 
Rhamnogalacturonan I Δtdk (isogenic parent strain) 0.0419 6.020 -2.843 0.490 
Rhamnogalacturonan I ΔBT2802-2809 (rus) 0.0464 6.020 -3.512 0.497 
Inulin  Δtdk (isogenic parent strain) 0.0074 27.593 18.729 0.695 
Inulin  ΔBT2802-2809 (rus) 0.0059 27.091 17.558 0.637 
Levan  Δtdk (isogenic parent strain) 0.1191 8.529 -0.334 0.896 
Levan  ΔBT2802-2809 (rus) 0.1265 8.696 -0.836 0.868 
Pullulan  Δtdk (isogenic parent strain) 0.1040 18.897 10.033 0.974 
Pullulan  ΔBT2802-2809 (rus) 0.1144 18.897 9.364 0.976 
Glycogen  Δtdk (isogenic parent strain) 0.1038 15.218 6.354 0.972 
Glycogen  ΔBT2802-2809 (rus) 0.1081 13.378 3.846 0.994 
AP  Δtdk (isogenic parent strain) 
   
0.334 
AP  ΔBT2802-2809 (rus) 






Footnote: Abbreviations (NA : Not applicable, NG : No Growth, NT : Not Tested, NC: Not calculated due to poor/weak growth). 
When no growth was seen for wild-type (Δtdk), which is the isogenic parent strain background that all deletion strains were made 
in, the indicated substrate was not tested for rus deletion strains. Unless otherwise noted, substrates were a final concentration of 
5 mg/ml and 0.5 mg/ml were added to all substrates except glucose 
Genetic manipulation and recombinant protein purification in E. coli  
  To create a nucleoside hydrolase-free expression background, E. coli BL21-AITM One 
Shot® cells (Invitrogen) were manipulated using lambda red recombineering to introduce genetic 
deletions of the ribose-inducible hydrolase genes (rih) to avoid contaminating activity in 
downstream applications of purified proteins38. The E. coli gene deletion procedure developed by 
Datsenko and Wanner39 was followed with few modifications. Briefly, BL21-AI cells were 
transformed with the pKD46 plasmid. Transformed cells were grown overnight in LB + Amp100 
and sub-cultured, when the culture absorbance (600 nm) reached 0.1, L-arabinose was added to 
10 mM final concentration to induce the PBAD promoter of pKD46, cells were allowed to grow to 
an OD between 0.6-0.8 and made competent for electroporation by cold water washes and stored 
in 10% glycerol aliquots. For recombineering, 400ng of gel-purified PCR product was added to 
freshly made cells and incubated for 10 minutes on ice, electroporated in a 2mm gap cuvette at 
2500 V, recovered in 1 ml LB at 30°C for 5 hours. All knockouts were made sequentially in this 
manner via introduction of the following antibiotic cassettes (spectinomycin from K11497 for 
ΔrihA; hygromycin from K11521 for ΔrihB; gentamicin from K11590 for ΔrihC), and the 
following concentrations of antibiotic were used for selection: Spec80, Hygro200, Gent10. 
Following construction of the last deletion, the pKD46 plasmid was heat-cured by passaging 
twice at 42°C in LB. To better control background expression of the T7 promoter, the T7 
lysozyme containing plasmid, pLysS from BL21 (DE3) (Lucigen) was introduced into the strain 
via Ca2+ chemical competence/heat shock. Protein purification was accomplished using the 
pETite N-His vector (Lucigen). PCR primers were designed to amplify products for BT2803, 
BT2804, BT2807 and BT2808 containing all amino acids for BT2804 residues 1-311, or all 
amino acids downstream of the predicted signal peptide sequences, residues 22-539 for BT2807 
and residues 22-338 for BT2808, for BT2803 two constructs were made containing either all 
amino acids 1-321 or a construct based on an alternative start site containing residues 15-321 
(only this construct produced robust expression, while the full length failed to provide active 
product or good expression), amplified and transformed into Hi-Control 10G cells according to 





plasmids containing BT2803, BT2804, or BT2807 were transformed into E. coli strains TUNER 
or for BT2808 into BL21-AI ΔrihABC + pLysS. A single colony was grown in 5 mL of 
LB+Kan50 for 16h. This pre-inoculum was added to to 1L of Terrific-Broth with 50ng/ul of 
Kanamycin and 10 ng/ul of Chloramphenicol (BT2808) or 50ng/ul of Kanamycin (BT2807) and 
culture was grown with shaking at 37 °C until absorbance 0.4 at 600nm. BT2807 and BT2808 
cells were induced with a final concentration of 0.2mM or 1 mM IPTG and 0.2% 20mM L-
arabinose, respectively, and temperature was reduced to 16°C and outgrown overnight. The 
recombinant proteins were purified by immobilized metal ion affinity chromatography using 
cobalt (BT2807) or nickel-affinity (BT2808) columns was accomplished as described 
previously40. 
 
Measurements of transcriptional responses by qPCR 
  Bt and other Bacteroides strains were grown to mid-exponential phase 0.6-0.8 
(absorbance at 600nm) in MM-ribose, MM-arabinose, MM-xylose, or MM-glucose, two 
volumes of RNA protect added, followed by centrifugation and storage of cell pellets at -80°C. 
Total RNA was extracted using the RNeasy mini kit buffers (Qiagen) and purified on RNA-
binding spin columns (Epoch), treated with TURBO DNaseI (Ambion) or DNase I (NEB) after 
elution and purified again using a second RNeasy mini kit isolation column. Reverse 
transcription was performed using SuperScript III reverse transcriptase and random primers 
(Invitrogen). The abundance of each target transcript in the resulting cDNA was quantified using 
either KAPA SYBR® FAST qPCR mix (KAPA Biosystems) or a homemade qPCR mix as 
described previously41. Each 20 uL reaction contained 1X Thermopol Reaction Buffer (NEB), 
125uM dNTPs, 2.5mM MgSO4, 1X SYBR Green I (Lonza), 500nM gene specific or 65nM 16S 
rRNA primer and 0.5 units Hot Start Taq Polymerase (NEB), and 10ng of template cDNA. For 
the KAPA mix, 400 nM of primers specific for genes in the rus locus of Bt or the rusC-like gene 
of other Bacteroides species or 62.5 nM of 16S rRNA primers and 10ng of template cDNA as 
described previously42. Using the ddCT method, raw values were normalized to 16S rRNA 
values and then MM+ribose values were referenced to the values obtained in MM-glucose to 
obtain a fold-change. Measurements of transcriptional response over time in MM-ribose or 
nucleosides was performed similarly to previously described40. Briefly, strains were grown in 





MM-no carbon and resuspended in MM-ribose with time points being taken every 5 min for the 
first 30 min and every 15 min for a total of 120 min. Measurements of transcriptional responses 
to varying amounts of ribose were performed similarly as above, but only one time point was 
taken after 30 min of exposure to varying concentration of MM-ribose ranging from 0.0005 
mg/ml to 5mg/ml.  
 
Antibody production, western blotting and immunofluorescent microscopy 
  Purified recombinant BT2807 and BT2808 proteins were used as antigens to raise rabbit 
polyclonal antibodies (Cocalico Biologicals, Inc, Stevens PA). Antibody specificity and cellular 
localization for BT2807 and BT2808 were determined by western blotting of wild-type and 
relevant mutant strains and by immunofluorescent microscopy of Bt VPI-5482 grown in 
MM+glucose or MM+ribose. Growth conditions are described above, cells for WB were grown 
to mid-log optical absorbance (600 nm) 0.6-0.7 or 0.4-0.5 for IF. Western blots of Bt whole cell 
lysates were performed using the primary, polyclonal antibodies mentioned above and secondary 
antibody conjugated to goat anti-Rabbit IgG conjugated alkaline phosphatase (Sigma) and 
detected with NBT/BCIP (Roche). Surface expression of BT2807 or BT2808 was examined by 
staining with a BT2807- or BT2808-specific primary antibody in non-permeabilized 
formaldehyde-fixed Bt cells and detected with Alexa-Flour® 488 conjugated goat anti-Rabbit 
IgG secondary (Molecular Probes), as described previously40. Cells were imaged on an IX-70 
inverted microscope (Olympus) with images captured at 100x magnification. A minimum of five 
fields of view per slide was observed with n=2 biological replicates.   
 
RNAseq analysis 
  To determine the global transcriptional response to growth in ribose as the sole carbon 
source, Bt cells were grown overnight in rich TYG media then transferred to fresh MM 
containing either 5 mg/ml glucose or 5 mg/ml ribose. Cells were then grown until mid-log phase 
(absorbance between 0.6-0.8) and two volumes of RNA Protect (Qiagen) were added to cells. 
RNA was isolated as described above and purified whole RNA was then rRNA depleted using 
the Ribo-Zero Bacterial rRNA Removal Kit (Illumina Inc.) and concentrated with the RNA 
Clean and Concentrator-5 kit (Zymo Research Corp, Irvine, CA). Samples were multiplexed for 





was analyzed using Arraystar software (DNASTAR, Inc.) using RPKM normalization with 
default parameters. Gene expression in ribose was compared to gene expression in a glucose 
reference. Genes with significant up- or down-regulation were determined by the following 
criteria: genes with an average fold-change >5-fold and with at least 2/3 biological replicates 
with a normalized expression level >1% of the overall average RPKM expression level in either 
glucose or ribose, and a p-value < 0.05 (t test with Benjamini-Hochberg correction) (Table 2.3).  



















BT0094 5.842 4.72E-04 conserved protein found in 
conjugate transposon 
NA DUF4133  
BT0107 6.766 6.22E-03 hypothetical protein NA Helix-turn-helix motif, HTH_17 
BT0437 5.038 1.05E-02 N-acylglucosamine 2-epimerase NA  GlcNAc_2-epim  
BT0565 8.201 7.66E-04 putative heat shock protein NA HSP20 
BT0656 5.324 4.72E-04 hypothetical protein NA None 
BT0786 6.639 4.72E-04 putative integral membrane 
protein 
NA DUF4396 





8.087 5.07E-04 succinyl-CoA synthetase (ADP-
forming) beta subunit 
NA Ligase_CoA, ATP-grasp_2  
BT0805 5.023 4.72E-04 hypothetical protein NA DUF2776  
BT0854 6.653 3.68E-03 hypothetical protein NA None 
BT0970 0.121 2.52E-04 haloacid dehalogenase-like 
hydrolase 
NA HAD_2 
BT1009 6.775 1.65E-03 dihydroorotate dehydrogenase NA None 
BT1096 5.378 4.72E-04 transposase NA DDE_Tnp_4, DDE superfamily 
endonuclease 
BT1097 5.207 7.28E-04 hypothetical protein NA None 
BT1196 5.011 4.72E-04 pyruvate carboxylase subunit B) NA HMGL-like, PYC_OADA 
BT1259 5.335 4.72E-04 choloylglycine hydrolase NA CBAH, Linear amide C-N hydrolases, 
choloylglycine hydrolase family 
BT1323 5.560 4.72E-04 putative ABC transporter 
permease protein 
NA Binding-protein-dependent transport 
system inner membrane component 
BT1435 6.042 4.72E-04 hypothetical protein NA None 
BT1448 8.568 1.20E-03 biotin carboxyl carrier protein NA PF00364, Biotin_lipoyl  
BT1449 
(accC1) 
6.820 7.16E-04 biotin carboxylase NA None 





0.190 1.65E-02 7-cyano-7-deazaguanine reductase 
(Queuosine biosynthesis) 
QueF  
BT1757 6.243 4.72E-04 fructokinase NA None 
BT1758 21.519 1.04E-03 glucose/galactose transporter NA None 
BT1759 12.264 5.44E-04 levanase precursor (2,6-beta-D- 
fructofuranosidase) 
GH32 None 
BT1760 16.220 2.87E-03 glycosylhydrolase GH32 None 
BT1761 15.049 2.87E-03 hypothetical protein NA None 
BT1762 17.388 4.84E-03 putative outer membrane protein, probably 
involved in nutrient binding 
None 
BT1763 13.577 2.00E-03 putative outer membrane protein, probably 






BT1765 13.231 2.19E-04 levanase precursor (2,6-beta-D- 
fructofuranosidase) 
GH32 None 
BT1914 7.540 5.35E-04 thioredoxin-like protein, 
putative thioredoxin 
NA None 
BT1960 5.196 2.28E-02 integrase NA Phage integrase SAM-like domain 
BT2082 5.906 4.72E-04 hypothetical protein NA Outer membrane protein beta-barrel 
domain 
BT2083 6.627 4.72E-04 hypothetical protein NA Calycin-like beta-barrel domain 
BT2156 0.044 5.59E-04 putative sugar phosphate 
isomerase/epimerase 
NA AP_endonuc_2 (Xylose isomerase-
like TIM barrel) 
BT2157 0.040 4.91E-04 hypothetical protein NA DUF1080  
BT2158 0.042 9.12E-04 putative dehydrogenases and 
related proteins 
NA GFO_IDH_MocA (Oxidoreductase 
family, NAD-binding Rossmann fold) 
BT2159 0.041 4.72E-04 putative oxidoreductase NA GFO_IDH_MocA (Oxidoreductase 
family, NAD-binding Rossmann fold) 
BT2167 8.370 5.77E-03 elongation factor G NA None 
BT2178 0.056 4.72E-04 hypothetical protein NA None 
BT2297 5.869 4.91E-04 putative reverse transcriptase NA None 
BT2298 6.578 1.76E-02 conserved protein found in 
conjugate transposon 
NA DUF3875  
BT2300 5.439 9.78E-03 conserved protein found in 
conjugate transposon 
NA DUF4134  
BT2304 6.707 8.52E-03 hypothetical protein NA None 
BT2323 5.654 1.31E-03 hypothetical protein NA DUF3945, DUF4099  
BT2334 6.376 9.85E-03 hypothetical protein NA Helix-turn-helix motif, HTH_17 
BT2442 6.746 1.75E-03 major outer membrane protein 
OmpA 
NA None 
BT2569 6.166 4.91E-04 RNA polymerase ECF-type 
sigma factor 
NA Sigma 70 
BT2756 5.109 7.30E-04 anaerobic C4-dicarboxylate 
transporter dcuB 
NA DcuA_DcuB 
BT2803 195.309 4.72E-04 ribokinase NA None 
BT2804 178.415 5.50E-04 ribokinase NA None 
BT2805 110.793 7.16E-04 SusC-like NA None 
BT2806 110.268 6.69E-04 SusD-like NA None 
BT2807 119.753 5.79E-04 GH* NA None 
BT2808 130.147 4.91E-04 putative inosine-uridine 
preferring nucleoside hydrolase 
NA None 
BT2809 146.585 4.72E-04 Permease  NA None 
BT2872 5.560 2.35E-03 putative capsular 
polysaccharide synthesis 
protein 
GT32 Capsular polysaccharide synthesis 
protein 
BT3024 0.126 1.92E-02 putative outer membrane protein, probably 
involved in nutrient binding 
TonB_dep_Rec  
BT3025 0.156 2.52E-02 putative outer membrane protein, probably 
involved in nutrient binding 
SusD, SusD-like_3  
BT3026 0.118 2.76E-02 glycosylhydrolase, putative 
xylanase 
GH30_6 Glyco_hydro_30 
BT3027 0.165 3.20E-02 hypothetical protein NA None 
BT3100 5.076 7.16E-04 lipase, putative esterase NA Abhydrolase_3, Peptidase_S9 
BT3113 0.186 4.91E-04 putative transmembrane efflux 
protein 
NA MFS_1 
BT3114 0.173 2.97E-03 beta-galactosidase GH2 Glyco_hydro_2_N, Glyco_hydro_2_N 
, PA14 
BT3167 9.709 1.02E-02 hypothetical protein NA HHH-3, Helix-hairpin-helix motif 
BT3344 0.044 9.01E-03 hypothetical protein NA DUF4361, DUF4973  
BT3345 0.034 7.15E-03 conserved hypothetical protein, putative 
outer membrane protein 





BT3346 0.096 1.37E-02 putative outer membrane protein, probably 
involved in nutrient binding 
TonB_dep_Rec  
BT3347 0.069 6.69E-03 hypothetical protein NA IPT/TIG domain 
BT3415 10.103 5.73E-03 hypothetical protein NA None 
BT3735 6.293 4.72E-04 hypothetical protein NA None 
BT3823 5.952 4.72E-04 hypothetical protein NA Ferritin  
BT3916 5.378 8.53E-04 site-specific recombinase IntIA NA Phage_integrase  
BT4542 5.835 6.40E-04 Type I restriction enzyme 
EcoR124II specificity protein 
NA Methylase_S  
BT4676 5.936 5.55E-04 putative periplasmic protein NA Putative beta-lactamase-inhibitor-like, 
PepSY-like 
BT4677 5.813 4.72E-04 hypothetical protein NA Putative beta-lactamase-inhibitor-like, 
PepSY-like 
BT4686 8.068 2.07E-02 hypothetical protein NA 
 
BT4688 5.808 8.56E-04 hypothetical protein NA Mechanosensitive ion channel 
BT4689 7.074 4.91E-04 pullulanase precursor GH13_14 Alpha-amylase, CBM_48 
BT4690 5.562 4.72E-04 alpha-amylase precursor GH13_5 Alpha-amylase  
BT4744 5.231 4.72E-04 putative multiple inositol polyphosphate 
histidine phosphatase 1 
Histidine phosphatase superfamily 
(branch 2) 
Footnote: This list was trimmed using the following parameters,  gene represented above 1% of total RPKM abundance in at least 
2 replicates of one condition either glucose or ribose. The list was further trimmed by only including genes with a p-value < 0.05. 
Lastly, we only considered genes of greater than a 5 fold up- or downregulation compared to growth in glucose. Abbreviations: 
NA (not applicable), GH (glycoside hydrolase), GT (glycosyl or glycoside transferase), CAZY (Carbohydrate Active Enzymes).  
 
Functional annotation and comparative genomics of rus PULs across Bacteroidetes genomes 
  Initial functional annotations of Bt rus genes were taken from the Integrated Microbial 
Genomes (IMG) database using the Pfam, InterPro, COG, or KOG predictions. In cases where 
multiple annotations, we selected the more inclusive terms (e.g. nucleoside phosphorylase 
instead of purine or pyrimidine-specific nucleoside phosphorylase). A total of 354 different 
Bacteroidetes strains were tested for growth on ribose as a sole carbon source as shown in 
(Figure 2.10A) and summarized in (Table 2.4). The ability to use ribose is shown in the context 
of a previously published human gut Bacteroidetes phylogeny that used 14 conserved genes 
across phylum members10. To search for rus locus homologs across the Bacteroidetes phylum, 
we used the amino acid sequences of the rusK1, rusK2, rusT, and rusR genes from the Bt type 
strain as deletion of these genes yielded growth defects on ribose. We searched the IMG database 
(current as of May 2018) and performed phylum-level BLAST searches with an E-value cutoff 
of 1e-50. We chose this stringent cutoff as initial searches using lower values obtained many 
non-specific hits of genes encoding other kinases and permeases that did not appear to be 
specific for ribose, including in the Bt VPI-5482 genome for which Rusk1 and RusK1 are the 
only kinases able to promote ribose growth. After we completed our search for rusK, rusT, and 
rusR homologs we used the Gene Neighborhood tool in IMG to determine if these hits were 





two adjacent rus gene homologs was required to count the presence of a candidate utilization 
locus. Following this first round of searching we observed that many of the rus loci contained 
one or more nucleoside cleaving enzymes such as homologs of Bt rusNH or ADP-
ribosylglycohydrolases (RGH) and upstream putative regulatory genes. To give our search more 
power and potentially find additional rus homologs we performed additional searches with the 
same E-value threshold for homologs of Bt rusNH, or homologs of the ADP-RGH in B. 
xylanisolvens XB1A. When assembling the comparative genomics data, gene names and 
glycoside hydrolase family assignments are shown as predicted within IMG by either annotation, 
Pfam and/or InterPro predictions or confirmed by BLAST of the amino acid sequence of 
individual genes. Further, in refinement, a handful of genes were found below our E-value, but 
included in the table as it is clear from gene neighborhood views in IMG that it is likely part of a 
rus locus due to adjacent hits of rus homologs. Types of rus have been assigned based only on 
gene content and arrangement as a way to indicate differences, however subtle. In completing 
our table, we have included the bit score as well as the amino acid % identities compared to Bt 
rus genes or Bx XB1A ADP-RGH genes. All of the positive gene hits with locus tag information, 
isolation location, and other relevant strain information is summarized in the published 
manuscript of this chapter, but due to concerns of including 75 pages worth of tables has been 
omitted here.  





























B. caccae ATCC 43185 100 (type strain) Human pre-1980 1.02 0.00156 
B. caccae VPI-3452A 100 (type strain) Human pre-1980 0.00 0.00000 
B. caccae VPI-B6-11 99.8 (836/838) Human pre-1980 1.13 0.00114 
B. caccae WH110 99.6 (795/798) Human 1995-99 1.09 0.00146 
B. caccae VPI-C14-3 99.6 (830/833) Human pre-1980 0.00 0.00000 
B. caccae VPI-C7-8 99.6 (832/835) Human pre-1980 1.28 0.00134 
B. caccae WAL8714 99.6 (832/835) Human unknown 0.90 0.00058 
B. caccae WH719 99.5 (770/774) Human 1995-99 0.72 0.00033 
B. caccae VPI-T1-1 99.5 (850/854) Human pre-1980 0.85 0.00040 
B. caccae VPI-8608 99.4 (834/839) Human pre-1980 1.20 0.00165 
B. caccae CL03T12C61 99.4 (994/1000) Human 2000 or later 1.20 0.00153 
B. caccae VPI-C10-2 99.1 (778/785) Human pre-1980 0.96 0.00119 
B. cellulosilyticus DSM 14838 100 (type strain) Human 2000 or later 1.20 0.00192 
B. cellulosilyticus WH1 99.9 (795/796) Human 1995-99 1.13 0.00178 
B. cellulosilyticus WH403 99.8 (851/853) Human 1995-99 1.13 0.00211 
B. cellulosilyticus WH206 99.8 (844/846) Human 1995-99 1.11 0.00227 
B. cellulosilyticus WH2 99.8 (838/840) Human 1995-99 1.19 0.00185 
B. cellulosilyticus WH401 99.8 (838/840) Human 1995-99 1.15 0.00195 





B. cellulosilyticus WH402 99.6 (844/847) Human 1995-99 1.11 0.00183 
B. cellulosilyticus WH405 99.5 (827/831) Human 1995-99 1.19 0.00201 
B. cellulosilyticus WH101 99.4 (802/807) Human 1995-99 1.22 0.00201 
B. clarus DSM 22519 100 (type strain) Human 2000 or later 0.00 0.00000 
B. dorei DSM 17855 100 (type strain) Human 2000 or later 0.00 0.00000 
B. dorei CL02T12C06 100 (1520/1520) Human 2000 or later 0.31 0.00018 
B. dorei WH106 100 (792/792) Human 1995-99 0.00 0.00000 
B. dorei WH26 100 (830/830) Human 1995-99 0.00 0.00000 
B. dorei WH303 100 (870/870) Human 1995-99 0.92 0.00040 
B. dorei WH512 99.9 (870/871) Human 1995-99 0.00 0.00000 
B. dorei 9_1_42FAA 99.9 (859/860) Human 2000 or later 0.00 0.00000 
B. dorei 3_1_33FAA 99.9 (858/859) Human 2000 or later 0.00 0.00000 
B. dorei VPI-2277 99.9 (853/854) Human pre-1980 0.86 0.00082 
B. dorei WH607 99.9 (852/853) Human 1995-99 0.00 0.00000 
B. dorei VPI-6598B 99.9 (845/846) Human pre-1980 0.00 0.00000 
B. dorei WH104 99.8 (811/813) Human 1995-99 0.00 0.00000 
B. dorei CL02T00C15 99.7 (882/885) Human 2000 or later 0.30 0.00016 
B. dorei CL03T12C01 99.6 (956/960) Human 2000 or later 0.00 0.00000 
B. eggerthii DSM 20697, ATCC 27754 100 (type strain) Human pre-1980 0.00 0.00000 
B. eggerthii 1_2_48FAA 99.6 (844/847) Human 2000 or later 0.00 0.00000 
B. eggerthii VPI-S1A-52 99.5 (831/835) Human pre-1980 0.00 0.00000 
B. finegoldii DSM 17565 100 (type strain) Human 2000 or later 0.00 0.00000 
B. finegoldii WH508 99.6 (843/846) Human 1995-99 0.00 0.00000 
B. finegoldii CL09T03C10 96.9 (991/1023) Human 2000 or later 0.00 0.00000 
B. fluxus DSM 22534 100 (type strain) Human 2000 or later 0.00 0.00000 
B. fragilis NCTC 9343, ATCC 25285 100 (type strain) Human pre-1980 0.00 0.00000 
B. fragilis VPI-4517 100 (836/836) Human pre-1980 0.00 0.00000 
B. fragilis VPI-4509b 100 (848/848) Human pre-1980 0.00 0.00000 
B. fragilis VPI-BF7639 99.9 (850/851) Human pre-1980 0.00 0.00000 
B. fragilis VPI-6779 99.9 (849/850) Human pre-1980 0.00 0.00000 
B. fragilis VPI-5383 / 23745 99.9 (843/844) Human pre-1980 0.00 0.00000 
B. fragilis VPI-BF7397 99.9 (842/843) Human pre-1980 0.00 0.00000 
B. fragilis VPI-BF119 99.9 (841/842) Human pre-1980 0.00 0.00000 
B. fragilis VPI-BF7567 99.9 (839/840) Human pre-1980 0.00 0.00000 
B. fragilis VPI-BF8371 99.9 (839/840) Human pre-1980 0.00 0.00000 
B. fragilis VPI-3277 99.9 (830/831) Human pre-1980 0.00 0.00000 
B. fragilis VPI-2553 99.9 (791/792) Human pre-1980 0.00 0.00000 
B. fragilis VPI-1582 99.9 (785/786) Human pre-1980 0.00 0.00000 
B. fragilis VPI-BF V479 99.8 (871/873) Human pre-1980 0.00 0.00000 
B. fragilis VPI-BF-CEST 99.8 (846/848) Human pre-1980 0.00 0.00000 
B. fragilis WH709 99.8 (845/847) Human 1995-99 0.00 0.00000 
B. fragilis VPI-1522 99.8 (845/847) Human pre-1980 0.00 0.00000 
B. fragilis WAL8762 99.8 (845/847) Human unknown 0.00 0.00000 
B. fragilis VPI-499 99.8 (840/842) Human pre-1980 0.00 0.00000 
B. fragilis 638R 99.8 (840/842) Human pre-1980 0.00 0.00000 
B. fragilis WH706 99.8 (824/826) Human 1995-99 0.00 0.00000 
B. fragilis WH707 99.8 (820/822) Human 1995-99 0.00 0.00000 
B. fragilis CL05T12C13 99.7 (985/988) Human 2000 or later 0.00 0.00000 
B. fragilis CL07T00C01 99.6 (897/901) Human 2000 or later 0.00 0.00000 
B. fragilis VPI-BF-ERL 99.6 (855/858) Human pre-1980 0.00 0.00000 
B. fragilis WAL8916 99.6 (855/858) Human unknown 0.00 0.00000 
B. fragilis 2_1_56FAA  99.6 (853/856) Human 2000 or later 0.00 0.00000 
B. fragilis VPI-4361 99.6 (849/852) Human pre-1980 0.00 0.00000 
B. fragilis VPI-BF8223 99.6 (846/849) Human pre-1980 0.00 0.00000 
B. fragilis WAL8774 99.6 (845/848) Human unknown 0.00 0.00000 
B. fragilis WH705 99.6 (836/839) Human 1995-99 0.00 0.00000 
B. fragilis VPI-2044 99.6 (833/836) Human pre-1980 0.00 0.00000 





B. fragilis VPI-12256  99.6 (832/835) Human pre-1980 0.00 0.00000 
B. fragilis WH718 99.6 (807/810) Human 1995-99 0.00 0.00000 
B. fragilis CL03T00C08 99.6 (1026/1030) Human 2000 or later 0.00 0.00000 
B. fragilis YCH46 99.5 (776/780) Human unknown 0.00 0.00000 
B. fragilis VPI-BF8928 99.4 (852/857) Human pre-1980 0.00 0.00000 
B. fragilis 3_2_5 99.4 (845/850) Human 2000 or later 0.00 0.00000 
B. fragilis VPI-29765 99.4 (844/849) Human pre-1980 0.00 0.00000 
B. fragilis WAL8790 99.4 (835/840) Human unknown 0.00 0.00000 
B. fragilis WH605 99.4 (815/820) Human 1995-99 0.00 0.00000 
B. fragilis CL05T00C42 99.4 (1090/1096) Human 2000 or later 0.00 0.00000 
B. fragilis VPI-2556I 99.3 (834/840) Human pre-1980 0.00 0.00000 
B. fragilis CL07T12C05 99.3 (1051/1058 Human 2000 or later 0.00 0.00000 
B. fragilis CL03T12C07 99.3 (1014/1021) Human 2000 or later 0.00 0.00000 
B. fragilis VPI-2552 98.7 (820/831) Human pre-1980 0.00 0.00000 
B. fragilis 3_1_12  98.6 (838/850) Human 2000 or later 0.00 0.00000 
B. fragilis VPI-2627-J2 98.6 (804/815) Human pre-1980 0.00 0.00000 
B. fragilis VPI-3392 98.5 (842/855) Human pre-1980 0.00 0.00000 
B. fragilis VPI-4076 98.5 (835/848) Human pre-1980 0.00 0.00000 
B. fragilis VPI-4225 98.5 (834/847) Human pre-1980 0.00 0.00000 
B. fragilis VPI-2393 98.5 (780/792) Human pre-1980 0.00 0.00000 
B. fragilis VPI-2343 98.5 (779/791) Human pre-1980 0.00 0.00000 
B. fragilis VPI-A11-24B 98.4 (782/795) Human pre-1980 0.00 0.00000 
B. fragilis VPI-4117 98.1 (773/788) Human pre-1980 0.00 0.00000 
B. intestinalis DSM 17393 100 (type strain) Human 2000 or later 0.99 0.00145 
B. intestinihominis DSM 21032 100 (type strain) Human 2000 or later 0.00 0.00000 
B. massiliensis B84634, DSM 17679  100 (type strain) Human 2000 or later 0.00 0.00000 
B. massiliensis JCM12982 99.7 (1486/1491) Human 2000 or later 0.00 0.00000 
B. massiliensis A03 99.5 (865/869) Human 2000 or later 0.12 0.00002 
B. nordii CL02T12C05 100 (type strain) Human 2000 or later 0.00 0.00000 
B. nordii WAL7936 99 (852/861) Human unknown 0.00 0.00000 
B. nordii WH103 99 (806/814) Human 1995-99 0.00 0.00000 
B. nordii WAL7935 98.8 (848/858) Human unknown 0.00 0.00000 
B. oleiciplenus DSM 22535 100 (type strain) Human 2000 or later 1.04 0.00171 
B. ovatus ATCC 8483 100 (type strain) Human pre-1980 0.88 0.00048 
B. ovatus NLAE-zl-C34 99.9 (787/788) Cow 2000 or later 1.00 0.00057 
B. ovatus NLAE-zl-C11 99.9 (787/788) Cow 2000 or later 1.00 0.00068 
B. ovatus WH702 99.9 (756/757) Human 1995-99 1.12 0.00137 
B. ovatus WH711 99.9 (687/688) Human 1995-99 1.16 0.00083 
B. ovatus WH211 99.8 (850/852) Human 1995-99 1.14 0.00091 
B. ovatus WH214 99.8 (827/829) Human 1995-99 1.15 0.00114 
B. ovatus CL02T12C04 99.7 (1032/1035) Human 2000 or later 1.02 0.00075 
B. ovatus 3_8_47FAA 99.6 (849/852) Human 2000 or later 1.14 0.00148 
B. ovatus VPI-3049 99.6 (845/848) Human pre-1980 1.05 0.00085 
B. ovatus VPI-C1-45 99.6 (837/840) Human pre-1980 1.13 0.00072 
B. ovatus VPI-4104 99.6 (834/837) Human pre-1980 1.05 0.00082 
B. ovatus WH713 99.6 (811/814) Human 1995-99 1.03 0.00150 
B. ovatus WAL7922 99.5 (859/863) Human unknown 1.08 0.00184 
B. ovatus WH208 99.5 (818/822) Human 1995-99 1.16 0.00137 
B. ovatus VPI-8653 99.5 (786/790) Human pre-1980 1.00 0.00090 
B. ovatus VPI-435 99.4 (820/825) Human pre-1980 1.16 0.00207 
B. ovatus NLAE-zl-H366 99.4 (1387/1395) Human 2000 or later 0.93 0.00117 
B. ovatus NLAE-zl-H251 99.4 (1383/1391) Human 2000 or later 0.81 0.00115 
B. ovatus VPI-38 99.3 (801/807) Human pre-1980 0.88 0.00083 
B. ovatus CL03T12C18 99.3 (1023/1030) Human 2000 or later 0.99 0.00150 
B. ovatus WH514 99.1 (851/859) Human 1995-99 1.00 0.00062 
B. ovatus VPI-B4-11 99.1 (843/851) Human pre-1980 1.11 0.00186 
B. ovatus NLAE-zl-H163 98.7 (1377/1395) Human 2000 or later 0.93 0.00082 





B. ovatus NLAE-zl-H361 98.5 (1380/1401) Human 2000 or later 0.96 0.00136 
B. ovatus VPI-C16-22 98.4 (825/838) Human pre-1980 1.17 0.00230 
B. ovatus 3_1_23 98.3 (834/848) Human 2000 or later 0.94 0.00045 
B. ovatus WH601 97.9 (834/852) Human 1995-99 1.04 0.00201 
B. ovatus WH604 97.7 (834/854) Human 1995-99 1.09 0.00128 
B. ovatus WH606 97.7 (821/840) Human 1995-99 1.12 0.00109 
B. ovatus D2 (2_1_39) 97.7 (817/836) Human 2000 or later 1.14 0.00126 
B. ovatus NLAE-zl-H59 97.3 (1249/1284) Human 2000 or later 0.98 0.00144 
B. ovatus NLAE-zl-H73 95 (1218/1284) Human 2000 or later 0.98 0.00133 
B. plebeius DSM 17135 100 (type strain) Human 2000 or later 0.00 0.00000 
B. salyersae DSM 18765, ATCC BAA-997 100 (type strain) Human 2000 or later 0.00 0.00000 
B. salyersae WAL7960 99.4 (846/851) Human unknown 0.00 0.00000 
B. salyersae WAL9166 99.3 (832/838) Human unknown 0.00 0.00000 
B. salyersae VPI-2828 99.2 (845/852) Human pre-1980 0.00 0.00000 
B. salyersae CL02T12C01 98.9 (842/851) Human 2000 or later 0.00 0.00000 
B. stercoris ATCC 43183, VPI B5-21 100 (type strain) Human pre-1980 0.00 0.00000 
B. stercoris WH102 99.7 (807/809) Human 1995-99 1.23 0.00163 
B. stercoris WH22 99.6 (833/836) Human 1995-99 0.80 0.00069 
B. stercoris VPI-B5-21 99.5 (846/850) Human pre-1980 0.00 0.00000 
B. stercoris WH24 99.5 (824/828) Human 1995-99 0.80 0.00075 
B. stercoris VPI-C8-19 99.3 (845/851) Human pre-1980 1.02 0.00092 
B. stercoris VPI-C51-6 99 (825/833) Human pre-1980 0.00 0.00000 
B. thetaiotaomicron VPI-5482, ATCC 29148 100 (type strain) Human pre-1980 1.21 0.00143 
B. thetaiotaomicron NLAE-zl-G288 100 (1223/1233) Goat 2000 or later 1.39 0.00120 
B. thetaiotaomicron NLAE-zl-H492 100 (1227/1227) Human 2000 or later 0.98 0.00074 
B. thetaiotaomicron NLAE-zl-H463 100 (1228/1228) Human 2000 or later 1.05 0.00088 
B. thetaiotaomicron VPI-2808B 100 (751/751) Human pre-1980 1.19 0.00184 
B. thetaiotaomicron VPI-BT7853 100 (751/751) Human pre-1980 1.31 0.00133 
B. thetaiotaomicron 7330 99.9 (840/841) Human pre-1980 1.24 0.00182 
B. thetaiotaomicron VPI-3731 99.9 (826/827) Human pre-1980 1.13 0.00143 
B. thetaiotaomicron VPI-BT-DOT2 99.8 (854/856) Human pre-1980 0.00 0.00000 
B. thetaiotaomicron 1_1_6 99.8 (848/850) Human 2000 or later 0.98 0.00106 
B. thetaiotaomicron 23685 99.8 (846/848) Human unknown 0.97 0.00103 
B. thetaiotaomicron VPI-3164 99.8 (846/848) Human pre-1980 1.19 0.00217 
B. thetaiotaomicron VPI-0633-1 99.8 (844/846) Human pre-1980 1.21 0.00197 
B. thetaiotaomicron WH25 99.8 (822/824) Human 1995-99 1.26 0.00163 
B. thetaiotaomicron NLAE-zl-P32 99.8 (1417/1420) Pig 2000 or later 1.00 0.00123 
B. thetaiotaomicron NLAE-zl-P699 99.8 (1416/1419) Pig 2000 or later 1.06 0.00130 
B. thetaiotaomicron NLAE-zl-C523 99.8 (1239/1241) Cow 2000 or later 1.33 0.00154 
B. thetaiotaomicron WAL8669 99.7 (864/867) Human unknown 1.17 0.00173 
B. thetaiotaomicron WH510 99.7 (783/785) Human 1995-99 1.19 0.00126 
B. thetaiotaomicron WAL8713 99.6 (854/857) Human unknown 1.17 0.00162 
B. thetaiotaomicron WH503 99.6 (833/836) Human 1995-99 1.29 0.00108 
B. thetaiotaomicron WH507 99.6 (810/813) Human 1995-99 0.00 0.00000 
B. thetaiotaomicron VPI-J19-343 99.5 (850/854) Human pre-1980 1.15 0.00164 
B. thetaiotaomicron 23722 99.5 (838/842) Human unknown 1.11 0.00185 
B. thetaiotaomicron WH502 99.5 (834/838) Human 1995-99 1.30 0.00127 
B. thetaiotaomicron WH509 99.5 (823/827) Human 1995-99 1.19 0.00152 
B. thetaiotaomicron 1_1_14 99.5 (730/734) Human 2000 or later 1.11 0.00144 
B. thetaiotaomicron NLAE-zl-C425 99.5 (636/639) Cow 2000 or later 1.18 0.00141 
B. thetaiotaomicron VPI-0940-1 99.4 (841/846) Human pre-1980 1.17 0.00077 
B. thetaiotaomicron NLAE-zl-P750 99.4 (790/795) Pig 2000 or later 1.00 0.00072 
B. thetaiotaomicron NLAE-zl-H353 99.4 (785/790) Human 2000 or later 0.99 0.00042 
B. thetaiotaomicron NLAE-zl-H486 99.4 (498/501) Human 2000 or later 0.97 0.00062 
B. thetaiotaomicron NLAE-zl-G234 99.4 (497/500) Goat 2000 or later 1.00 0.00044 
B. thetaiotaomicron NLAE-zl-P696 99.4 (496/499) Pig 2000 or later 1.10 0.00133 
B. thetaiotaomicron NLAE-zl-P737 99.4 (496/499) Pig 2000 or later 1.13 0.00130 





B. thetaiotaomicron NLAE-zl-C504 99.3 (711/716) Cow 2000 or later 1.27 0.00171 
B. thetaiotaomicron VPI-3443 99.2 (851/858) Human pre-1980 1.13 0.00159 
B. thetaiotaomicron VPI-C11-15 99.2 (842/849) Human pre-1980 1.13 0.00181 
B. thetaiotaomicron NLAE-zl-H39 99.2 (789/795) Human 2000 or later 1.07 0.00108 
B. thetaiotaomicron NLAE-zl-C15 99.2 (708/714) Cow 2000 or later 1.04 0.00105 
B. thetaiotaomicron dnlkv9 99.2 (1371/1382) Mouse 2000 or later 1.25 0.00158 
B. thetaiotaomicron ATCC 29741 99.1 (783/790) Human unknown 1.11 0.00163 
B. thetaiotaomicron WH501 99 (829/837) Human 1995-99 1.27 0.00121 
B. thetaiotaomicron NLAE-zl-G303 98.7 (790/800) Goat 2000 or later 1.33 0.00104 
B. thetaiotaomicron NLAE-zl-H23 98.7 (779/789) Human 2000 or later 1.09 0.00108 
B. thetaiotaomicron VPI-BF6436-5 98.7 (777/787) Human pre-1980 1.26 0.00215 
B. thetaiotaomicron NLAE-zl-H207 98.7 (1404/1422) Human 2000 or later 1.10 0.00054 
B. thetaiotaomicron MAJ 27  (B. faecis) 98.5 (1402/1424) Human 2000 or later 1.19 0.00122 
B. thetaiotaomicron NLAE-zl-G493 98.4 (784/797) Goat 2000 or later 1.09 0.00101 
B. thetaiotaomicron MAJ 26 (B. faecis) 98.2 (853/869) Human 2000 or later 1.22 0.00126 
B. thetaiotaomicron WAL8736 98.1 (839/855) Human unknown 1.14 0.00132 
B. thetaiotaomicron WH21 98.1 (836/852) Human 1995-99 1.17 0.00148 
B. thetaiotaomicron WH3 97.9 (782/799) Human 1995-99 1.09 0.00140 
B. thetaiotaomicron VPI-BT8702 97.4 (829/851) Human pre-1980 1.18 0.00208 
B. thetaiotaomicron NLAE-zl-G295 97.3 (796/818) Goat 2000 or later 1.10 0.00082 
B. thetaiotaomicron NLAE-zl-P718 97.2 (486/500) Pig 2000 or later 1.07 0.00121 
B. thetaiotaomicron VPI-11984 97.1 (802/826) Human pre-1980 1.15 0.00197 
B. uniformis ATCC 8492 100 (type strain) Human pre-1980 0.34 0.00034 
B. uniformis WH506 100 (822/822) Human 1995-99 0.38 0.00015 
B. uniformis WH505 100 (835/835) Human 1995-99 0.69 0.00032 
B. uniformis VPI-60-50 99.9 (867/868) Human pre-1980 0.00 0.00000 
B. uniformis WH207 99.9 (857/858) Human 1995-99 0.33 0.00009 
B. uniformis WH703 99.9 (849/850) Human 1995-99 0.00 0.00000 
B. uniformis WH504 99.9 (835/836) Human 1995-99 0.35 0.00013 
B. uniformis WH710 99.9 (835/836) Human 1995-99 0.23 0.00024 
B. uniformis WH23 99.9 (827/828) Human 1995-99 0.00 0.00000 
B. uniformis VPI-52 99.9 (825/826) Human pre-1980 0.00 0.00000 
B. uniformis WH10 99.9 (822/823) Human 1995-99 0.56 0.00015 
B. uniformis WH701 99.9 (810/811) Human 1995-99 0.25 0.00019 
B. uniformis WH12 99.9 (743/744) Human 1995-99 0.51 0.00013 
B. uniformis R3-39 99.8 (989/991) Human unknown 0.42 0.00027 
B. uniformis VPI-S5A-14 99.8 (848/850) Human pre-1980 0.00 0.00000 
B. uniformis WH4 99.8 (842/844) Human 1995-99 0.00 0.00000 
B. uniformis WH20 99.8 (841/843) Human 1995-99 0.00 0.00000 
B. uniformis WH215 99.8 (835/837) Human 1995-99 0.00 0.00000 
B. uniformis WH704 99.8 (835/837) Human 1995-99 0.00 0.00000 
B. uniformis dnlkv2 99.7 (1370/1374) Mouse 2000 or later 0.52 0.00039 
B. uniformis CL03T00C23 99.6 (984/988) Human 2000 or later 0.00 0.00000 
B. uniformis VPI-C20-25 99.6 (852/855) Human pre-1980 0.37 0.00016 
B. uniformis WH203 99.6 (844/847) Human 1995-99 0.49 0.00010 
B. uniformis 2_2_43B 99.6 (834/837) Human 2000 or later 0.25 0.00019 
B. uniformis WH205 99.6 (817/820) Human 1995-99 0.34 0.00025 
B. uniformis WH712 99.4 (846/851) Human 1995-99 0.00 0.00000 
B. uniformis WH204 99.4 (834/839) Human 1995-99 0.38 0.00023 
B. uniformis WH11 99.4 (798/803) Human 1995-99 0.98 0.00075 
B. uniformis WH511 99.4 (786/791) Human 1995-99 0.00 0.00000 
B. uniformis WH717 99.4 (785/790) Human 1995-99 0.20 0.00009 
B. uniformis WH714 99 (836/844) Human 1995-99 0.38 0.00022 
B. uniformis CL03T12C37 98.6 (931/944) Human 2000 or later 0.00 0.00000 
B. uniformis WH17 96.7 (797/824) Human 1995-99 0.00 0.00000 
B. uniformis WH15 96.7 (794/821) Human 1995-99 0.00 0.00000 
B. uniformis WH16 96.6 (792/820) Human 1995-99 0.00 0.00000 





B. vulgatus WH19 100 (813/813) Human 1995-99 0.00 0.00000 
B. vulgatus WH14 100 (825/825) Human 1995-99 0.00 0.00000 
B. vulgatus VPI-4025 100 (840/840) Human pre-1980 0.00 0.00000 
B. vulgatus WH13 100 (845/845) Human 1995-99 0.00 0.00000 
B. vulgatus WH18 100 (850/850) Human 1995-99 0.00 0.00000 
B. vulgatus RJ2H1 100 (965/965) Mouse 2000 or later 0.00 0.00000 
B. vulgatus WH119 99.9 (850/851) Human 1995-99 0.00 0.00000 
B. vulgatus PC510 99.9 (1417/1418) Human unknown 0.00 0.00000 
B. vulgatus RJ2L3 99.9 (1416/1418) Mouse 2000 or later 0.00 0.00000 
B. vulgatus 274_1D4 99.9 (1111/1112) Human unknown 0.00 0.00000 
B. vulgatus WH108 99.8 (849/851) Human 1995-99 0.00 0.00000 
B. vulgatus WH6 99.8 (841/843) Human 1995-99 0.00 0.00000 
B. vulgatus WH8 99.8 (840/842) Human 1995-99 0.00 0.00000 
B. vulgatus VPI-BV8526 99.8 (834/836) Human pre-1980 0.00 0.00000 
B. vulgatus VPI-4496.2 99.8 (825/827) Human pre-1980 0.00 0.00000 
B. vulgatus VPI-5710 99.8 (804/806) Human pre-1980 0.00 0.00000 
B. vulgatus WH516 99.7 (789/791) Human 1995-99 0.00 0.00000 
B. vulgatus CL09T03C04 99.6 (898/902) Human 2000 or later 0.00 0.00000 
B. vulgatus WH9 99.6 (848/851) Human 1995-99 0.00 0.00000 
B. vulgatus WH202 99.6 (847/850) Human 1995-99 0.00 0.00000 
B. vulgatus VPI-C1-13 99.6 (836/839) Human pre-1980 0.00 0.00000 
B. vulgatus VPI-4245 99.6 (818/821) Human pre-1980 0.00 0.00000 
B. vulgatus dnlkv7 99.6 (1373/1379) Mouse 2000 or later 0.25 0.00012 
B. vulgatus VPI-4506 99.5 (848/852) Human pre-1980 0.00 0.00000 
B. vulgatus WH109 99.5 (842/846) Human 1995-99 0.00 0.00000 
B. vulgatus WH715 99.5 (825/829) Human 1995-99 0.00 0.00000 
B. vulgatus WH515 99.5 (792/796) Human 1995-99 0.12 0.00006 
B. vulgatus WH7 99.5 (786/790) Human 1995-99 0.00 0.00000 
B. vulgatus 4_3_47FAA 99.4 (840/845) Human 2000 or later 0.00 0.00000 
B. vulgatus WH5 99.4 (803/808) Human 1995-99 0.00 0.00000 
B. vulgatus WH716 99.3 (822/828) Human 1995-99 0.00 0.00000 
B. vulgatus 3_1_40A  98.9 (833/842) Human 2000 or later 0.00 0.00000 
B. xylanisolvens XB1A, DSM 18836 100 (type strain) Human 2000 or later 1.01 0.00229 
B. xylanisolvens WH301 99.9 (810/811) Human 1995-99 0.00 0.00000 
B. xylanisolvens WH210 99.8 (849/851) Human 1995-99 1.09 0.00128 
B. xylanisolvens WH212 99.8 (847/849) Human 1995-99 1.18 0.00167 
B. xylanisolvens WH213 99.8 (847/849) Human 1995-99 0.57 0.00096 
B. xylanisolvens VPI-Bov7991 99.8 (847/849) Human pre-1980 1.04 0.00165 
B. xylanisolvens WH209 99.8 (846/848) Human 1995-99 1.17 0.00158 
B. xylanisolvens NLAE-zl-C29 99.7 (769/771) Cow 2000 or later 1.06 0.00080 
B. xylanisolvens NLAE-zl-C178 99.7 (684/686) Cow 2000 or later 0.84 0.00077 
B. xylanisolvens NLAE-zl-G310 99.6 (849/852) Goat 2000 or later 0.68 0.00035 
B. xylanisolvens NLAE-zl-G421 99.6 (849/852) Goat 2000 or later 0.57 0.00016 
B. xylanisolvens NLAE-zl-C182 99.6 (849/852) Cow 2000 or later 0.77 0.00045 
B. xylanisolvens NLAE-zl-C339 99.6 (849/852) Cow 2000 or later 0.84 0.00059 
B. xylanisolvens 2_1_22 99.6 (848/851) Human 2000 or later 1.02 0.00074 
B. xylanisolvens 3_1_13 99.6 (848/851) Human 2000 or later 1.07 0.00083 
B. xylanisolvens D1 (1_1_22) 99.6 (848/851) Human 2000 or later 0.99 0.00071 
B. xylanisolvens NLAE-zl-P393 99.6 (846/849) Pig 2000 or later 0.92 0.00111 
B. xylanisolvens NLAE-zl-P352 99.6 (846/849) Pig 2000 or later 1.02 0.00130 
B. xylanisolvens NLAE-zl-P727 99.6 (846/849) Pig 2000 or later 1.00 0.00119 
B. xylanisolvens NLAE-zl-P736 99.6 (846/849) Pig 2000 or later 1.05 0.00135 
B. xylanisolvens WH305 99.6 (842/845) Human 1995-99 0.99 0.00053 
B. xylanisolvens NLAE-zl-H465 99.6 (833/836) Human 2000 or later 0.78 0.00031 
B. xylanisolvens CL03T12C04 99.6 (701/704) Human 2000 or later 1.14 0.00186 
B. xylanisolvens NLAE-zl-P218 99.6 (553/555) Pig 2000 or later 1.07 0.00140 
B. xylanisolvens NLAE-zl-P349 99.6 (552/554) Pig 2000 or later 1.04 0.00132 





B. xylanisolvens NLAE-zl-G39 99.5 (848/852) Goat 2000 or later 0.69 0.00041 
B. xylanisolvens WH302 99.5 (847/851) Human 1995-99 0.93 0.00057 
B. xylanisolvens D22 (1_2_8) 99.5 (847/851) Human 2000 or later 1.15 0.00115 
B. xylanisolvens NLAE-zl-H194 99.5 (846/850) Human 2000 or later 0.89 0.00048 
B. xylanisolvens NLAE-zl-P732 99.5 (845/849) Pig 2000 or later 1.03 0.00136 
B. xylanisolvens WH307 99.5 (789/793) Human 1995-99 0.75 0.00023 
B. xylanisolvens WH404 99.4 (795/800) Human 1995-99 1.08 0.00146 
B. xylanisolvens NLAE-zl-G37 99.3 (842/848) Goat 2000 or later 0.61 0.00025 
B. xylanisolvens 1_1_30 99.2 (763/769) Human 2000 or later 1.21 0.00180 
B. xylanisolvens NLAE-zl-G44 99.1 (846/854) Goat 2000 or later 0.76 0.00042 
B. xylanisolvens NLAE-zl-H40 99.1 (841/849) Human 2000 or later 0.84 0.00031 
B. xylanisolvens WH304 99 (788/796) Human 1995-99 0.82 0.00027 
B. xylanisolvens NLAE-zl-G346 98.7 (844/855) Goat 2000 or later 0.31 0.00020 
B. xylanisolvens NLAE-zl-G109 98 (837/854) Goat 2000 or later 0.95 0.00068 
B. xylanisolvens 2_2_4 97.7 (814/833) Human 2000 or later 1.09 0.00153 
B. xylanisolvens NLAE-zl-C257 99.5 (997/1002) Cow 2000 or later 0.74 0.00047 
B. xylanisolvens NLAE-zl-C233 99.6 (1282/1287) Cow 2000 or later 0.59 0.00042 
B. xylanisolvens NLAE-zl-C315 99.6 (1259/1264) Cow 2000 or later 0.84 0.00054 
B. xylanisolvens NLAE-zl-G406 98.8 (1355/1372) Goat 2000 or later 0.90 0.00086 
D. gadei ATCC BAA-286 100 (type strain) Human 2000 or later 0.00 0.00000 
D. mossii DSM 22836 100 (type strain) Human 2000 or later 0.68 0.00044 
O. splanchnicus DSM 20712,  ATCC 29572 100 (type strain) Human 2000 or later 0.00 0.00000 
P. distasonis ATCC 8503 100 (type strain) Human pre-1980 0.82 0.00049 
P. distasonis VPI-4243 99.9 (744/745) Human pre-1980 0.83 0.00060 
P. distasonis 3_1_19 99.6 (923/927) Human 2000 or later 1.28 0.00095 
P. distasonis VPI-BD6781 99.5 (862/866) Human pre-1980 1.26 0.00130 
P. distasonis VPI-C14-2 99.3 (859/865) Human pre-1980 1.32 0.00098 
P. distasonis VPI-BD6803 99.2 (858/865) Human pre-1980 1.16 0.00113 
P. distasonis VPI-C18-7 99.2 (841/849) Human pre-1980 1.34 0.00079 
P. distasonis VPI-56A-56 99.1 (850/858) Human pre-1980 1.28 0.00128 
P. distasonis 2_1_33B 99 (873/882) Human 2000 or later 1.28 0.00098 
P. distasonis VPI-T3-25 98.8 (837/847 Human pre-1980 1.14 0.00091 
P. distasonis VPI-C19-17 98.7 (830/841) Human pre-1980 1.36 0.00097 
P. distasonis VPI-C30-45 98.6 (825/837) Human pre-1980 1.31 0.00090 
P. distasonis VPI-B1-20 98.5 (834/847) Human pre-1980 0.15 0.00008 
P. distasonis WAL8975 98.2 (834/849) Human unknown 0.97 0.00053 
P. distasonis WAL9063 98.1 (833/849) Human unknown 0.19 0.00003 
P. distasonis WH517 98.1 (807/823) Human 1995-99 0.00 0.00000 
P. goldsteinii DSM 19448, WAL 12034 100 (type strain) Human 2000 or later 0.00 0.00000 
P. goldsteinii dnlkv18 99.1 (1374/1382) Mouse 2000 or later 0.00 0.00000 
P. gordonii DSM 23371 100 (type strain) Human 2000 or later 0.00 0.00000 
P. johnsonii DSM 18315 100 (type strain) Human 2000 or later 1.14 0.00073 
P. merdae ATCC 43184 100 (type strain) Human 2000 or later 1.40 0.00140 
P. merdae T4-1 99.6 (1019/1023) Human unknown 1.22 0.00089 
P. merdae VPI-BD6944 96.7 (841/870) Human pre-1980 1.32 0.00098 
Footnotes: 1Strains are classified into species based on >97% 16S rDNA sequence identity to the type strain of each species. 
Type strains for each species are underlined and listed first in each group. 
 
Enzyme assays  
  Recombinant proteins purified in E. coli, were used to determine enzyme kinetics for 
RusGH, RusNH, RusK1, and RusK2. For RusNH we used a p-nitrophenol-ribofuranoside 
substrate with absorbance readings at 405nm over a 24-hour period as described previously26, 





a buffer containing 20mM Hepes and 100mM NaCl, at pH 6.7 at 37°C and continuous 
absorbance readings. For RusGH, a panel of other 4-nitrophenol based substrates in addition to 
p-NP-ribofuranoside were tested at pH 9.0 in 100 mM Tris at 37°C for 16h with 1.5-15 µM of 
enzyme and using endpoint absorbance measurements. Ion requirements of the RusGH were 
assayed in p-NP-ribofuranoside by addition of divalent cations in the form of CaCl2, ZnCl2, or 
MgCl2, at 2, 5, or 10 mM concentrations, or in the presence of 10 mM EDTA. Specificity and 
kinetic parameters for RusNH on natural nucleoside substrates were determined as described 
previously using a UV-based assay43. Briefly, a 96-well, UV-compatible microplate (Santa Cruz 
Biotechnologies) was used with substrate concentrations ranging from 0.025mM-2.5mM, and 
enzyme concentrations of 0.25-1uM. Assays were immediately read after addition of enzyme by 
continuous reading of absorbance at 262nm or 280nm with time points taken every 2.5 minutes 
over 12-24 hours at 37°C. Volume was 250uL in all assays and carried out in buffer containing 
20mM Hepes and 100mM NaCl, at pH 6.7, adjusted with acetic acid. As a measure of catalytic 
efficiency, (Kcat/KM) was unable to be determined by classical Michaels-Menton kinetics as 
Vmax was never reached and therefore Km values were not accurate, so we used a previously 
established method of estimating this value13. Briefly, we used a single substrate concentration to 
calculate (kcat/KM) and checked to be <<KM by halving and doubling the substrate concentration 
and observing a proportionate increase or decrease in rate. Therefore the equation, V0 = 
(kcat/KM)[S][E] was used to calculate kcat/KM in our case. For, RusGH a panel of other 4-
nitrophenol based substrates in addition to p-NP-ribofuranoside were tested at pH 9.0 in 100 mM 
Tris at 37°C for 16h with 1.5-15 µM of enzyme with endpoint absorbance measurements. Ion 
requirements of the RusGH were assayed in p-NP-ribofuranoside by addition of divalent cations 
in the form of CaCl2, ZnCl2, or MgCl2, at 2, 5, or 10 mM concentrations, or in the presence of 1 
mM EDTA.  The RusGH was tested against a panel of oligosaccharides, nucleosides and 
nucleotides. Briefly, the reactions were performed with 10 M of RusGH, 8mg/ml substrate or 
5mM monosaccharide in 50 mM TRIS pH 9.0 at 37 °C for 16h. A control reaction was 
performed in the same conditions without enzyme. The activity was qualitative determined by 
thin layer chromatography. 6 l of the reaction was spotted on foil backed silica plate (Silicagel 
60, 20 x 20, Merck) and develop in butanol:acetic acid:water 2:1:1 (mobile phase). The products 





acid/ethanol/water 3:70:20 v/v, orcinol 1 %) for 30 seconds and heating to 100 °C for 2 minutes. 
A standard of ribose was run in all TLC plates. For RusK1/K2 a phosphatase-coupled, universal 
kinase assay was used according to manufacturer instructions to determine a specific activity of 
the kinases on pentose sugars. (R&D Systems, Minneapolis, MN)44. Specifically, all reactions 
were carried out in buffer containing 70 mM Tris, 100 mM KCl, and 5 mM MgCl2 at pH 7.5, this 
buffer is based on previous studies examining ribokinase activities and showing this buffer 
provided maximal enzymatic activity45. Reactions were carried out in 50 µL at 37°C for 30 
minutes. All reactions contained 1 mM ATP, 100 ng of coupling phosphatase, and a range of 
enzyme concentrations ranging from 0.1-10 µM of RusK1, RusK2, or E. coli RbsK 
(MyBioSource, San Diego, CA), as a positive control, and for the acceptor substrate either 10 
mM of ribose or deoxyribose or 200 mM of all other sugars tested including: arabinose, xylose, 
glucose or fructose etc. Determination of specific activity was based off of a coupling rate of 
0.399 and a rate constant of 97.78 nmol/min/µg/mM (empirically determined by the kit 
manufacture). In brief, our specific activity is based on an endpoint observation across a 
minimum of 5 enzyme concentrations, the resulting absorbance is fit to a known phosphate 
standard curve equation and the resulting rate is nM (product formed)/min (held standard at 30 
min)/uM enzyme/mM of substrate. This is the specific activity at a defined endpoint and so 
should not be confused with a rate taken at several enzyme concentrations over different time 
points, but rather used a crude measurement for which to compare different enzymes.    
 
Determination of free and acid hydrolysable monosaccharide content in diets and cecal contents 
using GC/MS 
  Prior to analysis, diets were ground to a fine powder using a blender followed by mortar 
and pestle, while cecal contents were dried by lyophilization. Samples were analyzed for free and 
linked monosaccharides using the following method described46. In brief, all reactions began 
with 1-3mg of sample and samples were hydrolyzed in 100ul of 2.5 M TFA for 90 min at 121 
°C. Samples were allowed to cool to room temperature (RT) and myo-inositol was added as an 
internal standard (20ul of 2.5mg/ml) and dried under nitrogen. 150ul of methanol was added, 
dried and repeated once more. Dried samples were then reduced by dissolving in 50ul of 2M 
NH4OH followed by addition of 50 ul of freshly made 1M NaDB4 in 2M NaOH. This mixture 





hours. 23ul of glacial acetic acid was added and samples dried and evaporated 2x with 250ul of 
5% (v/v) acetic acid in methanol, followed by 2x evaporation with 250ul of methanol, drying 
after each step. Acetylation was done by addition of 250ul acetic anhydrate and sonicated 5 min 
followed by incubation at 100 °C for 2.5 hours. 2ml of ddH2O was added and sample vortexed to 
dissolve residue, followed by room temperature incubation for 10 min. 1ml of dichloromethane 
(DCM) was added and vortexed followed by centrifugation at 2000 rpm for 2.5 min. The 
aqueous phase was discarded and the DCM phase washed 2x with 2 ml of ddH2O. DCM phase 
was dried and residue dissolved in 250 ul acetone. For free monosaccharide analysis the initial 
hydrolysis step with TFA was not performed. To establish a limit of detection in cecal contents, 
varying amounts of ribose (0.00002-0.2 mg, in 10-fold increments) were added at the same time 
as the myo-inositol standard to establish percent recovery throughout the methods used. 
Acetylated samples were analyzed on a gas chromatography (Agilent Technologies model 
7890A) coupled mass spectrometer (Agilent Technologies model 5975C) using a fused silica 
capillary column (60m x 0.25 mm x 0.2µm SP-2330, Supelco Analytical).  
 
LC/MS/MS Determination of positional ribose phosphorylation by rus ribokinases 
  Samples were prepared as follows with reactions containing the following: 1µM of either 
enzyme (RusK1 or RusK2), 10mM of a starting substrate (ribose, ribose 1-phosphate, or ribose 
5-phosphate), 1mM ATP, with all components dissolved in a buffer containing 70 mM Tris, 100 
mM KCl, and 5 mM MgCl2 at pH 7.5and incubated at 37°C for 30 minutes. Reactions were then 
flash frozen and stored at -80°C until processing. For analysis, 100% MeOH was added to 
thawed samples in buffer at a 4:1 ratio to extract metabolites. Samples were then dried down and 
reconstituted in 45 µL of 1:1 MeOH/H2O. Samples were run on a 6470 Series Agilent 
Technologies Triple Quadrupole Mass Spectrometer with Ion-Pairing chromatography. The 
acquisition method was programed to detect for dynamic multiple reaction monitoring (dMRM) 
of four compounds of interest: ribose, ribose 1-phosphate, ribose 5-phosphate, and ribose 1,5-
bisphosphate. The dMRM scan is used with a 0.07 min peak width and acquisition time of 24 
min. The detected fragments displayed the following dMRM transitions:  ribose 149->89 at 1.31 
min with collision energy (CE) of 5 eV; ribose-1-phosphate 229->210 at 9.4 min with CE of 
9eV; ribose-5-phosphate 229-> 97 at 7.9 min with CE of 13eV; ribose-1,5-bisphosphate 309-





method: delta retention time of plus and minus 1 min, fragmentor of 40 eV and cell accelerator 
of 5 eV. Agilent Qualitative Analysis version 7.00 was used for post-acquisition analysis. Our 
empirically determined range of detection was established above a noise baseline determined by 
running enzyme, buffer, sample, and internal controls for each species of interest where we did 
not anticipate these species being detected. This was determined to be 103 which was our highest 
background reading (Table 2.2E). Detailed instrumentation running parameters are here 
described. The following solvents were used during processing, Solvent A: 97% H2O and 3% 
MeOH, Solvent B: 15 mM acetic acid and 10 mM tributylamine at pH 5.  Solvent C: 15 mM 
acetic acid and 10 mM tributylamine in MeOH.  Washing Solvent D is 100% acetonitrile.  LC 
system seal washing solvent is 90% water and 10% isopropanol, while the needle washing 
solvent is 75% methanol and 25% water. The Agilent Technologies Triple Quad 6470 LC/MS 
system used here consists of 1290 Infinity II LC Flexible Pump (Quaternary Pump), 1290 
Infinity II Multisampler, 1290 Infinity II Multicolumn Thermostat with 6 port valve and 6470 
triple quadrupole mass spectrometer.  Agilent Masshunter Workstation Software LC/MS Data 
Acquisition for 6400 Series Triple Quadrupole MS with Version B.08.02 is used for compound 
optimization and data acquisition. The following column was used for separation: Agilent 
ZORBAX RRHD Extend-C18, 2.1 × 150 mm, 1.8 um and ZORBAX Extend Fast Guards for 
UHPLC are used in the separation.  LC gradient profile is: at 0.25 ml/min, 0-2.5 min, 100% A; 
7.5 min, 80% A and 20% C; 13 min 55% A and 45% C; 20 min, 1% A and 99% C; 24 min, 1% 
A and 99% C; 24.05 min, 1% A and 99% D; 27 min, 1% A and 99% D; at 0.8 ml/min, 27.5-
31.35 min, 1% A and 99% D; at 0.6 ml/min, 31.50 min, 1% A and 99% D; at 0.4 ml/min, 32.25-
39.9 min, 100% A; at 0.25 ml/min, 40 min, 100% A.  Column temperature is kept at 35 ̊C, 
samples at 4 ̊C, and injection volume is 2 µl. The 6470 Triple Quad MS was calibrated with ESI-
L Low concentration Tuning mix.  Source parameters: Gas temp 150 ̊C, Gas flow 10 l/min, 
Nebulizer 45 psi, Sheath gas temp 325 ̊C, Sheath gas flow 12 l/min, Capillary -2000 V, Delta 
EMV -200 V.  
 
Quantification and Statistical Analysis 
  Student’s t-tests for in vivo data were performed for each time point in GraphPad Prism 
version 8.1 with a paired, two-tailed distribution. Detailed statistical information is included in 





Table 2.5 Strains, vectors, and primers used in this study 
Strain Genotype Features Reference 
 Bacteroides 
thetaiotaomicro
n (B. theta) tdk- 
ATCC 29148 tdk- Parent strain of all deletion 




 B. theta Δrus ATCC 29148 tdk-, BT2802-2809- rus PUL deletion strain, unable 
to grow on any ribose 
containing substrate and unable 
to activate rus transcript 
This study 
 B. theta ΔrusR ATCC 29148 tdk-, BT2802- Putative upstream regulator of 
rus PUL deletion strain, unable 
to grow on any ribose 
containing substrate and unable 
to upregulate rus transcript 
This study 
 B. theta ΔrusK1 ATCC 29148 tdk-, BT2803- First ribokinase deletion of the 
rus PUL, exhibits delayed 
growth and transcript activation 
on ribose, with absent growth 
on nucleosides/RNA 
This study 
 B. theta ΔrusK2 ATCC 29148 tdk-, BT2804- Second ribokinase deletion of 
the rus PUL, no growth on any 
ribose substrates. Normal rus 
transcript activation dynamics 
This study 
 B. theta 
ΔrusK1/K2 
ATCC 29148 tdk-, BT2803-2804- Both ribokinases deleted from 
the rus PUL, no growth on any 
ribose substrates, no rus 
transcript activation 
This study 
 B. theta ΔrusC ATCC 29148 tdk-, BT2805- Deletion of the susC homolog 
within the rus PUL. Wild-type 
levels of growth on all 
substrates and normal transcript 
activation.  
This study 
 B. theta ΔrusD ATCC 29148 tdk-, BT2806- Deletion of the susD homolog 
within the rus PUL. Wild-type 
levels of growth on all 
substrates and normal transcript 
activation.  
This study 
 B. theta 
ΔrusC/D 
ATCC 29148 tdk-, BT2805-2806- Deletion of both susC and susD 
homologs within the rus PUL. 
Wild-type levels of growth on 
all substrates.  
This study 
 B. theta 
ΔrusGH 
ATCC 29148 tdk-, BT2807- Deletion of a predicted 
glycoside hydrolase of 
unknown function or family 
within the rus PUL. Wild-type 
levels of growth on all 
substrates. 
This study 
 B. theta 
ΔrusNH 
ATCC 29148 tdk-, BT2808- Deletion of a confirmed 
nucleoside hydrolase of IUNH 
family within the rus PUL. 
Wild-type levels of growth on 
all substrates. 
This study 
 B. theta 
ΔrusGH/NH 
ATCC 29148 tdk-, BT2807-2808- Deletion of  predicted glycoside 
hydrolase and nucleoside 
hydrolase of rus PUL. Wild-







 B. theta ΔrusT ATCC 29148 tdk-, BT2809- Deletion of putative rus-
encoded ribose-specific 
permease. Exhibits both delayed 
growth and lower overall 
growth on all ribose substrates, 
as well as a decrease in rus 
transcript activation levels 
This study 
 B. theta 
ΔBT0184 
ATCC 29148 tdk-, BT0184- Deletion of predicted uridine or 





 B. theta 
ΔBT1881 
ATCC 29148 tdk-, BT1881- Deletion of predicted purine 
nucleoside phosphorylase. 
Growth defects on some 
nucleosides, but not on ribose or 
RNA 
This study 
 B. theta 
ΔBT4330 
ATCC 29148 tdk-, BT4330- Deletion of predicted 
nucleoside permease. Growth 
defects on nucleosides, normal 
growth on ribose and RNA 
This study 
 B. theta 
ΔBT4554 
ATCC 29148 tdk-, BT4554- Deletion of predicted purine 
nucleoside phosphorylase. 
Growth defects on some 
nucleosides, but not on ribose or 
RNA 
This study 
 B. theta ΔrusR 
:: BT2802 
ATCC 29148 tdk-, BT2802- :: pNBU2-bla-ermG 
BT2802 
Trans-complementation of the 
ΔrusR (BT2802) deletion strain 
with native promoter, restores 
growth on ribose 
This study 
 B. theta 
ΔrusK1/K2 :: 
BT2803-04 
ATCC 29148 tdk-, BT2803-04- :: pNBU2-bla-ermG 
BT2803-04 
Trans-complementation of the 
ΔrusK1/K2 (BT2803-04) 
deletion strain with native 
promoter restoring growth on 
ribose, also used for in vivo 
studies 
This study 
B. theta tdk- 
+Tag1 
ATCC 29148 tdk- ::pNBU2-bla-tetQb Tag1 Parent strain of single cps-
expressing strains with unique 




B. theta tdk- 
Δrus +Tag14 
ATCC 29148 tdk-, BT2802-2809- ::pNBU2-bla-tetQb 
Tag14 
Δrus strain with unique barcode 
inserted used for in vivo studies 
This study 
B. theta tdk- 
ΔrusR +Tag14 
ATCC 29148 tdk-, BT2802- ::pNBU2-bla-tetQb 
Tag14 
ΔrusR strain with unique 
barcode inserted used for in 
vivo studies 
This study 
B. theta tdk- 
ΔrusK1 +Tag14 
ATCC 29148 tdk-, BT2803- ::pNBU2-bla-tetQb 
Tag14 
ΔrusK1 strain with unique 
barcode inserted used for in 
vivo studies 
This study 
B. theta tdk- 
ΔrusK2 +Tag14 
ATCC 29148 tdk-, BT2804- ::pNBU2-bla-tetQb 
Tag14 
ΔrusK2 strain with unique 
barcode inserted used for in 
vivo studies 
This study 
B. theta tdk- 
ΔrusK1/K2 
+Tag14 
ATCC 29148 tdk-, BT2803-2804- ::pNBU2-bla-tetQb 
Tag14 
ΔrusK1/K2 strain with unique 
barcode inserted used for in 
vivo studies 
This study 
B. theta tdk- 
ΔrusC/D 
+Tag14 
ATCC 29148 tdk-, BT2805-2806- ::pNBU2-bla-tetQb 
Tag3 
ΔrusC/D strain with unique 
barcode inserted used for in 
vivo studies 
This study 
B. theta tdk- 
ΔrusGH/NH 
+Tag14 
ATCC 29148 tdk-, BT2807-2808- ::pNBU2-bla-tetQb 
Tag9 
ΔrusGH/NH strain with unique 







B. theta tdk- 
ΔrusT +Tag14 
ATCC 29148 tdk-, BT2809- ::pNBU2-bla-tetQb 
Tag14 
ΔrusT strain with unique 
barcode inserted used for in 
vivo studies 
This study 
B. theta tdk- 
ΔBT4554 
+Tag14 
ATCC 29148 tdk-, BT4554- ::pNBU2-bla-tetQb 
Tag14 
ΔBT4554 strain with unique 




AITM   
B. coli B strain, F-, ompT, hsdSB (rB'mB'), gal, dcm, 
araB::T7RNAP-, tetA 
Parent E. coli expression strain 
used to construct deletions in 
for downstream protein 
purification of B. theta proteins. 
Invitrogen 
E. coli BL21-
AITM  ΔrihABC 
B. coli B strain, F-, ompT, hsdSB (rB'mB'), gal, dcm, 
araB::T7RNAP-, tetA, rihA-, rihB-, rihC-,   
E. coli strain lacking 
chromosomal ribose-inducible 
hydrolases (rih) genes ised in 
the production of the B. theta 
nucleoside hydrolase, BT2808 
(RusNH), to avoid 
contaminating nucleoside 
hydrolase activity from E. coli 
This study 
    





   




   
BT2802-2809 
5'Up Xbal 






















GCGTCTAGACGGCTCCATAAAGGTTATC BT2802 Gene Knockout 
 
BT2802 3'Out  AGGGAACTCTTTGCATTAGTA BT2802 Gene Knockout 
 
BT2802 5'Out TACTAATGCAAAGAGTTCCCT 
AGAGTAAGGTGTTTGATTCGT 












BT2803 Gene Knockout 
 










GCGGTCGACCGGCCTGCAAGCATTGGA BT2804 Gene Knockout 
 
BT2804 3'Out  GTGTCGATTAGTTTTCATAATCCATGAAATTT
GAACAGATTTATGTGTTTAAC 
BT2804 Gene Knockout 
 


































BT2805 Gene Knockout 
 












BT2806 Gene Knockout 
 














BT2807 Gene Knockout 
 












BT2808 Gene Knockout 
 












BT2809 Gene Knockout 
 














BT0184 Gene Knockout 
 














BT1881 Gene Knockout 
 


















BT4330 Gene Knockout 
 





































GCGGTCGACAGAGTAAGGTGTTTGATTCGT BT2803-04 Gene Complement 
 
cBT2803-04 
3’Down Xbal  
GCGTCTAGAGTGTCGATTAGTTTTCATAATCC
ATGAAAT 
BT2803-04 Gene Complement 
 
NBU2 att1 F CCTTTGCACCGCTTTCAACG pNBU2 insertion site 
determinaton 
 
NBU2 att1 R TCAACTAAACATGAGATACTAGC pNBU2 insertion site 
determinaton 
 
NBU2 att2 F TATCCTATTCTTTAGAGCGCAC pNBU2 insertion site 
determinaton 
 
NBU2 att2 R GGTGTACCTGGCATTGAAGG pNBU2 insertion site 
determinaton 
 








Amplification of SpecR Gene from E. coli 








Amplification of SpecR Gene from E. coli 








Amplification of HygroR Gene from E. coli 








Amplification of HygroR Gene from E. coli 








Amplification of GentR Gene from E. coli 








Amplification of SpecR Gene from E. coli 
K11590 and Lamda Red Recombineering into 
BL21-AI Cells 





qPCR Primers Primer Use 
 
BT2801 F taaaccgacggctctccatctg B. thetaiotaomicron Ribose 
PUL Flanking Gene Expression 
 
BT2801 R gccgccgaataatcccactt B. thetaiotaomicron Ribose 
PUL Flanking Gene Expression 
 
BT2802 F tacagagctgccttaaattcatacaaa B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2802 R gctcacagaccgcaggctacc B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2803 F caggtgccggagatgtattttg B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2803 R accgattcgcgtgactgctat B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2804 F ttctgtggtgcattggctgtaa B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2804 R tcgagagtaggaatagacggttgg B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2805 F tccacgccccgatataatgtagg B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2805 R accgtttgcaccccagaagtagtaa B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2806 F taaagcggcacaaatcatagcaga B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2806 R tgtgttgtagcgcctccataaaag B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2807 F tatgcgctggttgccgagaa B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2807 R tgccgccaagccttttatgag B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2808 F caggaaatgccatatgacagagaaa B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2808 R taagtgcgttgcgggttgc B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2809 F tattctcctttccgcctcagtatcc B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2809 R tgttattggttcccgccttttg B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2810 F tgcagcccggtcaaaagtattatta B. thetaiotaomicron Ribose 
PUL Expression 
 
BT2810 R cacaaagcccggaaggtatgg B. thetaiotaomicron Ribose 
PUL Expression 
 
BT0348 F tgcggcaaccaaattcaacaaa B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0348 R accaagtgccccattcgtcaag B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0349 F tccgccaagccagtgaagaa B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0349 R ttagcccggcggaaatgac B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0350 F attgcggtggtctcctctcctac B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0350 R tcctccgtgacctgtgattctgt B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0351 F gattgctgtctggatgcgtgttt B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0351 R cccatgcgttgttctgcttctac B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0352 F ataaaagtttggagttcgctgttcg B. thetaiotaomicron arabinose 






BT0352 R caatactctgtttcgttcgcttcct B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0353 F cgaaatcggcggagtggtg B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0353 R ccgctgtgcaggggattg B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0354 F cgatccaggcgaaagggtagtt B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0354 R agtgcggggagttcgttgatg B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0355 F acgccgttacaatcctcagtcac B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0355 R ggcggcaatccagaagaagtc B. thetaiotaomicron arabinose 
gene cluster expression 
 
BT0790 F cattgccggttccgattgttc B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0790 R ggcgcgtacccctagagtgtttt B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0791 F gaccgggcactggacaagaatc B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0791 R cctcaactgggcagcggtaaat B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0792 F ccggatgggcagaacaaga B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0792 R caccgcacgagaatcacaccag B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0793 F ggtttcggaaggtgccagtgt B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0793 R ctctccgccaagttcaatcgtt B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0794 F ggcggtttgctcttcggttatga B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0794 R cccccagcacgcagcctatc B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0795 F cgagatatcatgcccgactggttgta B. thetaiotaomicron xylose gene 
cluster expression 
 
BT0795 R atattttcggcacggatttctttg B. thetaiotaomicron xylose gene 
cluster expression 
 
BXY19480 F cccgccaggtggatgagttta B. xylanisolvens XB1A Ribose 
PUL Flanking Gene Expression 
 
BXY19480 R tcgtggcgtcctatggtcctatt B. xylanisolvens XB1A Ribose 
PUL Flanking Gene Expression 
 
BXY19510 F caggataacgcaatgataagagga B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19510 R aatacgagtaataggagggttcaaatagt B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19520 F gagctctcgcctatgaaaacaataa B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19520 R gcacaatccgccgcagaa B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19530 F atcggctacggctctaccacaaag B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19530 R gcacctgccaccccatcaat B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19540 F tgttcccgcttgtggtggttc B. xylanisolvens XB1A Ribose 
PUL Expression 
 







BXY19550 F tatgcgggattttggctatgttgt B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19550 R ggagatggtggctgcctgattat B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19560 F gtatctacacgccacatcggttcc B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19560 R ggctggttctactttgcggtctg B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19570 F aatgcggcttactgcgtgatg B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19570 R tcgagtgccggtttccagtatt B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19590 F cttattcggctctgtcgttgcgttat B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19590 R tgcggagggtggaaagaatgtg B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19600 F tgccgctatttggggagtatt B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19600 R cccaaaccaaccaggaagaag B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19610 F ttggctggttgaaactggtctctt B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19610 R tccgtcatagtttttgctttcctctt B. xylanisolvens XB1A Ribose 
PUL Expression 
 
BXY19620 F caacgggtagccaatgtgataaataat B. xylanisolvens XB1A Ribose 
PUL Flanking Gene Expression 
 
BXY19620 R gtgcgggcctcttctctacca B. xylanisolvens XB1A Ribose 
PUL Flanking Gene Expression 
 





TCGGAGCCGGATATTTGTTGTT B. caccae ATCC 43185 rusC 
homolog Expression 
 
Bacint_01219 F TTCATTGGGCTCGCGTATTAGTG B. intestinalis DSM 17393 rusC 
homolog Expression 
 





CACTCTGGAGCCCGAAAACAAACT B. oleiciplenus DSM 22535 




TCAGACCGCGCATAGATTCCACT B. oleiciplenus DSM 22535 




AACTCCCGAGGCATACGCTTCA B. oleiciplenus DSM 22535 




CAATAAATGCCGCCTCCCAGAT B. oleiciplenus DSM 22535 









GCACCTGCCACCCCATCAAT B. ovatus ATCC 8483 rusC 
homolog Expresion 
 
C799_03204 F TGCCGACTTAATTGTTCCCTCTTC B. theta dnLKV9 rusC homolog 
Expression 
 





TTAGCGCCCAATTATCCAGAGC B. celluosilyticus DSM 14838 




GTTTTACGACCGCCATTTTTCATT B. celluosilyticus DSM 14838 


















GTAAGGTGTTTGATTCGTATTTCAGACG In vivo Quantification of 





TTATAAGTTATCAGGTGGACAGCTTTCTTTA In vivo Quantification of 
ΔBT2803-04 :: BT2803-04 
Complemented strain 
 
Tag1 ATGTCGCCAATTGTCACTTTCTCA In vivo Quantification of 
barcoded wild-type strain 
 
Tag3 TTATGACCAGCCGCAAATGAAAAG In vivo Quantification of 
barcoded ΔBT2805-06 
 
Tag9 TCAAATCCGGGGACTGGGCTTAGA In vivo Quantification of 
barcoded ΔBT2807-08 
 
Tag14 GGCACGCCATTCTTCATCTAACTG In vivo Quantification of 
barcoded strains: ΔBT2802, 
ΔBT2803, ΔBT2804, ΔBT2803-
04, ΔBT2809, ΔBT4554,  
 
Universal Tag R CACAATATGAGCAACAAGGAATCC Reverse primer for all barcode 
qPCR primers 
 




   










Amplification and Cloning of BT2803, C-





Amplification and Cloning of BT2803, C-





Amplification and Cloning of BT2804, N-





Amplification and Cloning of BT2804, N-






Amplification and Cloning of BT2807, N-






Amplification and Cloning of BT2807, N-







Amplification and Cloning of BT2808, N-






Amplification and Cloning of BT2808, N-
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  T cell responses to symbionts in the intestine drive tolerance or inflammation depending 
on the genetic background of the host. These symbionts in the gut sense the available nutrients 
and adapt their metabolic programs to use these nutrients efficiently. Here, we ask whether diet 
can alter the expression of a bacterial antigen to modulate adaptive immune responses. We 
generated a CD4+ T cell hybridoma, BθOM, specific for Bacteroides thetaiotaomicron (Bt). 
Adoptively transferred transgenic T cells expressing the BθOM TCR proliferated in the colon, 
colon-draining lymph node, and spleen in Bt–colonized healthy mice and differentiated into 
regulatory T cells (Tregs) and effector T cells (Teffs). Depletion of Bt–specific Tregs resulted in 
colitis, showing that a single protein expressed by Bt can drive differentiation of Tregs that self-
regulate Teffs to prevent disease. We found that BθOM T cells recognized a peptide derived from 
a single Bt protein, BT4295, whose expression is regulated by nutrients, with glucose being a 
strong catabolite repressor. Mice fed a high-glucose diet had a greatly reduced activation of 
BθOM T cells in the colon. These studies establish that the immune response to specific bacterial 
antigens can be modified by changes in the diet by altering antigen expression in the microbe. 
 
Introduction 
  Dietary components and metabolites produced by host and microbial enzymes modulate 
the function of a variety of host immune cells including T cells1-3. These products can have local 
effects on the intestinal immune system and in more distant organs4. For instance, host enzymes 
break down starch and various disaccharides in the diet to produce glucose, which is required 
systemically for maximal effector T cell (Teff) stimulation
5,6. Microbial metabolites derived from 





activities3,7-10. As examples, short-chain fatty acids from fiber fermentation promote the 
development of intestinal regulatory T cells (Tregs)
3, modulate macrophage polarization11, and 
suppress innate lymphoid cell development12. Further, tryptophan catabolites act via the aryl 
hydrocarbon receptor to induce T cell cytokine production13; taurine-conjugated bile acids 
formed from milk-derived dietary fat induce a proinflammatory T helper type 1 (TH1) immune 
response14, and, last, the microbial metabolite desaminotyrosine derived from flavonoids 
stimulates type I interferons (IFNs) and modulates macrophage activation and cytokine 
production15. Recently, ascorbate, a microbial metabolite altered in Crohn’s disease, has been 
shown to modulate T cell activity16. Other dietary components such as excess salt can change the 
composition of the microbiome and favor pathogenic T helper 17 (TH17) responses
17. 
Conversely, an iron-deficient diet can dampen intestinal inflammation18. Collectively, these 
studies reveal the dominant effects of dietary components and their immediate or downstream 
metabolites on the immune system. 
  CD4+ T cells play a critical role in the response to specific microbial antigens in the 
intestine19-23. Symbiotic bacteria that do not damage the host produce tolerogenic Treg responses, 
whereas pathogens that cause damage elicit Teff responses. In both cases, microbe-specific 
antigens drive these responses, and these intestinal bacteria are well known to be modulated by 
diet. However, the effect of diet on T cells that recognize these different groups of symbionts has 
not been tested. This latter question is of importance due to the effects of diet on the composition 
and physiology of the microbiome, which has a multitude of effects on the host. It is unclear 
whether specific dietary components have effects at the level of specific bacterial antigens and 
the T cells that recognize them. 
  We hypothesized that the CD4+ immune response to specific bacterial antigens can be 
modified by changes in the diet through effects on antigen expression of the microbe. Progress in 
this area has been hampered by the lack of a model system in which a CD4+T cell response 
against a specific gut symbiont can be examined. To this end, we developed a CD4+ T cell 
model, termed BθOM, specific for an outer membrane (OM) antigen from Bacteroides 
thetaiotaomicron (Bt, Bθ). Bt is a prototypic gut symbiont that degrades a wide variety of 
dietary, host, and microbial glycans and is a representative of a prominent genus found in most 
human microbiomes24. In healthy mice gavaged with Bt, we found that TCR (T cell receptor) 





BθOM Tregs induced colitis by activated BθOM T cells, revealing that the symbiont-specific 
CD4+ T cells were no longer able to self-regulate to prevent T cell–mediated disease. 
The Bt antigen recognized by BθOM T cells was identified to be BT4295, an OM protein 
contained in one of Bt’s many polysaccharide utilization loci (PULs). We found that we can 
modify the response of BθOM T cells to their cognate antigen by altering the salts and glycans 
available to Bt. Glucose was identified as a catabolite repressor of BT4295 expression. Mice fed 
a high-glucose diet had greatly reduced activation of BθOM T cells, establishing a direct link 
between dietary regulation of a microbial antigen and CD4+ T cell activation. These results show 




The Bt–specific CD4+ T cell response is sensitive to changes in Bt growth media 
  To determine how dietary components and metabolites can affect the interactions 
between a symbiont and the host immune system, we developed a bacteria-specific CD4+ T cell 
model. We chose to focus our study on Bt, a model gut symbiont that is known to adapt to 
changes in the available nutrients, especially by changing expression of carbohydrate utilization 
gene loci. We immunized C57BL/6J mice with the human Bt strain VPI-5482 (herein referred to 
as Bt) and produced T cell hybridoma cell lines that responded to Bt. We screened the T cell 
hybridomas for reactivity against Bt outer membrane vesicles (OMVs), which have been shown 
to be a source of antigen to the immune system25. To identify a T cell sensitive to changes in 
available nutrients, we took advantage of a fortuitous observation that Bt grown in two different 
formulations of tryptone-yeast-glucose (TYG) media—classic TYG (TYG) and modified TYG 
(mTYG) (Table 3.1)—stimulated T cells differently. We chose one T cell hybridoma clone 
(herein denoted as Bt outer membrane or “BθOM”) that showed a robust response to both Bt and 
OMVs in T cell stimulation assays (Figure 3.1, A and B). When we cultured BθOM T cell 
hybridomas with bone marrow–derived macrophages (BMDMs) along with Bt grown in the 
different media, BθOM T cell activation was highest with Bt grown in TYG media (Figure 
3.1C); no stimulation of these T cells was observed when Bt was grown in mTYG media (Figure 
3.1C). Thus, BθOM T cells were sensitive to changes in the nutrients in the media used to 






Figure 3.1 Generation and characterization of the BθOM TCR transgenic mouse. 
A and B) IL-2 levels in picogram per milliliter after generated T cell hybrid clones were cultured with BMDMs loaded with A) Bt 
(n = 2, one experiment) or B) OMVs (n = 2, one experiment). C) IL-2 levels in picogram per milliliter after the BθOM T cell hybrid 
was cultured with BMDMs loaded with Bt grown in TYG or mTYG (n = 2; both replicates are shown). D) Representative flow 
cytometry plot with Vβ12 staining on blood leukocytes of C57BL/6J mice (left) or BθOM transgenic mice (middle) (n = 3, three 
experiments). Representative TCRα1 PCR on DNA isolated from tails of C57BL/6J mice and BθOM transgenic mice (right) (x = 
3, three experiments). E) Representative histograms of CD69, CD25, and CD44 expression (left) and quantification of the 
percentage of CD69, CD25, and CD44 cells among all CD4 cells (right) isolated from the mLNs and spleen of C57BL/6J mice 
(red) or BθOM transgenic mice (blue) (x = 5, three experiments). F) Representative flow cytometry plots of CD4 and CD8 staining 
of thymic cells isolated from C57BL/6J mice or BθOM transgenic mice (x = 5, three experiments) and quantification of the 
percentage of CD8 T cells among the thymic leukocyte population. G) Percentage of Tregs in the thymus (n ≥ 6, three experiments), 





BθOM transgenic mice (gray). Student’s t test: (E) *P < 0.1 and **P < 0.01; (F) ***P = 0.0004; (G) ****P < 0.0001 and ***P 
= 0.0001 
We next created a transgenic mouse line expressing the BθOM TCR genes on a  
C57BL/6J-Rag1−/−-CD45.1 genetic background (BθOM Rag1−/− mouse strain). The TCR 
transgenic T cells from this line were I-Ab restricted, expressed Vα1 and Vβ12 (Figure 3.1D), 
and were specific for Bt (human or mouse isolates) (Figure 3.2A). The peripheral T cells from 
BθOM Rag1−/− mice were essentially all naive, expressing low levels of CD69, CD25, and 
CD44 proteins (Figure 3.1E); the thymus was also devoid of CD8+ T cells (Figure 3.1F). We 
found that BθOM transgenic mice develop few, if any, thymic or peripheral Tregs compared with 
nontransgenic C57BL/6J mice (Figure 3.1G). Isolated naive T cells from BθOM Rag1−/− mice 
could be activated when stimulated in vitro with BMDM incubated with either Bt or OMVs 
(Figure 3.2, A and B). Stimulation of the BθOM TCRtg T cells by Bt was confirmed to be 
sensitive to nutrients in TYG media (Figure 3.2C), enabling the use of BθOM T cells to study the 
effect of diet on symbiont-host interactions. 
Figure 3.2 Bt activates BθOM T cells in a nutrient-dependent manner. 
A and B) Percentage of CD69 expressing BθOM T cells after a 24-hour culture with BMDM loaded with A) Bacteroidaceae family 
[human: B. thetaiotaomicron (n = 4, four experiments); mouse: B. fragilis, B. vulgaris, Parabacteroides goldsteinii, E. coli, B. 
sartorii (n = 3, three experiments)] or B) human Bt OMVs (75 μg/ml: n = 7, six experiments; 37.5 μg/ml: n = 6, six experiments; 
18.75 μg/ml: n = 5, four experiments; 10 μg/ml: n= 8, six experiments; 1 μg/ml: n = 3, three experiments; 0.1 μg/ml: n = 4, four 
experiments; 0.01 μg/ml: n = 3, three experiments). Flow cytometry plots are gated on CD4+ CD45.1+leukocytes. C) Percentage 
of CD69 expressing BθOM hybridoma T cells after a 24-hour culture with BMDM loaded with human Bt grown in TYG (n = 13, 





Means with asterisks are significantly different by Tukey’s multiple comparisons test. Student’s t test: (C) ****P < 0.0001, ***P = 
0.0001, and **P < 0.01. 
We then evaluated the function of BθOM T cells in vivo by transferring them into 
antibiotic pretreated Rag1−/− mice. Mice were pretreated with antibiotics for 3 weeks to allow 
colonization with the subsequently gavaged human isolate of Bt, which we previously showed 
colonize mice under these conditions26. Sorted naive (CD44loCD62Lhi) 
CD25−CD4+CD45.1+ BθOM T cells (Figure 3.3A) were transferred into Rag1−/− mice that had  
Figure 3.3 Sorting strategy and Bt colonization for in vivo BθOM T cell transfer experiments. 
A) Example flow cytometry plots of the gating strategy for sorting CD4+V+CD44-CD62L+CD25- cells9 and post-sort flow 
cytometry plots showing no CD4+V+CD44-CD62L+CD25+ cells in the sorted population (bottom). B) Colonization levels of Bt 
(total DNA of Bt/gram of fecal matter) on days 4 PBS (n=6, 5 experiments) and day 4 and day 7 Bt (n≥14, 9 experiments) gavaged 
Rag1-/- mice transferred with BθOM T cells. C) Representative flow cytometry plots of Rort and Foxp3+ staining of colonic cells 





been previously colonized by Bt for 4 days (Figure 3.3B). We identified CD4+CD45.1+ T cells in 
the lamina propria, colon-draining lymph node (cdLN), which refers to the lymph node within 
the mesenteric lymph node (mLN) that drains the colon, and spleen 7 days after T cell transfer 
(Figure 3.4, A and B). In these mice, BθOM T cell localization in the colon lamina propria and 
cdLNs was dependent on Bt colonization (Figure 3.4C). We also found BθOM T cells in the 
spleen of Bt–colonized Rag1−/− mice (Figure 3.4C). The BθOM T cells proliferated in the lamina 
propria, cdLN, and spleen, revealing that they were exposed to their cognate antigen (Figure 3.4, 
D and E). Bt–gavaged BθOM Rag1−/− mice did not have obvious signs of disease such as weight 
loss (Figure 3.5A). 
Figure 3.4 BθOM T cells proliferate in the colon in Bt–colonized mice. 
A) Schematic of adoptive transfer of BθOM T cells into Rag1−/− mice gavaged with PBS or Bt. B) Representative flow cytometry 





cells among live leukocytes that are CD45.2−CD45.1+CD4+ in PBS or Bt–gavaged mice in the colon (n ≥ 6, ≥ five experiments), 
cdLN (n ≥ 5, ≥ three experiments), and spleen (n ≥ 6, ≥ four experiments). D) Representative histograms of adoptively transferred 
carboxyfluorescein diacetate succinimidyl ester (CFSE)–labeled BθOM T cells in the colon (n ≥ 3, ≥ three experiments), cdLN (n ≥ 
3, three experiments), and spleen (n ≥ 3, ≥ three experiments) of Bt–gavaged mice compared with PBS-gavaged mice. E) 
Quantification of the percentage of proliferated CFSE low CD45.2−CD45.1+CD4+ T cells in the colon (n ≥ 3, ≥ three experiments), 
cdLN (n ≥ 3, three experiments), and spleen (n ≥ 3, ≥ three experiments). Mann-Whitney test for non-normally distributed data: 
(C) ****P < 0.0001 and ***P = 0.0006. Student’s t test: (E) ****P < 0.0001, ***P = 0.0005, and *P = 0.0160. 
 
Figure 3.5 BθOM T cells do not cause weight loss in Bt–colonized mice.  
Weight changes calculated as the percentage of the initial weight in Rag1-/- mice transferred with BθOM T cells and gavaged with 
PBS (n=5, 2 experiments) or Bt (n=5, 2 experiments). 
 
BθOM T cells differentiate into Teffs and Tregs that self-regulate to prevent colitis 
  Because Bacteroides have been previously shown to be strong drivers of Treg induction
27, 
we reasoned that the BθOM Tregs would mediate tolerance to Bt. We transferred BθOM T cells 
into Rag1−/− mice; the transferred cells were presorted for CD4+CD44loCD62LhiCD25− to ensure 
that there was no transfer of preexisting Tregs into recipients (Figure 3.3A). Characterization of 
the BθOM T cells in multiple locations showed a mixture of Teff and FoxP3
+ Tregs in the lamina 
propria and cdLN with a lower percentage of Tregs found in the spleen (Figure 3.6, A-C). 
Treg development in the peripheral lymphatics and the colonic tissue was dependent 
on Bt colonization because few to no Tregs were found in phosphate-buffered saline (PBS)–
gavaged mice (Figure 3.6B and Figure 3.3B). Despite the presence of Tregs in both the cdLN and 
colonic lamina propria, the cdLNs had many more Tregs expressing CD25 than the colon, where 
most of the Tregs expressing FoxP3 lacked CD25 expression (Figure 3.6D). Consistent with 
previous reports with polyclonal Tregs exposed to Bacteroides in the lamina propria
28,29, 50% of 
BθOM FoxP3+ Tregs express RORγt (Figure 3.3C). This finding is also consistent with a report 





expressing specific induced Tregs (iTregs) in the large intestine
30. Together, these data reveal that 
the same TCR can differentiate into both Teffs and Tregs
19. 
Figure 3.6 BθOM T cells in the colon differentiate into Tregs. 
A) Flow cytometry plots of CD45.1+CD4+ BθOM T cells in the colon, cdLN, and spleen of PBS or Bt–gavaged Rag1−/− mice 
transferred with naive CD25− BθOM T cells. B) The number of CD4+CD45.1+FoxP3+ BθOM Tregs cells in the colon (n ≥ 6, ≥ five 
experiments), cdLN (n ≥ 5, ≥ three experiments), and spleen (n ≥ 6, ≥ four experiments) of PBS or Bt–gavaged Rag1−/− mice after 
CD25− BθOM T cell transfer. C) Percentage of FoxP3+ Tregs in the colon (n = 27, nine experiments), cdLNs (n = 25, seven 
experiments), and spleen (n = 20, seven experiments) of Rag1−/− mice that received naive CD25− BθOM T cells and were gavaged 
with Bt. D) Percentage of CD25high versus CD25low CD4+FoxP3+ Tregs in the colon (n = 27, nine experiments) and cdLNs (n = 25, 
seven experiments) of Rag1−/− mice gavaged with Bt and injected with naive BθOM T cells. Mann-Whitney test for non-normally 
distributed data: (B) ****P < 0.0001 and **P = 0.004. Kruskal-Wallis with Dunn’s posttest for non-normally distributed data: 






  We hypothesized that Bt–specific Tregs produced sufficient regulation in the colonic 
mucosa to prevent Bt–specific CD4+ T cells from inducing colitis upon exposure to Bt To test 
this hypothesis, we crossed the BθOM transgenic mouse to FoxP3-DTR-GFP mice, which 
permits the in vivo depletion of Tregs upon diphtheria toxin (DT)
31 treatment and includes a green 
fluorescent protein (GFP) marker for Treg identification
30. We transferred naive,  
 
Figure 3.7 Depletion of BθOM Tregs drives BθOM CD4+ Teff to cause colitis. 
A) Schematic of adoptive transfer of BθOM or BθOM-FoxP3-DTR T cells into Rag1−/− mice gavaged with PBS or Bt and treated 
with DT (31) to deplete BθOM Tregs. B) Percentage of BθOM Tregs after depletion in the mLN (n ≥ 12, five experiments) or spleen 
(n ≥ 14, five experiments). (C to E) Histology (C), quantification of the number of mitotic figures/10 crypts (D), and average crypt 
height (E) in cecal sections from Rag1−/− mice given BθOM T cells and DT (n = 6, three experiments) compared with those given 
BθOM-FoxP3-DTR T cells and DT (n = 10, three experiments). Scale bars, 120 μm. (F) Cytometric bead array used to quantify 





the mLN were stimulated with PMA for 5 hours. Student’s t test: (B) ***P = 0.0002 and **P = 0.0055; (D) **P = 0.0029; (E) 
****P < 0.0001; (F) *P = 0.0205 and **P = 0.098. 
GFPlo BθOM T cells into Rag1−/− mice colonized with Bt that were treated with DT on days 9, 
11, and 13 (Figure 3.7A). We confirmed depletion of Tregs in the cdLNs and spleen (Figure 
3.7B). We found that Rag1−/−mice that received BθOM-FoxP3-DTR cells and DT developed 
colitis, with an increase in hyperproliferative crypts, epithelial proliferation, lymphocyte 
infiltrate, mitotic figures, and crypt height compared with control mice that received BθOM T 
cells and DT (Figure 3.7C-E). Cells isolated from the mLN of Rag1−/− mice transferred with 
BθOM-FoxP3-DTR T cells and treated with DT to deplete Tregs showed an increase in 
proinflammatory cytokines [interleukin-17A (IL-17A), IFN-γ, and IL-6] compared with cells 
isolated from Rag1−/− mice receiving wild-type BθOM T cells and treated with DT (Figure 3.7F 
and Figure 3.8A-B). Both BθOM-FoxP3-DTR T cells and wild-type BθOM T cells isolated from  
Figure 3.8 Cytokines not altered by BθOM Treg depletion.  
(A-B) Cytometric bead array used to quantify (A) TNF- (n≥10, 3 experiments), IL-2 (n≥10, 3 experiments), IL-4 (n≥10, 3 





experiments), TNF (n≥9, 3 experiments), IL-2 (n≥9, 3 experiments), IL-10 (n≥9, 3 experiments), and IL-4 (n≥9, 3 experiments) 
after cells were isolated from the (A) mesenteric lymph node and (B) spleen and were stimulated with PMA for 5 hours. Student’s 
t test: not significant.  
the colon lamina propria and mLN differentiated into TH1 cells (Figure 3.9A). BθOM-FoxP3-
DTR T cells can also differentiate into TH17 cells; however, variable levels of TH17 induction 
were observed between experiments (Figure 3.9B-C). These findings are a direct demonstration 
that symbiont-specific CD4+ T cells can develop into both Teffs and Tregs and that these Tregs can 
self-regulate. 
Figure 3.9 BθOM T cells primarily differentiate into TH1 cells in vivo in the colon lamina propria and mLN.  
The percentage of cells isolated from the colon and mLN and stimulated with PMA and ionomycin for 5 hours that were (A) IFNγ+ 
(n=27 mice, 2 experiments) or (B-C) IL-17A+. Both IL-17A+ replicates are shown with 1 replicate in (B) n=8, 1 experiment and 
1 replicate in (C) n=19, 1 experiment). Student’s t test: (B) **P=0.0097 
The antigen recognized by BθOM T cells, BT4295, is expressed in a PUL 
  To elucidate how diet could affect a bacterial antigen expression, we needed to identify 
the antigen recognized by BθOM T cells. To identify this Bt antigen, we used positive functional 





material, we performed a T cell activation assay from 20 fractions of isolated proteins separated 





Figure 3.10 BθOM T cells specifically recognize the BT4295(541–554) epitope. 
(A) Two parallel methods, T cell Western with proteomics (left) and transposon mutagenesis (TM) screen20 (right), used to identify 
the antigen that stimulates BθOM T cells. (B) Schematic of the PUL80 affected by BT4298 disruption by TM. The arrow represents 
the direction of transcription. (C to G) Percentage of CD69 expressing BθOM T cells after culture with BMDM loaded with (C) E. 
coliexpressing the full-length BT4295 (n = 3, three experiments for each dilution) or three consecutive segments of BT4298 
(BT4298A, BT4298B, and BT4298C) (n = 3, three experiments for each dilution), (D) Bt (n = 4, four experiments) or Δ4295 (n = 
4, four experiments), or (E) E. coli expressing two consecutive segments of BT4295 (BT4295A and BT4295B) (n = 3, three 
experiments for each dilution). (F) Synthetic 20-amino acid peptides overlapping by 12 amino acids. The asterisks represent the 
P5 position. (G) Bt (n = 4, four experiments, same data as Figure 3.2E or Δ4295 (n = 3, three experiments). One-way ANOVA 
analysis: (C) **P < 0.01, ***P < 0.001, and ****P < 0.0001. Means with asterisks are significantly different by Tukey’s multiple 
comparisons test. Student’s t test: (D) ***P < 0.001 and ****P < 0.0001; (E) *P < 0.1, **P < 0.01, and ***P < 0.001; (G) 
***P < 0.001 and ****P < 0.0001. 
 
a single fraction of Bt OMV proteins that stimulated BθOM T cells (Figure 3.10A). Mass 
spectrometry analysis of this fraction identified 322 distinct proteins (Figure 3.10A). To refine 
the list of potential antigens, we generated a Bt transposon insertion library32 and screened 
individual clones using the in vitro T cell activation assay for BθOM T cells (Figure 3.10A). In a 
screen of 2300 clones, we identified five genes that, when knocked out, no longer stimulated 
BθOM T cells (Figure 3.10A and Figure 3.11B). One of the five Bt gene candidates (BT4298) 
was identified in the mass spectrometry analysis (Figure 3.10A). The other four hits were all in 
one additional unlinked locus (BT1220-23) containing genes encoding enzymes in the pentose 
phosphate pathway. 
Figure 3.11 Identification of the epitope recognized by BθOM T cells.  
(A) Bt OMVs were separated by molecular weight on a 10% SDS PAGE gel. Lane S is the molecular weight ladder. (B) The five 
genes identified when screening 2,300 individual clones (n=2 experiments) of a Bt transposon insertion library.  
  Expression in Escherichia coli of the BT4298 protein identified in both the mass 
spectrometry and transposon library, unexpectedly, did not stimulate BθOM T cells (Figure 
3.10C). However, many bacterial genes are organized into cotranscribed operons, and this is 
likely to be true for Bt. For example, the BT4294-4300 PUL was previously shown to be 





transposon insertion in the BT4298 gene exerts loss-of-function effects on downstream genes 
due to polarity (Figure 3.10B), including BT4295, which was also identified in our mass 
spectroscopy analysis (Figure 3.10A). Expression of BT4295 in E. coli resulted in strong 
stimulation of BθOM T cells (Figure 3.10C), demonstrating that the BT4295 was the antigen 
recognized by BθOM T cells. BT4295 is predicted to be a SusE/SusF lipoprotein that is 
ultimately trafficked to the OM, including OMVs (Figure 3.12A)26. We confirmed that BT4295 
was the only antigen recognized by BθOM T cells by generating an in-frame deletion mutant of 
BT4295 that disrupted its expression (BTΔ4295) and abolished its ability to stimulate BθOM T 
cells (Figure 3.10D). 
  To identify the epitope in BT4295 recognized by BθOM T cells, we expressed amino and 
carboxyl halves of the protein in E. coli (Figure 3.10E). We found that the carboxyl half of the 
protein activated BθOM T cells (Figure 3.10E). We then generated overlapping 20-mer peptides 
for the entire carboxyl half of BT4295 and tested them for their ability to activate BθOM T cells. 
A single peptide (536 to 555) stimulated BθOM T cells (Figure 3.10F). The antigenic epitope 
was further defined to be the highly stimulatory 14-mer (541 to 554) (EEFNLPTTNGGHAT), 
which contains a strong predicted I-Abbinding motif (P1 = F543) (Figure 3.12B). We identified  
Figure 3.12 BθOM T cells recognize BT4295(541-554) and schematic of the BT4295 PUL.  
(A) Schematic of the BT4295 PUL with BT4295 represented as the SusE/SusF proteins. (B) The percentage of CD69+ BθOM T 
cells after culture with BMDMs treated with BT4295(541-554) (n=2, 1 experiment). 
the threonine at the P5 position (T547) to be critical for TCR recognition and generated a point 
mutation at the P5 position (a threonine to a valine substitution, T547V) that resulted in the 
complete loss of BθOM T cell activation (Figure 3.10G). Together, these findings demonstrate 





the BT4295 protein, which is expressed in the Bt OM in response to mucin-type O-glycan 
(MOG) cues. 
Expression of BT4295 is regulated by available nutrients 
  Having identified BT4295 as the antigen recognized by BθOM T cells, we determined 
how specific nutrients altered its expression. On the basis of the differential ability of Bt grown 
in TYG versus in mTYG media to stimulate BθOM T cells (Figure 3.2C), we asked whether 
removing specific components (Table 3.1) from the TYG media or adding them to the mTYG 
media would alter the stimulatory ability of Bt grown in these modified media.  
 
Table 3.1 Composition of TYG vs. mTYG media 
Media Component TYG mTYG 
Tryptone 10g/L 20g/L 
Yeast Extract 5g/L 10g/L 
D-glucose 4g/L 5g/L 
KH2PO4 100mM 0.294mM 
K2HPO4   0.23mM 
(NH4)2SO4 8.5mM   
NaCl 15mM 1.4mM 
CaCl2•2H2O  0.0072mM 0.068mM 
FeSO4•7H2O 0.00263mM   
MgCl2 0.1mM   
MgSO4•7H2O   0.078mM 
NaHCO3   0.024mM 
Hematin 0.0019mM 0.0079mM 
Vitamin K3 0.01mM   
Vitamin B12 0.00000369mM   
L-histidine 0.2mM   
L-cysteine 0.413mM 8.25mM 





Individually removing vitamin B12, vitamin K3, histidine, cysteine, FeSO4, or MgCl2 from TYG 
media had no effect on the ability of Bt to stimulate BθOM T cells (Figure 3.13A-B). However, 
when we removed salts [KH2PO4, (NH2)4SO4, and NaCl] from TYG, Bt grown in this altered 
media no longer stimulated BθOM T cells (Figure 3.13A-B). Because removing salts  
Figure 3.13. The effect of various nutrients on BθOM T cell activation. 
(A) T cell stimulation results after various media components were removed from TYG media or added to mTYG media. (B) A 





TYG, TYG lacking various individual media components, TYG without salts, and TYG with mTYG salts (n=6, 3 experiments). (C) 
A representative plot of the BT4295 protein standard curve used in the BT4295 ELISA. 
from the TYG media did reduce Bt growth to some extent, we also tested the addition of these 
salts to mTYG media that contained notably lower concentration of salts (KH2PO4, K2HPO4, and 
NaCl) (Figure 3.14A). Adding TYG salts to mTYG media resulted in a significant increase in 
BθOM T cell activation (Figure 3.14A). The ability of Bt grown in TYG, mTYG, and mTYG 
with TYG salts to stimulate BθOM T cells directly correlated with the level of BT4295 protein 
expression as determined by a quantitative enzyme-linked immunosorbent assay (ELISA; Figure 
3.14B and Figure 3.13C). 
Figure 3.14 Salt and glycan regulate BT4295 expression and alter BθOM T cell activation. 
(A) Percentage of CD69 expressing BθOM T cells after a 24-hour culture with BMDM loaded with Bt grown in mTYG (n = 4, four 
experiments), TYG (n = 2, two experiments), and mTYG supplemented with TYG salts (n = 4, four experiments). (B) The 
concentration in microgram per milliliter of BT4295 protein expressed in Bt grown in TYG, mTYG, and mTYG supplemented with 
TYG salts (n = 4, four experiments) as determined by a quantitative ELISA. (C) Percentage of CD69 expressing BθOM T cells 
after a 24-hour culture with BMDM loaded with Bt grown in mTYG, TYG, mTYG supplemented with MOG and TYG supplemented 
with MOG (n = 2, two experiments). (D) The concentration in microgram per milliliter of BT4295 protein expressed in Bt grown 





quantitative ELISA. One-way ANOVA analysis: (A) *P < 0.1, **P < 0.01, ***P < 0.001, and ****P < 0.0001; (B) **P = 0.0093; 
(D) ****P < 0.0001 and **P = 0.0065. Means with asterisks are significantly different by Tukey’s multiple comparisons test. 
  Previous transcriptional analysis showed that, in the absence of dietary glycans, Bt in vivo 
increases the expression of the BT4294-4300 PUL likely to break down endogenous mucin 
glycans, which is supported by in vitro expression of this PUL in response to purified mucin 
glycans34,35. Therefore, we tested whether growing Bt in mTYG with porcine MOG would 
increase the expression of BT4295 and drive BθOM T cell activation. We found that Bt grown in 
mTYG supplemented with MOG now strongly activated BθOM T cells (Figure 3.14C) and led to 
increased BT4295 protein expression (Figure 3.14D). Thus, BT4295 expression can be up-
regulated by MOG in mTYG media, which alone did not induce expression. Together, these 
findings demonstrate that, by changing available nutrients (salts or glycans), the expression of a 
specific symbiont-derived antigen can be markedly affected. 
 
Glucose catabolically represses BT4295 
  The four transposon mutant hits in the pentose phosphate pathway that significantly 
decreased expression of BT4295 (Figure 3.10A) implicated glucose metabolism as another 
potential regulator of BT4295 expression. To test the involvement of glucose on the regulation of 
BT4295 expression, we eliminated glucose from the TYG and mTYG media (Table 
3.1). Bt grew in both media in the absence of glucose, but at slightly reduced rates. We found 
that BθOM T cells were now stimulated by Bt grown in mTYG in the absence of glucose (Figure 
3.15A). Similarly, Bt grown in TYG without glucose also stimulated BθOM T cells, even 
stronger than in the presence of glucose (Figure 3.15A). Thus, glucose appeared to be acting as a 
repressor of BT4295 expression. Catabolite repression is a well-established regulatory process in 
bacteria, including Bt, in which other metabolic pathways are repressed in the presence of 
glucose or other high-priority nutrients36,37. Using a quantitative ELISA for BT4295 protein, we 
tested whether the increase in stimulatory ability of Bt grown in the absence of glucose was due 
to increased BT4295 protein expression. Removing glucose from the mTYG media resulted in a 
14.5-fold increase in the expression of BT4295, and removing it from TYG media resulted in a 
4-fold increase (Figure 3.15B). This finding again shows a direct correlation between the level of 
BT4295 protein expression and the ability to stimulate BθOM T cells, providing proof that 





the presence of glucose, Bt shuts down the expression of the BT4294-4300 PUL, thereby 
reducing production of the BT4295 antigen. 
 
Figure 3.15 Dietary glucose represses BT4295 expression, decreasing the activation of BθOM T cells in vivo. 
(A) Representative plot of the percentage of CD69 expressing BθOM T cells after culture with BMDM loaded with Bt grown in 
TYG and mTYG media with or without glucose (n = 6, three experiments). (B) The concentration in microgram per milliliter of 
BT4295 protein expressed in Bt grown in TYG and mTYG media with or without glucose (n = 6, three experiments). The percent 
difference in the number of (C) CD4+CD45.1+ BθOM T cells or (D) CD4+CD45.1+CD44+CD62L− activated BθOM T cells in the 
colon (n = 26, x = 3 experiments) and cdLN (n = 16, two experiments) of Bt–colonized mice given water or 30% glucose water 
and adoptively transferred with 200,000 CD4-enriched BθOM T cells. (C and D) The percent difference was calculated from the 
mean of each experiment. ANOVA multiple comparison analysis: (A) *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001; 
(B) ****P < 0.0001 and *P = 0.0190. Means with asterisks are significantly different by Tukey’s multiple comparisons test. Mann-
Whitney test for non-normally distributed data: (C) ***P = 0.0002 and **P = 0.0052; (D) ***P = 0.0002 and *P = 0.0115. 
Dietary glucose decreases the stimulation of BθOM T cells in vivo 
  We next determined whether exogenous glucose affected the ability of BθOM T cells to 
be stimulated in vivo by decreasing BT4295 expression. We added 30% glucose to the drinking 
water of recipient mice and maintained them on the standard chow throughout the course of the 
experiment. The addition of 30% glucose to the drinking water had no effect on Bt colonization 
levels (Figure 3.16A). The number of BθOM T cells in the colon and cdLN markedly decreased 
in the recipient mice fed 30% glucose drinking water (Figure 3.15C). Although there was no 
difference in Tregs (Figure 3.16B), the number of activated BθOM T cells was also decreased 





resulting in weaker stimulation of the BθOM T cells. This finding establishes that diet can affect 
the expression of a specific symbiont antigen and modulate a CD4+ T cell response in vivo. 
Figure 3.16 The addition of 30% glucose to the drinking water has no effect on Bt colonization or Treg differentiation.  
(A) Colonization levels of Bt (total DNA of Bt/gram of fecal matter) on days 0, 4, and 7and the (B) percentage of FoxP3+ Tregsin 
the colon and cdLN (n=14, 2 experiments) in Bt gavaged Rag1-/-mice transferred with BθOM T cells and given regular water or 
water with 30% glucose. 
 
Discussion 
  We developed a symbiont-specific T cell model to study how diet could affect the 
interactions between a symbiont and the host immune system. We show that BθOM T cells 
respond to Bt and OMVs but not to other Bacteroides family members. Next, we identified 
BT4295, a SusE/F homolog, as the BθOM T antigen. Transfer of BθOM T cells into Bt–
colonized Rag1−/− mice showed that antigen-specific T cells differentiate into Tregs and Teffs. 
Upon depletion of BθOM Tregs, the BθOM Teffs cause colitis. We show that the expression of 
BT4295 can be altered by glycans, salts, and glucose. A high-glucose diet reduced activation of 
the BθOM T cells, making BT4295 a nutrient-sensitive antigen able to alter T cell responses to 
microbes. This study definitively shows that diet can play a role in altering antigen expression 
thereby affecting immune responses. 
  TCR transgenic models have been previously developed to study antigen-specific 





intestine have revealed how symbiotic microbes contribute to driving organ-specific 
autoimmunity23. The CBir1 TCR transgenic mice are widely used to study antigen-specific 
microbial interactions21; however, CBir1 T cells do not recognize their antigen during 
homeostasis despite the abundance of microbial antigen in the lumen38. More 
recently, Helicobacter species–specific transgenic T cells were shown to respond differently 
during homeostasis and mucosal injury/inflammation19,29. In all of these cases, microbial 
antigens were not shown to cross the epithelial barrier except in the context of inflammation. 
Therefore, we developed a symbiont-specific T cell that responds to Bt and OMVs, a relevant 
source of antigen that crosses the colonic epithelium and interacts with the host immune system 
during homeostasis25,39. 
  Although our study focused on a single T cell and its cognate antigen, this approach is 
likely relevant because of the concept of immunodominance. Despite a theoretically large 
number of potential microbial epitopes, which can be recognized by CD4+ T cells, the immune 
system generally focuses on a few immunodominant epitopes. As one example, the CD4+ T cell 
response in mice to SFB focuses on two dominant antigens of this microbe23. We propose that 
the TCR we identified in this study may be specific for a dominant Bt antigen. 
Our data directly show the conversion of a naive Bt–specific T cell into Tregs. Using the 
diphtheria toxin receptor (DTR) system, we deplete Bt–specific Tregs and show that, in the 
absence of these cells, symbiont-specific T cells cause colitis. To determine the mechanism of 
Treg induction, we identified the antigen driving T cell activation. Previous reports on B. 
fragilisidentified capsular polysaccharides on OMVs that induce Tregs
40, suggesting that 
bacterially derived polysaccharides have immunomodulatory effects on the host immune system. 
Our study extends the types of Bacteroides antigens that can participate in T cell development, 
including induction of Tregs. 
  One potential factor we have not controlled for is a direct effect of glucose on T cells. 
There is significant literature showing that glucose enhances T cell responses31,41,42. To our 
knowledge, there are no reported studies showing that increased glucose in vivo would decrease 
T cell responses or homeostatic proliferation. Although we cannot definitively rule out that 
increased glucose in vivo was directly inhibiting BθOM T cells, the literature supports our 
conclusion that increased dietary glucose caused a decrease in T cell proliferation due to a direct 





  Inflammatory bowel disease (IBD) involves a potentially definable number of chronically 
activated T cells and microbial antigen specificities. We now show that specific TCR/cognate 
antigen pairs can be modulated by altering dietary components to affect gene expression of such 
a key microbial antigen. Future work developing additional TCR/antigen systems from other 
symbionts, including those that are enriched in patients with IBD, will be valuable to test 
whether this paradigm established with Bt can be extended to other key microbial antigens. If 
glucose repression or salt stimulation of dominant microbial antigens is widespread, then such 





  The objective of this study was to generate a Bt–specific T cell system (BθOM T cells) to 
identify the interactions between the immune system and an antigen expressed on a highly 
prevalent colonic symbiont and determine the role that diet plays in altering those interactions. 
We designed and performed experiments in cellular immunology, protein biochemistry, and 
mass spectrometry. The number of independent experiments is outlined in the figure legends. 
 
Mice. 
  All experimental procedures were performed under approval by Washington University’s 
Animal Studies Committee. Mice were housed in an enhanced specific pathogen–free facility. 
BθOM transgenic mice on the Rag1−/− background were maintained by breeding to a 
nontransgenic Rag1−/− mouse. BθOM-FoxP3-DTR mice were generated by breeding BθOM 
transgenic mice with FoxP3-DTR mice30. 
 
Generation of the BθOM transgenic mouse. 
  Bt was grown to confluence and washed with PBS. C57BL/6J mice were immunized 
subcutaneously in the rear footpads with Bt mixed with incomplete Freund’s adjuvant (IFA; 
Difco) in a 1:1 ratio. One week later, draining popliteal lymph nodes were harvested and 
stimulated in vitro with Bt for 3 days. Stimulated T cells were fused following a standard 





BMDMs. The BθOM clone was selected for further analysis, and its TCR genes were sequenced 
and cloned into TCR expression vectors (43). TCRα and TCRβ constructs were co-injected into 
C57BL/6J pronuclei in the Washington University Department of Pathology and Immunology’s 
Transgenic Core Facility. Transgenic mice were identified by polymerase chain reaction (PCR) 
amplification of the Vα1 and Vβ12 transgenes from tail DNA (Vα1 forward primer 
GTTTCCAAGCAGGTGTGAGGAG and reverse primer CAAAACGTACCAGGGCTTACC; 
Vβ12 forward primer CTTCTCTTCTAGGTGATGCTG and reverse primer 
CCCAGCTCACCGAGAACAGTC). 
 
Antibodies and reagents.  
  The following reagents were purchased: CD62L (MEL-14) and CD45.1 (A20) (BD 
Biosciences); CD4 (GK1.5), CD69 (H1.2F3), CD45.1 (A20), CD44 (IM7), CD25 (PC61), 
CD45.2 (104), CD25 (PC61), Vβ12 (MRII-I), and Mouse TH1/TH2/TH17 Cytometric Bead Array 
Kit (BioLegend); CD25 (eBio3C7), CD4 (RM4-5), FoxP3 (FJK-16 s), IFN-γ (XMG1.2), and IL-
17A (TC11-18H10.1) (eBiosciences); CellTrace CFSE Cell Proliferation Kit and LIVE/DEAD 
Fixable Blue Dead Cell Stain Kit (Life Technologies); deoxyribonuclease 1 from bovine 
pancreas grade II (Roche); and collagenase from Clostridium histolyticum (Sigma). Homemade 
cocktail antibodies for negative selection of CD4+ T cells were purchased: anti-mouse Ter-119, 
CD11c (clone N418), CD11b (M1/70), CD8α (53-6.7), CD19 (1D3), and CD45R/B220 (RA3-
6B2) (Tombo); CD49b (DX5) and CD24 (M1/69) (BioLegend); anti-biotin microbeads (Miltenyi 
Biotec). 
Media recipes. 
   The following components of TYG medium were purchased: tryptone (10 g/liter) and 
yeast extract (5 g/liter) (BD Bacto); D-glucose (4 g/liter), 100 mM KH2PO4, 8.5 mM (NH2)4SO4, 
15 mM NaCl, 10 μM vitamin K3, 2.63 μM FeSO4•7H2O, 0.1 mM MgCl2, 1.9 μM hematin, 0.2 
mM L-histidine, 3.69 nM vitamin B12, and 413 μM L-cysteine (Sigma); 7.2 μM CaCl2•2H2O 
(Mallinckrodt). mTYG medium: The following components of mTYG medium were purchased: 
tryptone (20 g/liter) and yeast extract (10 g/liter) (BD Bacto); D-glucose (5 g/liter), 8.25 mM L-
cysteine, 78 μM MgSO4•7H2O, 294 μM KH2PO4, 230 μM K2HPO4, 1.4 mM NaCl, 7.9 μM 






Preparation of OMVs.  
Bt OMVs were purified with multiple rounds of centrifugation and filtering25. 
 
Functional in vitro macrophage T cell assay.  
BMDM was stimulated with IFN-γ at 2000 U/ml in I-10 medium [Iscove’s Modified 
Dulbecco’s Medium (IMDM) 10% fetal bovine serum, glutamine, and gentamicin] and plated on 
a 96-well plate at 1 × 105 cells per well. The cells were washed with PBS 24 hours later and kept 
in 100 μl of fresh I-10 medium without IFN-γ for another 24 hours. A total of 5 × 
105 splenocytes or 1 × 105 isolated BθOM CD4+ T cells were added per well in 50 μl with 50 μl 
of half log dilutions of Bacteroidaceae strains and OMV. Bacteroidetes were grown in a 5-ml 
TYG or mTYG culture at 37°C overnight to mid-log phase. Cultures were washed twice with 
PBS and resuspended in medium before adding to the assay. Twenty-four hours later, the 
supernatant containing the T cells was transferred to a fresh 96-well plate and spun down at 1200 
rpm. The cells were washed with fluorescence-activated cell sorting buffer and stained for CD69 
expression. 
 
In vivo experiments.  
Bacterial stocks: Bacteroidetes were grown anaerobically from single isolates in standing 
culture in TYG at 37°C for 24 hours33. Each culture was concentrated by centrifugation, mixed 
with sterile, prereduced PBS and glycerol to a final concentration of 20% glycerol, and frozen at 
−80°C in single-use aliquots. Gavage: Rag1−/− mice were placed on antibiotics at 3 to 4 weeks of 
age for 3 to 4 weeks. Antibiotic treatment consisted of ciprofloxacin (0.66 mg/ml), 
metronidazole (2.5 mg/ml; Sigma), and sugar-sweetened grape Kool-Aid Mix (20 mg/ml; Kraft 
Foods) in the drinking water44. Mice were gavaged with 100 μl of antibiotic water on the first 2 
days and the last 2 days of the 3- to 4-week duration. For the bulk of the experiments, mice were 
taken off antibiotic water and given Kool-Aid. For the in vivo glucose experiments, mice were 
taken off antibiotic water and given water or 30% glucose water. Two days later, mice were 
gavaged with 100 μl of Bt strains at a concentration of 1 × 108 colony-forming units/ml. Fecal 
pellets were obtained on days 0, 4, and 7 to determine colonization. BθOM T cell transfer: Three 
days after gavage, Rag1−/− mice were injected with BθOM T cells isolated from the peripheral 





negative selection using a homemade cocktail of antibodies (see reagents) and sorted for 
CD4+CD44loCD62LhiCD25− T cells. Cells (1 × 105 to 2 × 105) were injected retrorbitally. 
Lamina propria dissociation: Seven days after T cell transfer, mice were euthanized, and 
leukocytes were isolated from the lamina propria following the Lamina Propria Dissociation Kit 
protocol published by Miltenyi Biotec. Peripheral tissue processing: The cdLN and spleen were 
removed and processed using frosted microscope slides (Thermo Fisher Scientific). Samples 
were filtered through a 70-μm filter. DT depletion of BθOM FoxP3+ Tregs. Treg depletion. 
Antibiotic treated Rag1−/− mice were gavaged with Bt and injected with enriched and sorted 1 × 
105 BθOM-FoxP3-DTR or BθOM T cells. Intraperitoneal injections of DT (10 μg/kg) were 
performed on days 9, 11, and 13 after gavage. Depletion was confirmed by staining for Tregs on 
day 21 after gavage in mLNs and spleen. Cytokines: On day 21 after gavage, 5 × 104 mLNs and 
2 × 106 splenocytes were stimulated with phorbol 12-myristate 13-acetate (PMA; 50 ng/ml) and 
ionomycin (500 ng/ml) for 5 hours at 37°C. TH1/TH2/TH17 cytokines were quantified in the 
supernatant using the BD Cytometric Bead Array following the manufacturer’s instructions. 
Supernatants from splenocyte samples were diluted 1:2. T cell differentiation: On day 24 after 
gavage, cells isolated from the colon lamina propria and mLN were stimulated with PMA (50 
ng/ml) and ionomycin (500 ng/ml) for 1 hour at 37°C, Brefeldin A was added (5 μg/ml), and the 
cells were stimulated for four additional hours at 37°C. TH1 and TH17 cells were identified by 
intracellular staining with IFN-γ and IL-17A antibodies. 
 
Tissue harvest, fixation, and preparation for histology. 
  Ceca and colons were fixed in methacarn fixative for 12 to 16 hours at 24°C. Samples 
were washed two times with 100% methanol for 30 min, followed by 100% ethanol for 20 min 
(two times), and then stored in 70% ethanol. Five-micrometer sections were stained with 
hematoxylin and eosin (H&E). Representative images of cecal histology were taken with an 
Olympus BX51 microscope. Blinded microscopic analysis for mitotic figures using H&E-stained 
histologic sections was performed at 20× magnification on well-oriented crypts as previously 
described44. 
Fecal bacterial DNA extraction and quantitative PCR amplification.  
  Fecal bacterial DNA extraction and quantitative PCR amplification were performed 





T cell Western assay.  
  Bt OMV antigens were separated using a T cell Western blot assay as described46. 
Briefly, 500 μg of OMVs was separated on a 10% SDS–polyacrylamide gel electrophoresis 
(SDS-PAGE) gel on both the left and right sides of the gel with molecular weight standards on 
both sides. For the left side, the proteins were transferred to nitrocellulose (each lane cut into 20 
strips), dissolved in dimethyl sulfoxide, and precipitated with sodium carbonate/sodium 
bicarbonate. The nitrocellulose particles from each strip were tested for their ability to stimulate 
BθOM T cells using BMDM as antigen presenting cells (APCs). The corresponding position of 
the active fraction on the right side of the SDS-PAGE gel was further analyzed by mass 
spectrometry. 
 
Proteomic analysis of OMVs.  
  Proteomic analysis of the corresponding T cell stimulatory SDS-PAGE fraction of OMVs 
from TYG-grown Bt was performed using standard procedures at MS Bioworks (Ann Arbor, 
MI). Briefly, the gel slices were digested with trypsin and analyzed by nano liquid 
chromatography–tandem mass spectrometry with a Waters NanoAcquity HPLC system 
interfaced to a Thermo Fisher Q Exactive. The data were searched using Mascot against the 
UniProt Bt reference proteome. Mascot DAT files were parsed into Scaffold for validation, 
filtering, and creation of a nonredundant list per sample, requiring at least two unique peptides 
per protein. 
 
B. thetaiotaomicron transposon mutagenesis library and screen.  
  Transposon mutagenesis of Bt was performed as described previously32. Briefly, 
mutagenesis was carried out on an acapsular Bt strain (ΔCPS) lacking all capsular polysaccharide 
loci, which was previously characterized37. Here, we used the pSAM_Bt vector 
containing mariner transposon and an ermG cassette. S17 E. coli was used to deliver the vector 
through conjugative transfer into Bt. DNA isolation from selected mutants was performed using 
the Qiagen DNeasy Blood and Tissue Kit. Two-round PCR was performed to identify the 
transposon insertion site with the following conditions: round 1; 1 cycle at 95°C (3 min); 5 
cycles at 95°C (30 s), 30°C (30 s), and 72°C (45 s); 32 cycles at 95°C (30 s), 55°C (30 s), and 





Kit, and 100 to 200 ng of product were used as a template for round 2; 1 cycle at 95°C (3 min); 
35 cycles at 95°C (30 s), 55°C (30 s), 72°C (45 s). Reactions from round 2 were run on a 2% 
agarose-Tris-Borate-EDTA gel, and bands were extracted using the Qiagen Gel Extraction Kit. 
These products were then sequenced using the primers previously described32.  
  The library was frozen in 96-well plates. The plates were thawed and spun down, and the 
medium was removed, washed once in 200 μl of PBS, and then suspended in 100 μl of complete 
medium. Ten microliters of each was screened using the in vitro macrophage T cell assay during 
the primary screen, and hits were retested in duplicate for conformation before sequencing. 
Generation of the BT4295 mutant. BT4295 gene deletion and amino acid substitutions within this 
gene were done using allelic exchange as described previously47. Briefly, all manipulations were 
done in a Δtdk strain background of Bt using the pExchange-tdk vector48, and primers are listed 
in Table 3.2. All Bacteroides strains and mutants were grown in TYG medium or brain-heart 
infusion agar with 10% horse blood added. The following antibiotics were used as needed: 
gentamicin (200 μg/ml), erythromycin (25 μg/ml), and 5-fluoro-2′-deoxyuridine (200 μg/ml). 
 
Table 3.2 BT4295 Primers 
Primer Sequence (5’ to 3’) Use 
BT4295 5’ 
UpSal1 
GCGGTCGACTGCCAAACTGCTTCCCGATGA Deletion of BT4295 
BT4295 3’ Out 
TTCTTCGTCAGTCTTTTCTTGTTTTACTTGATTTGATTACAAGT
TATCTAC 
Deletion of BT4296 
BT4295 5’ Out GTAAAACAAGAAAAGACTGACGAAGAA Deletion of BT4297 
BT4295 3’ 









T547V Amino Acid conversion 
of BT4296 
BT4295_SPdel 
5’UpSal1  GCGGTCGACTGCCAAACTGCTTCCCGATGA 
Signal peptide deletion of 
BT4295 (this is the same primer 

















Signal peptide deletion of 
BT4297 
BT4298 
segment A CATCATCACCACCATCACAGAAATAATTTTCTACTGATTGTA Forward Primer 
BT4298 
segment A GTGGCGGCCGCTCTATTATTGGCACGATAGGTTATTTTT Reverse Primer 
BT4298 
segment B CATCATCACCACCATCACAAAATAACCTATGGTGGCAATATT  Forward Primer 
BT4298 
segment B GTGGCGGCCGCTCTATTATCGATACCAAAGTTGAGTT Reverse Primer 
BT4298 
segment C CATCATCACCACCATCACAAGAAACTCAACTTTGGTATCG  Forward Primer 
BT4298 
segment C GTGGCGGCCGCTCTATTATATAACTGCAGTTAGAATTTAAG Reverse Primer 
BT4295 Full 
length CATCATCACCACCATCACAAAATAACCTATCGTGCCAATATT Forward Primer 
BT4295 Full 
length GTGGCGGCCGCTCTATTATATACTGCAGTTAAATGCCTAG Reverse Primer 
BT4295 
segment A CATCATCACCACCATCACAAAATAACCTATCGTGCCAATATT Forward Primer 
BT4295 
segment A GTGGCGGCCGCTCTATTATATTCGTACTCTTGAAGGTTATCT   Reverse Primer 
BT4295 
segment B CATCATCACCACCATCACCCTCGTGAAGGAAAGATAACC Forward Primer 
BT4295 
segment B GTGGCGGCCGCTCTATTATATACTGCAGTTAAATGCCTAG Reverse Primer 
 
Generation of the BT4295 T->V mutant.  
  Construction of the T547V mutation was done using site-directed mutagenesis via 
overlapping PCR. Forward and reverse primers were synthesized containing the desired 
mutation, and outside primers were constructed to contain the entire BT4295 gene. Once a 
verified construct was sequenced as containing the mutation, we followed a similar strategy to 
construct the deletion mutants (e.g., 4295 or SPdeletion). E. coli containing the T547V construct 
was mated with the BT4295 deletion strain, therefore complementing the BT4295 gene back, but 







Expression of BT4295 and BT4298 in E. coli.  
  To express BT4295 and BT4298 in E. coli, we used the Lucigen Expresso T7 Cloning 
and Expression System and followed the manufacturer’s protocol. Briefly, we expressed BT4295 
and BT4298 in the pETite N-His Kan vector and designed oligonucleotides for cloning full-
length or partial proteins listed in Table 3.2. 
Sequence-confirmed clones of each were transformed into BL21(DE3) E. coli and grown 
overnight at 37°C with shaking. Fresh 2-ml cultures were inoculated and grown to an 
OD600 (optical density at 600 nm) of 0.5, induced with 1 mM of isopropyl-β-D-
thiogalactopyranoside (IPTG) and grown for 5 hours at 37°C with shaking, harvested by 
centrifugation, washed once with PBS, and suspended in 1 ml of PBS. Samples were heat-
inactivated for 20 min at 95°C and then stored at 4°C until use. 
 
Production of recombinant BT4295.  
  BT4295 was expressed in Pet-ite expression vector by cloning the sequence distal to the 
SPII cleavage motif and including a 5′6 His tag using the oligos 
CATCATCACCACCATCACTCGCCCGATTACGAAACCGAGTT (forward) and 
GTGGCGGCCGCTCTATTATATACTGCAGTTAAATGCCTAG (reverse)49. The construct 
was verified by sequencing and expressed in the E. coli strain BL21(DE3). Bacteria were grown 
at 37°C until mid-log phase growth was reached. The culture was induced with 1 mM IPTG and 
grown overnight at 19°C. Cells were collected by centrifugation, lysed [50 mM NaH2PO4, 300 
mM NaCl, 10 mM imidazole, lysozyme (1 mg/ml; HEL), and protease inhibitors at pH value of 
8.0] for 30 min on ice, sonicated, and centrifuged to remove insoluble material. Supernatants 
were passed over a Qiagen NiNTA column, washed, and eluted in 50 mM NaH2PO4, 300 mM 
NaCl, 250 mM imidazole, and protease inhibitors at pH value of 8.0. Eluted material was buffer-
exchanged into PBS with an Amicon Ultra 15 10-kDa concentrator to 1 to 2 ml of the final 
volume and quantified by absorbance at 280 nm (A280). 
 
Generation of monoclonal antibodies against BT4295.  
  C57BL/6J mice were immunized subcutaneously with 100 μg of recombinant protein 





in IFA every 4 weeks, followed by an intravenous (IV) boost of 50 μg rBT4295 3 days before 
harvest. Splenic B cells were fused with P3Ag8.6.5.3 myeloma cells to create hybridomas. 
Hybridomas were screened by ELISA against rBT4295, and positives were screened against 
whole Bt or OMV preparations to confirm specificity. Two clones (ERC-11 and 4E9) were 
selected for further characterization. They were subcloned by limit dilution, and both antibodies 
isotyped as IgG2b,κ. The antibodies were purified from culture supernatants on a Protein A–
Sepharose column. Purified 4E9 was biotinylated using the Pierce Ez-Link Sulfo-NHS-SS-Biotin 
reagent following the manufacturer’s protocol. 
 
Quantitative ELISA for BT4295.  
  BT4295 protein levels in Bt samples were determined using a quantitative ELISA assay. 
Samples were obtained from equivalent numbers of Bt from OD600-measured cultures. Bacteria 
were lysed in 100 mM CHAPS detergent (Sigma) and incubated with agitation for 1 hour at 
room temperature (RT). Insoluble material was removed by centrifugation, and samples were 
stored at 4°C. Purified anti-BT4295 antibody, ERC11, was coated on an Immulon 2 ELISA plate 
overnight in carbonate coating buffer [5 μg/ml (pH value of 9.6)] at 4°C. Plates were washed and 
blocked with buffer (PBS with 0.5% bovine serum albumin and 0.1% Tween 20) for 1 hour at 
RT. Plates were washed and samples were added for 2 hours at RT, washed again, and then, the 
anti-BT4295 antibody biotin-4E9 (5 μg/ml) was added for 1.5 hours at RT. Plates were washed 
again, and 1:5000 dilution of streptavidin horseradish peroxidase (SouthernBiotech) was added 
for 1 hour at RT. Plates were washed and developed with 2,2’-azino-bis(3-ethylbenzothiazoline-
6-sulphonic acid) (ABTS) to completion, and A405 was determined. Unknown sample 
concentrations were quantitated by comparison to a standard curve of rBT4295 performed in the 
same ELISA using GraphPad Prism software. 
 
Statistical analysis.  
  Differences between two groups were evaluated using Student’s t test (or Mann-Whitney 
test, for non-normally distributed data), and those among more than two groups were evaluated 
using analysis of variance (ANOVA) with Tukey’s multiple comparisons test (or Kruskal-Wallis 
with Dunn’s posttest for non-normally distributed data) using GraphPad software. P values of 
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New Regulatory Strategies for Bacteroides thetaiotaomicron Polysaccharide Metabolism 
 
Abstract 
  The ability of commensal gut Bacteroides to sense and respond to specific nutrients in 
vivo promotes survival in the competitive and complex milieu of the intestine and may allow 
individual species to partition to different niches. Bacteroides devote large portions of their 
genomes towards accessing and degrading complex carbohydrates via expression of genetic 
clusters termed polysaccharide utilization loci (PULs). Generally, each PUL targets a single 
polysaccharide for depolymerization and subsequent assimilation of the released sugars. PULs 
are regulated locally through the recognition of one or more sugar cues, which is informative of 
the larger polysaccharide that is present. This regulatory ability is conferred by each PUL’s own 
regulatory protein(s) that sense and bind to the cognate substrate cue. Although this regulatory 
strategy is sufficient to activate individual PULs in the presence of particular glycans—usually 
through the activities of a positive feedback loop that controls only the associated PUL genes—it 
does not explain the control of previously observed nutrient hierarchies in Bacteroides. Here, we 
report that monosaccharides alter the prioritization hierarchy of Bacteroides thetaiotaomicron 
(Bt), and that the sugar ribose affects this hierarchy in the absence of the ability to grow on the 
sugar, suggesting that other regulatory elements are involved. We observe that members of two 
regulator families, whose coding genes are not genomically associated with PULs, are 
transcriptionally altered in the presence of the sugars: arabinose, xylose, and ribose. We 
identified 22 orphan extracytoplasmic function sigma (ECF-σ) factor regulators as well as 4 
orphan LacI family proteins and, through genetic deletions, probed the roles of 9 of these genes. 
Deletion of several individual genes drastically altered the growth phenotypes of Bt on multiple 
polysaccharides, suggesting that the regulators they encode govern higher-order regulons that 






  Many bacteria that successfully compete in the gut by utilizing multiple different 
nutrients have corresponding regulatory mechanisms to sense available nutrients and respond 
accordingly, only when cognate substrates are present. For some model organisms like E. coli, 
nutrient regulation mechanisms have been well characterized, revealing a multi-faceted network 
of interconnected local and global regulons. These networks involve global regulators such as 
ArcA/B, Crp, Cra, and Mlc 1, which exert effects on many different carbohydrate utilizations 
pathways at once. While more local (operon-regulating) proteins, such as LacI- and AraC-like 
regulators, play critical roles in responses to specific nutrients such as lactose and arabinose2, 3. 
Small-regulatory RNAs (sRNAs) also interact directly with the protein Hfq (and others) and alter 
genes involved in nutrient catabolism such as Crp (which is also a global regulator)4-6. Many 
organisms beyond E. coli, including the medically important pathogen Clostridium difficile and 
other Gram-positive Firmicutes, employ similar combinations of local and global regulation to 
express the optimal nutrient acquisition functions7, 8.  
  Sigma factors are proteins that direct RNA polymerase to particular promoters9 and are 
important in metabolism, stress responses, cell division and, many other bacterial processes. An 
important set of proteins modulating the activity of some sigma factors are the anti-sigma 
factors, which directly associate and inhibit transcriptional initiation10, 11. Some organisms, like 
Bacillus subtilis, use cascades of sigma factor activation to regulate complex processes like 
sporulation12, 13. Other organisms with amplified repertoires of sigma factors may use these 
transcription factors to govern multiple, individual regulons instead of cascades. One such 
organism in which sigma factors have been demonstrated to be important in nutrient metabolism 
is the important gut bacterial species Bacteroides thetaiotaomicron (Bt), which encodes 54 of 
these proteins14. A subset of Bt sigma factors that are associated with PULs and adjacent anti-
sigma factors has been shown to be important in the context of foraging of host-mucosal 
polysaccharides (both N- and O-linked glycans)15-18.  
  Some gut bacteria persist by being able to assimilate many different nutrients in the 
competitive environment of the mammalian gut, where nutrients are constantly fluctuating due to 
meal-to-meal fluctuations and other events. The Bacteroidetes devote large portions of their 
genome to carbohydrate degradation through expression of gene clusters termed polysaccharide 





their genome to nutrient foraging, there is a concurrent need to tightly regulate this ability to 
avoid wasteful expression of the encoded functions20. Individual species of Bacteroides have 
nutrient hierarchies that manifest as polyauxic growth in mixtures of polysaccharides21-24, but are 
thought to lack cyclic-AMP-based (i.e., classical CRP) regulation25 and lack Hfq, so they may 
rely on other global regulatory mechanisms such as small RNAs (sRNAs)26, 27, or additional 
uncharacterized regulators. One layer of PUL regulation is through the activity of local, mostly 
positive-acting regulatory proteins that are encoded within most individual PULs. The prominent 
classes of these regulators include a large suite of extracytoplasmic function sigma (ECF-σ) 
factors that within PULs are always paired with a corresponding anti-s factor, /anti-σ pairs15, 28, 
hybrid-two component systems (HTCS)14, and SusR29 or RusR-like (described in Chapter II) 
transcriptional activators.  Further, Bt is predicted to encode local-acting regulators of AraC-, 
LacI-, and GntR-type regulators inferred through bioinformatic prediction and preliminary 
studies on rhamnose and fucose metabolism30-32.  
  Recent work has uncovered a new layer of regulation via a protein with functions similar 
to Crp in Bt, BT4338 which has weak amino acid similarity to Crp homologs. When deleted, Bt 
is no longer able to grow on several monosaccharides such as ribose, galactose, uronic acids, and 
rhamnose to highlight a few, while polysaccharide utilization is relatively unchanged compared 
to wild-type33. Further, this same group of researchers who described the BT4338 Crp-like 
protein has recently described a separate regulatory protein, BT3172, that when deleted causes a 
defect in colonization of the mouse gut in a diet specific manner, hence termed the regulator of 
colonization or Roc34. This global effect on carbohydrate utilization via BT4338 and Roc, led us 
to search for additional regulatory proteins in Bt that may predominately act on polysaccharides 
compared to the BT4338 effects on monosaccharides as well as examine context-dependent (i.e. 
presence of specific sugars affects other metabolic pathways) nutrient utilization previously seen 
in Chapter II and with Roc.  
  Here, we investigate how the monosaccharide ribose alters the metabolic priority of 
other, non-ribose containing nutrients. The presence of the genes involved in ribose catabolism 
encoded in the ribose utilization system (rus) PUL affect the competitive fitness of Bt in glucose 
and rich media similar to the phenotype observed with Bt Roc30. Growth on pentose sugars 
xylose and arabinose also elicits changes in expression of other PULs and metabolic functions 





induced changes in metabolism we also report the discovery of a single orphan ECF-sigma 
factor, BT2492, that when deleted in Bt causes loss of growth on many of the polysaccharides, 
but few monosaccharides, that Bt normally utilizes for growth. Thus, this sigma factor may act 
similarly in nature to the global regulator BT433833. In addition, we show that three LacI-type 
regulators (BT0487, BT1434, and BT3613) are involved in the utilization of uronic-acids and 
polysaccharides containing these sugars, but not on those that lack these acidic sugars. Taken 
together, the results here demonstrate that Bt employs previously unknown regulatory 
mechanisms that further enhance its ability to quickly and efficiently respond to changes in 
available nutrient pools.   
 
Results  
Ribose alters polysaccharide prioritization and the ability to use ribose is associated with 
changes in competitive growth in vitro on non-ribose substrates 
  Our previous work examining the ribose utilization system (rus) PUL showed that, when 
Bt was grown in minimal media (MM) containing ribose as the sole carbon source, expression of 
genes located in other PULs and metabolic loci were transcriptional altered compared to growth 
in ribose, despite these genes not being linked to ribose catabolism (Figure 2.9). This suggests 
that the ability to respond to the presence of ribose may alter the hierarchy of nutrient 
prioritization. To test if the previously observed effect was dependent on both ribose and a 
functional rus PUL, we performed a transcriptional profiling experiment in which both wild type 
and Δrus Bt were grown in MM containing equal concentrations of 12 different polysaccharides 
(PSM12) or the PSM12, plus ribose (PSM12+R). We monitored the transcript of sentinel susC-
like genes in each of the PULs dedicated to utilization of the 12 individual substrates and 
compared to pre-PSM exposed (time 0) reference as previously reported22. Most of the 
transcriptional responses to the PSM12 mixture were similar for both wild type and Δrus (Figure 
4.1), which was also similar to a previous experiment22. However, a PUL involved in arabinan 
utilization was repressed earlier in the Δrus strain when ribose was both present and absent 
(Figure 4.1), but this behavior did not extend to the arabinose-containing polysaccharide 
arabinogalactan. To further explore the basis of this phenomenon, we examined the expression of 





Figure 4.1 Presence of ribose in a polysaccharide mixture alters Bt nutrient hierarchy irrespective of growth ability. 
Wild type Bt (blue lines) or a mutant unable to utilize ribose, Δrus (orange lines) assayed for transcript activation in a complex 
mixture of polysaccharides containing 12, PSM12 (dashed lines) or 13 PSM12+R (solid lines) substrates with ribose being 
the 13th. In each plot, an individual gene is probed for transcript over the 12 hour time course with samples taken every 30 
minutes. For PULs the susC-like homolog was probed, while for arabinose and xylose, the transporter genes were probed. 
Genes involved in the pentose phosphate pathway were also probed. Levels are compared to the transcript at time 0, when the 






xylose utilization loci. Similar to the arabinan response, genes in the arabinose utilization locus 
were repressed more quickly in the Δrus strain (with and without ribose) compared to wild type 
Bt (Figure 4.1). We suspect that the arabinogalactan PUL was not severely altered as it 
predominantly contains galactose. Interestingly, while changes in responses to arabinan and 
arabinose were different in the Δrus strain compared to wild type regardless of the presence of 
ribose, there were also some notable changes in the strain responses in PSM12 compared to 
PSM12+R. In the PSM12+R experiment, both wild type and Δrus strains displayed early 
repression in the time course for amylopectin (AP) maize and pectic galactan (PG) potato, but 
remained active long after expression had ceased in strains not exposed to ribose. In contrast, 
expression of the dextran PUL remained active for a longer period in the cultures not exposed to 
ribose versus those of the PSM12+R. Similar responses from the wild type and Δrus strains in 
the presence and absence of ribose suggests that the ability to utilize ribose is not what mediates 
the observed change in transcription. Rather, the presence of ribose alone alters the hierarchy by 
an unknown mechanism, although we cannot rule out that a small amount of ribose gets 
transported into the cell and phosphorylated by a different set of pentose permeases and kinases.  
Two of the polymers noted above contain only glucose, albeit AP maize and dextran elicit 
opposite responses in the presence and absence of ribose. To address if glucose metabolism may 
be altered in ways not associated with the ability to catabolize ribose as a nutrient, we performed 
in vitro competition assays between wild type Bt and the Δrus strain in MM containing glucose 
as a sole carbon source. For comparison, we used a rich media, tryptone-yeast extract-glucose 
(TYG) that also contains glucose plus a number of other non-glucose nutrients. We had 
previously seen in vivo that not all genes in the rus locus were required for competition, with the 
presence of some genes involved in outer membrane import and binding (ΔrusC/D) and 
hydrolase functions (ΔrusGH/NH) conferring a competitive disadvantage to wild type (Figures 
2.4 and 2.5). We used these strains grown in MM-ribose as a control for the phenotype 
previously seen in vivo. In support of our hypothesis that some genes of the rus loci are also 
important for competition in substrates where ribose is not appreciably present (nucleosides, 
which contain ribose, may be present in TYG), the Δrus mutant was MM-containing glucose and 
TYG (Figure 4.2G and H). As expected, the ΔrusC/D and ΔrusGH/NH strains both displayed a 





type, so much so, that after day 27, wild type fell below our detectable limits in MM-ribose 
(Figure 4.2F). However, the ΔrusC/D strain only displayed a slight competitive advantage in 
MM-ribose, perhaps suggesting a role in ribose scavenging in vitro (Figure 4.2C). Contrastingly, 
both ΔrusC/D and ΔrusGH/NH strains exhibited a strong advantage over wild type in glucose 
while only ΔrusGH/NH exhibited a strong advantage in TYG with ΔrusC/D at nearly equivalent 
levels as wild type Bt (Figure 4.2A-B and D-E). Wild type Bt displayed a large competitive 
advantage over the Δrus strain in both glucose and TYG, suggesting that perhaps nucleosides are 
present (TYG) or a ribose containing substrate is produced, or a metabolic pathway is affected 
Figure 4.2 Competitive fitness of rus PUL mutant strains are altered in vitro in several media. 
Wild type Bt (black line) or deletion mutants within the rus PUL (red lines) were competed in vitro in either tryptone-yeast 
extract-glucose (TYG) or minimal media (MM) plus glucose or ribose. A-C) ΔrusC/D was competed against wild type in TYG 
(A), MM+glucose (B) or MM+ribose (C). Similarly, ΔrusGH/NH was competed against wild type Bt (D-F) in TYG (D), 
MM+glucose (E), or MM+ribose (F). Δrus was competed against wild type in TYG (G) and MM+glucose (H), MM+ribose was 
not performed as the Δrus strain is unable to grow on ribose and therefore cannot compete for that nutrient. Each time point for 
each day and strain displays the mean ± the SEM (n=3) with relative abundance shown on the y-axis for all competitions and 






during growth on glucose that may be mediated by either the regulator rusR or the kinases 
rusK1/K2 (Chapter 2).We next wanted to examine further how ribose and the related pentose 
sugars arabinose and xylose may cause changes in the prioritization of polysaccharides similar to 
arabinan (Figure 4.1).  
 
Arabinose and xylose growth cause global transcriptional responses beyond direct metabolism 
of these sugars 
  Based on our previous result showing ribose causes transcriptional changes in a global 
regulatory network (Figure 2.9G), and because the absence of rus alters the response to 
arabinose/arabinan, we wanted to test if the related pentoses arabinose and xylose cause similar 
changes in global metabolism. We hypothesized that growth on these related sugars would cause 
similar transcriptional changes as growth on ribose and reveal metabolic networks or regulators 
that mediate these effects. In order to address this, we grew wild type Bt on arabinose or xylose 
as a sole carbon source and performed RNAseq analysis using MM-glucose as a common 
reference and using a 5-fold cut-off. Our data showed that, like growth on ribose (Figure 2.9G), 
xylose and arabinose also alter expression of PUL genes (both positively and negatively). 
Specifically, xylose repressed a single PUL, BT3344-3347, responsible for catabolism of an 
unknown substrate (Figure 4.3A), and this PUL was also repressed during ribose growth (Figure 
2.9G). Growth on xylose activated expression of 3 genes in the rus PUL (BT2803, BT2804, and 
BT2809), although not to nearly as high levels as ribose. Several other glycoside hydrolases were 
also upregulated and there was repression of the GH13, susA. As expected, growth on xylose 
cause upregulation of the genes involved in xylose catabolism, BT0791-0794 (Figure 4.3A), (this 
genetic locus was deleted, confirming involvement in xylose catabolism, data not shown). In 
contrast to xylose, growth on arabinose almost exclusively elicited transcriptional activation of 
PUL genes. Specifically, as was the case for ribose growth (Figure 2.9G), arabinose caused 
upregulation of the fructan PUL, BT1757-1765, and the rus PUL, BT2803-09 (Figure 4.3B). 
Growth on arabinose caused upregulation of an unknown, three gene PUL, BT4038-4040, and a 
PUL, BT4294-4299 (Figure 4.3B); the latter previously associated with mucin O-glycan 
degradation15, 35. The genes involved in fucose metabolism, BT1272-BT1277 were also 
upregulated when grown in arabinose (Figure 4.3B), and interestingly fucose is a predominantly 





responses of Bt as the host shifts between fiber rich and fiber free diets. As expected, the genes 
for arabinose metabolism, BT0348-BT0356, were upregulated (Figure 4.3B). For the most part, 
xylose and arabinose appear to affect different global transcriptomes compared to growth on 
ribose, however, the following loci all behaved similarly in response to growth on any of these 
pentoses, suggesting either a common regulatory link to metabolic pathways (i.e. pentose 
phosphate) or, more intriguingly, new functions for pentose assimilation. Among these functions 
were genes for sugar phosphate isomerization, BT2156-2159, that were repressed in all three 
Figure 4.3 RNAseq reveals that the monosaccharides arabinose and xylose alter expression of non-PUL-encoded metabolic 
loci, including orphan ECF-σ regulatory genes. 
RNAseq results of wild type Bt grown in either xylose (A) or arabinose (B) with fold change compared to cells grown in 
glucose as a sole carbon source. Locus tags are displayed along the x-axis. Genes in the same locus or PUL are colored the 
same within either A or B. Single genes displaying changes are labeled above or below the bar with the predicted gene 






conditions, and upregulation of a locus, BT3614-3617, that may be associated with substrate 
utilization based on the predicted, encoded enzymes (hydrolase, reductase, permease, 
dehydrogenase) (Figure 2.9G and Figures 4.3 B and C).  
  As we hypothesized, growth on each of these monosaccharides also affected the 
transcript levels of regulatory proteins, more specifically, orphan (non PUL or anti-σ-associated) 
ECF-σ factors. Within Bt there are 20 orphan ECF-σ factors throughout the genome14. While 
most of these did show altered expression, three genes encoding ECF-s factors were changed 
with BT2569 upregulated in both ribose and xylose (Figure 2.9G and Figure 4.3A), BT1572 
upregulated in xylose (Figure 4.3A), and BT2178 repressed in arabinose growth (Figure 4.3B). 
This result lead us to examine potential roles for additional orphan ECF-σ factors in the 
metabolism of carbohydrates. 
 
The orphan ECF-σ factor, BT2492 affects growth of Bt on many polysaccharides 
  In order to test the hypothesis that orphan ECF-σ factors are regulators of carbohydrate 
utilization, we made strains with single gene deletions for 6 of these regulators and then 
examined their growth profile on a panel of poly-, mono- and disaccharides that wild type Bt 
normally utilizes for growth as sole carbon sources. Of the 20 known orphan ECF-σ factors, we 
were able to successfully create deletion strains of BT0248, BT1197, BT1572, BT1817, BT2044, 
and BT2492. We attempted deletions of the additional ECF-σ factors BT2184 and BT2569 that 
were upregulated in the RNAseq results, as well as BT0326, BT1103, and BT1559 but were 
unable to obtain successful deletions, possibly due to an essential function in metabolism or 
another biological process as a previous transposon mutagenesis screen identified two of these 
factors as candidate essential genes36, and perhaps the frequency of successful allelic 
recombination is exceedingly rare due to requirements in biological processes. Within the six 
deletion strains, only ΔBT2492 displayed reduced growth (both rate and total biomass) on 12 
polysaccharides compared to wild type and the other deletion strains (Figure 4.4 A-L). 
Surprisingly, there does not appear to be a common pattern associated with the substrates that 
ΔBT2492 has defects on, meaning they do not readily share a common monosaccharide core or 
common linkages or source (i.e. plant-derived or host-derived). Further, ΔBT2492 did not 
display growth defects on monosaccharides and a few additional polysaccharides of inulin, 





BT2492 promoting growth is by transcribing genes essential for utilization of the indicated 
polysaccharides. These genes may be any essential component required for growth on these substrates, 
such as, BT4338 (MalR), PUL-specific regulators, or even machinery required for import (SusC 
transporters and TonB energizers). Although we do not directly test this, it is interesting that for all 
of the substrates that ΔBT2492 displayed defects on, the PUL-encoded regulators are hybrid two- 
Figure 4.4 The ECF-σ factor, BT2492 controls utilization of Bt metabolized polysaccharides. 
(A-L) Growth curves of Bt wild type (blue line), and individual ECF-σ factor deletions: BT0248 (red line), BT1197 (green line), 
BT1572 (purple line), BT1817 (orange line), BT2044 (black line), and BT2492 (brown line). All strains were grown on the following 
polysaccharides amylopectin maize (A), amylopectin potato (B), pullulan (C), dextran (D), glycogen (E), arabinogalactan (F), 
pectic galactan potato (G), pectic galactan lupin (H), arabinan (I), mucin-O-glycans (J), homogalacturonan (K), or chondroitin 
sulfate (L). Only the ΔBT2492 strain displayed growth defects compared to wild type for substrates shown. Growth was measured 







Figure 4.5 BT2492 and other ECF-sigma factors do not affect all substrates that Bt metabolizes. 
Data is related to Figure 4.4. Bt wild type (blue line), and individual ECF-σ factor deletions: ΔBT0248 (red line), ΔBT1197 (green 
line), ΔBT1572 (purple line), ΔBT1817 (orange line), ΔBT2044 (black line), and BT2492 (brown line) were grown on a panel of 
polysaccharides and monosaccharides. Each panel shows the growth of each strain on a particular substrate as a sole carbon 
source as measured by absorbance at 600nm. None of the deletion strains exhibited differences in growth compared to wild type 
except for minor growth defect of ΔBT2492 on ribose and glucosamine. Growth curves displayed are representative of n=3 






component systems (HTCS) or SusR. This suggests that the ECF-σ factor BT2492 acts upstream 
of PUL-encoded regulation and recruits RNA polymerase to initiate transcription of local 
regulators of these PULs or another component of their global regulation. A similar mechanism 
was recently described in the Bacteroidetes member Porphyromonas gingivalis within type IX 
secretion systems, whereby expression of two-component system proteins were further regulated 
by an orphan ECF-σ factor37. The promising results that disruption of at least one ECF-σ causes 
a phenotype that extends to multiple polysaccharides, led us to search within the genome of Bt 
for additional orphan regulators that may provide further evidence of global regulatory 
mechanisms.  
 
Orphan LacI-type regulators repress the catabolism of uronic acid-containing substrates 
  In order to identify additional orphan regulators, we used BLAST to search for homologs 
of LacI- and AraC-type regulators. We focused on four predicted LacI-type regulators, BT0487, 
BT0824, BT1434, and BT3613 that had been predicted through bioinformatics to be involved in 
utilization of uronic acid monosaccharides (glucuronate, galacturonate, mannuronante), but not 
experimentally tested32. To experimentally to test the roles of these regulators, we made single 
gene deletions, of three of these genes, BT0487, BT1434, and BT3613. We performed growth 
analysis of these mutants in MM containing poly- and monosaccharides that Bt is able to utilize. 
As predicted by previous bioinformatics, these regulators did show growth differences compared 
to wild type Bt on uronic acids, with better growth (defined as earlier or decreased lag time) than 
wild type (Figure 4.6). However, our results differ in the predicted substrates that these 
regulators control, and our analysis also detected altered growth in polysaccharide substrates. For 
ΔBT0487, earlier growth (decreased lag time) was seen in both galacturonic and glucuronic acid 
with glucuronic acid growth exhibiting a much improved lag compared to wild type (Figure 4.6 
A and D). In addition, ΔBT0487 also displayed better growth on rhamnose, hyaluronan (a 
polysaccharide of glucuronic acid and N-acetyl-D-glucosamine repeating units), 
homogalacturonan (HG, a polymer of galacturonic acid residues), and arabinogalactan, which in 
contrast to the other polysaccharides contains few uronic acid residues and consists mainly of 
galactose and arabinose units (Figure 4.6A-F). Similarly, the ΔBT1434 strain was only predicted 
to participate in catabolism of glucuronic acid, which we observed (Figure 4.6A), but we also 





strain behaved similarly to the ΔBT1434 strain, with enhanced growth characteristics on 
glucuronic acid, HG, and rhamnose (Figure 4.6A-C), despite only being predicted to participate 
in catabolism of mannuronic acid. We did not test mannuronic acid in our assays, but based on 
glucuronic acid, HG, and rhamnose (Figure 4.6A-C), despite only being predicted to participate 
in catabolism of mannuronic acid. We did not test mannuronic acid in our assays, but based on 
the observed defects, it is likely that all of the mutants would have also displayed enhanced 
growth. Interestingly, the genes immediately adjacent to the BT3613 LacI-typeregulator, 
BT3614-3617 were upregulated in arabinose, xylose, and ribose (Figure 4.3 A-B and Figure 
2.9G). It is possible that this locus participates in catabolism of uronic acids based on the results 
of the ΔBT3613 mutant strain growths. We did not observe defects on other non-uronic acid 
substrates other than rhamnose for any of the three LacI-type regulator deletions (Figure 4.7). 
The results obtained here help to clarify the function of these orphaned regulators, and for some, 
confirm what was previously predicted using bioinformatic techniques.  
 
 
Figure 4.6 Orphan LacI-type regulators in Bt repress metabolism of uronic-acid containing substrates. 
(A-E) Growth of wild type Bt (black line) or deletion strains lacking individual orphan LacI-type encoding genes: ΔBT0487 (pink 
line), ΔBT1434 (teal line), and ΔBT3613 (purple line). Each panel shows growth on an individual substrate as a sole carbon 
source: glucuronic acid (A), homogalacturonan (B), rhamnose (C), galacturonic acid (D), hyaluronan (E), or arabinogalactan 
(F). ΔBT0487 displayed increased growth compared to wild type for all substrates shown Growth curves displayed are 







  We show in this study the presence of additional regulatory mechanisms underpinning 
nutrient utilization in Bacteroides thetaiotaomicron (Bt). We demonstrated that the presence of 
monosaccharide ribose, but necessarily the ability to utilize it with full efficiency if at all, alters 
previously established nutrient prioritization hierarchy in Bt22. We determined that ribose alters 
the competitive fitness of Bt in vitro under conditions where ribose containing substrates are not 
thought to be prominent substrates present, representing only the second example in Bacteroides 
where the ability to catabolize one nutrient may affect the metabolism of or the ability to access 
other nutrients34. We extended these findings by examining the global transcriptional response to 
the related pentose sugars arabinose and xylose, demonstrating that (like ribose), these individual 
sugars create an altered global transcriptional response. These responses include activation and 
repression of genes not directly related to the metabolism of these nutrients was observed 
compared to growth in glucose. Interestingly, some of the genes for which we observed 
expression changes were predicted to encoded ECF-σ factors that are orphans, meaning they are 
not adjacent to known metabolism genes and for the ones we observed, did not have a canonical 
anti-σ factor located next to it in the genome. This led us to construct genetic deletions of 6 of 
these orphan ECF-σ factors and 3 orphan LacI-type regulators, leading to the result of 4 of these 
genes, especially BT2492, having substantial effects on the catabolism of 12 carbohydrate 
nutrients.  
  There have been previous studies that examined the prioritization of polysaccharides in 
Bacteroides and documented the diauxic or polyauxic growth of Bacteroides on polysaccharide 
mixtures21-24. It has been presumed that this transcriptional prioritization hierarchy both matches 
the utilization profiles of what is being consumed versus retained, and that the hierarchy is 
relatively stable unless other polysaccharides are introduced. The first assumption has recently 
been shown inaccurate for some Bacteroides as transcriptional activation of PULs for high-
priority glycans remains high, even after the substrate is largely24. Here, we tested the second 
assumption, and found that the prioritization changes when additional nutrients are added to the 
mixture. Interestingly, we were able to drive this change by addition of a monosaccharide 
(ribose), which in some cases exerted its effect without the presence of the PUL-encoded 
machinery for its. Nevertheless, our study demonstrated both that the presence of a 





presence of the ribose PUL even in the absence of ribose alters the hierarchy, suggesting a 
previously undescribed mechanism. It may be that the regulator or ribokinases found in the 
ribose PUL mediate utilization of other polysaccharides or their constituent monosaccharides, or 
a mechanism of repression exists, future studies will focus on these possible mechanisms. 
Additionally, in support of the idea that ribose PUL-encoded functions play a role in utilization 
Figure 4.7 Orphan LacI-type regulators do not substantially alter metabolism of non-uronic acid-based polysaccharides.  
Data is related to Figure 4.6. Growth curves of wild type or LacI-type deletion strains on polysaccharides or monosaccharides for 
which there were no detectable differences in growth for deletion strains compared to wild type Bt. Strains are color coded as 
follows: wild type (black line), ΔBT0487 (pink line), ΔBT1434 (teal line), and ΔBT3613 (purple line). Growth curves represent at 






of other nutrients, our in vitro competition assay showed that our Δrus PUL mutant was severely 
outcompeted by wild type Bt in both a rich media and a minimal media containing glucose as the 
sole carbon source. To fully evaluate, complementation studies as well as competitions in non-
glucose containing media should be performed in future experiments to rule out an intrinsic 
defect. We should note that a major component of TYG is glucose and so the defect observed in 
TYG may be due to presence of glucose, although other nutrients such as yeast extract are also 
present and could provide additional, albeit less defined, carbon sources that may contain small 
amounts of ribose-containing nutrients. These results reinforce previous work on the importance 
of ribose and nucleoside utilization and further suggest that the ribokinases, regulator, or 
permease encoded in rus act on non-ribose substrates, or that small amounts of ribose containing 
compounds (perhaps nucleosides) are sufficient to drive a competitive defect in glucose.  
Although previous studies in Bt have demonstrated its ability to grow on the monosaccharides: 
arabinose, xylose, rhamnose, and fucose, we are the first to show that growth on some of these 
monosaccharides affects transcriptional activation of genes not involved in metabolism of the 
cognate monosaccharide. Perhaps most intriguingly, arabinose and xylose show differential 
upregulation or repression of PULs for unknown substrates, stimulation of the ribose PUL, 
upregulation of a PUL known to be antigenic in vivo and the upregulation of the genes for fucose 
metabolism, a common component of mucosal polysaccharides. This result suggests that perhaps 
an additional level of regulation in Bacteroides is co-regulation of metabolic loci by specific 
nutrients that prime the cell for additional substrates.  
  The way in which Bt regulates its nutrient degrading capabilities is complex, involving 
locally-encoded, cis-acting PUL regulators such as HTCS, ECF-σ/anti-σ pairs, and SusR/RusR 
regulators, as well as small-RNAs. Over-arching these local regulons are global regulators, such 
as CRP-like proteins. Our observation that at least one orphan ECF-s factor plays a role in 
utilization of multiple polysaccharides suggest the existence of an undiscovered layer of global 
regulation mediating carbohydrate metabolism. We suspect that BT2492 acts as a global 
regulator, possibly aiding in the recruitment of RNA polymerase to transcripts normally under 
the control of HTCS and SusR/RusR regulatory mechanisms, or turns on expression of the PUL-
activating regulators themselves. Although direct evidence of RNA polymerase recruitment to 
HTCS and similar local regulator transcripts by orphan ECF-σ factors is lacking in Bt a 





  Although no LacI-type regulators showed altered expression in our RNAseq data, we 
identified four orphan LacI-type regulators within Bt. Deletion of three of LacI-type regulators 
(one was not attempted, BT0824), all yielded increased growth on uronic acid-based 
monosaccharides and some uronic acid-containing polysaccharides. Although several loci in Bt 
have previously been shown to be regulated by LacI-type transcriptional repressors31, we are the 
first to demonstrate how an orphaned repressor affects utilization of monosaccharides using a 
genetic deletion approach. Take together with the BT2492 data and the hierarchy reprogramming 
by monosaccharides, it suggests that there are several additional levels of regulation that Bt 
employs during carbohydrate degradation. The work presented here can be used to guide 
additional mechanistic studies exploring previously unknown regulatory functions in Bt by 
exploring the genome for orphaned, seemingly unlinked regulatory genes. Future work can be 
guided by bioinformatic predictions that have identified additional gene encoded regulators with 
DNA-binding motifs and subsequently deleting these genes individually and sequentially. 
Further, we believe binding and DNA foot printing studies will be an important aspect of later 
work in order to identify potential conserved DNA sequences that can be used to search for 
homologous sequences in related Bacteroides and discovery of the molecules mediating these 
transcriptional regulatory networks.  
  
Methods 
Bacterial strains, culturing conditions, and molecular genetics 
  B. thetaiotaomicron (Bt) ATCC 29148 (VPI-5482) and genetic mutants, were grown in 
tryptone-yeast extract-glucose (TYG) broth medium38, in minimal medium (MM), plus a single 
carbon source15, or on brain heart infusion agar with 10% defibrinated horse blood (Colorado 
Serum Co.). Carbon sources used in MM were added to a final concentration of 5 mg/ml or 10 
mg/ml with RGI and MOG (mucin-O-glycans). Cultures were grown at 37°C in an anaerobic 
chamber (10% H2, 5% CO2, and 85% N2; Coy Manufacturing, Grass Lake, MI). Genetic 
deletions were made by counter-selectable allelic exchange as described39. Primers used in this 
study are listed in Table 4.1. To quantify growth on carbon sources, increase in culture 
absorbance (600 nm) in 200µl cultures in 96-well plates was measured an automated plate reader 






In vitro competition assays 
  Bt wild type and mutant deletion strains (Δrus, ΔrusC/D, and ΔrusGH/NH) were initially 
started in TYG media and then washed 2X in MM with no carbon and subcultured together in 
pairs such with wild type always being present and the varying strain being one of the mutants. 
These strains were subcultured 1:25 into fresh TYG or MM containing 5 mg/ml glucose or 5 
mg/ml ribose. These mixtures of bacteria were continually passaged (subcultured) daily into 
fresh media of the specific type i.e. TYG grown competition was passaged into fresh TYG at 
roughly the same time every day for 42 days. At each day, DNA was extracted from fecal pellets 
throughout the experiment and strain abundance was quantified as described previously40. 
Relative abundance was plotted for each strain on a log scale by qPCR enumeration of unique 
barcoded tags in each strain.  
 
Measuring transcriptional dynamics by qPCR of polysaccharide hierarchy  
  Measurements of transcriptional response over time in a mixture of 12 polysaccharides 
(PSM12) or PSM12+ribose was done as described previously20, 22. Briefly, strains were grown in 
TYG, subcultured 1:50 into MM-glucose, at mid-exponential phase defined as 0.6-0.8 
(absorbance at 600nm), cells were washed twice in MM-no carbon and resuspended in PSM12 or 
PSM12+R with time points being taken every 30 min for 12 hours. To stabilize RNA, at each 
time point, two volumes of RNA protect were added, followed by centrifugation and storage of 
cell pellets at -80°C. Total RNA was extracted using the RNeasy mini kit buffers (Qiagen) and 
purified on RNA-binding spin columns (Epoch), treated with TURBO DNaseI (Ambion) or 
DNase I (NEB) after elution and purified again using a second RNeasy mini kit isolation column. 
Reverse transcription was performed using SuperScript III reverse transcriptase and random 
primers (Invitrogen). The abundance of each target transcript in the resulting cDNA was a 
homemade qPCR mix as described previously41. Detailed information regarding composition of 
each reaction ware included in the Methods of Chapter 2 and are derived from a previously 
established protocol21. The ddCT method was used to normalized to 16S rRNA values and then 
individual susC-like gene values within the PUL of interest were referenced to the values 








  To determine the global transcriptional response to growth in arabinose and xylose as 
sole carbon sources, Bt was grown in TYG media then transferred to fresh MM containing either 
5 mg/ml glucose or 5 mg/ml arabinose or 5 mg/ml xylose. Cells were then grown until mid-log 
phase (absorbance between 0.6-0.8) and two volumes of RNA Protect (Qiagen) were added to 
cells. RNA was isolated as described above and purified whole RNA was then rRNA depleted 
using the Ribo-Zero Bacterial rRNA Removal Kit (Illumina Inc.) and concentrated with the RNA 
Clean and Concentrator-5 kit (Zymo Research Corp, Irvine, CA). Samples were multiplexed for 
sequencing on the Illumina HiSeq platform at the University of Michigan Sequencing Core. Data 
was analyzed using Arraystar software (DNASTAR, Inc.) using RPKM normalization with 
default parameters. Gene expression in arabinose and xylose was compared to gene expression in 
a glucose reference. Genes with significant up- or down-regulation were determined by the 
following criteria: genes with an average fold-change >5-fold and a normalized expression level 
>1% of the overall average RPKM expression level in either glucose or ribose. Detailed gene 
information with significant hits for arabinose and xylose are listed in Table 4.2. 
Table 4.1 Strains, vectors, and primers used in this study 
Strain Genotype Features Reference 
 Bacteroides 
thetaiotaomicron 
(B. theta) tdk- 
ATCC 29148 tdk- Parent strain of all 
deletion strains, 
and refered to in 
text as "wild-type" 
Koropatkin et 
al. 2008 
 B. theta ΔBT0248 ATCC 29148 tdk-, BT0248- ECF-σ deletion 
(Sig1) 
This study 
 B. theta ΔBT1197 ATCC 29148 tdk-, BT1197- ECF-σ deletion 
(Sig2) 
This study 
 B. theta ΔBT1572 ATCC 29148 tdk-, BT1572- ECF-σ deletion 
(Sig3) 
This study 
 B. theta ΔBT1817 ATCC 29148 tdk-, BT1817- ECF-σ deletion 
(Sig4) 
This study 
 B. theta ΔBT2044 ATCC 29148 tdk-, BT2044- ECF-σ deletion 
(Sig5) 
This study 
 B. theta ΔBT2492 ATCC 29148 tdk-, BT2492- ECF-σ deletion 
(Sig6) that losses 
growth on ~ half 
of substrates tested 
for growth 
compared to the 
parent strain 
This study 












and rhamnose and 
arabinogalactan 
 B. theta ΔBT1434 ATCC 29148 tdk-, BT1434- LacI-type 
regulator deletion 





 B. theta ΔBT3613 ATCC 29148 tdk-, BT3613- LacI-type 
regulator deletion 





 B. theta Δrus ATCC 29148 tdk-, BT2802-2809- Strain lacking the 
rus PUL, unable to 
grow on or 
respond to ribose 
Glowacki et al. 
2019 
  
   








































BT0248 5’ Up 
Sal1 
GCGGTCGACCGGATGCTGGATTTACTTGAC BT0248 Gene 
Knockout 
 





BT0248 5’ Out TCATATATGGAACTGGAAGAACTG BT0248 Gene 
Knockout 
 
BT0248 3’ Down 
Xbal 
GCGTCTAGAGGCAGCCAGTAGAGGATTCTCAGC BT0248 Gene 
Knockout 
 
BT1197 5’ Up 
Sal1 
GCGGTCGACGGTACCCAGGTCGAACATGAT BT1197 Gene 
Knockout 
 





BT1197 5’ Out ATAGGGATAACACATTAGTCA BT1197 Gene 
Knockout 
 
BT1197 3’ Down 
Xbal 
GCGTCTAGAGCGACCGACACCTGCCATAT BT1197 Gene 
Knockout 
 
BT1572 5’ Up 
Sal1 

















GCGTCTAGACACCACTTCCTGCAACGCATAAGT BT1572 Gene 
Knockout 
 
BT1817 5’ Up 
Sal1 
GCGGTCGACGGCTGGTTATCGAAAGAGAAT BT1817 Gene 
Knockout 
 





BT1817 5’ Out AAGAGAGGATATGGAAGAGGAAAG BT1817 Gene 
Knockout 
 
BT1817 3’ Down 
Xbal 
GCGTCTAGACCATCGGTTGTGGCAATCGGC BT1817 Gene 
Knockout 
 
BT2044 5’ Up 
Sal1 
GCGGTCGACCTCTCTGGCAAACGCCCAGAA BT2044 Gene 
Knockout  
 





BT2044 5’ Out TGATAAACTTCTGAAAGATTTCTT BT2044 Gene 
Knockout  
 
BT2044 3’ Down 
Xbal 
GCGTCTAGAGTCGGATATAGGAATCCCTGA BT2044 Gene 
Knockout  
 
BT2492 5’ Up 
Sal1 
GCGGTCGACCGGTGAAATGACTTACGGCGC BT2492 Gene 
Knockout 
 










BT2492 3’ Down 
Xbal 
GCGTCTAGACATCGACAAAACGAACAAAAC BT2492 Gene 
Knockout 
 
BT0487 3’ Up 
Sal1 
GCGGTCGACCGGAAATTCAAGTCAACCGAT BT0487 Gene 
Knockout 
 
BT0487 5’ Out ACGATCACCTTATTTATATAG BT0487 Gene 
Knockout 
 





BT0487 5’ Down 
Xbal 
GCGTCTAGAGGCATATAAATCGCGCAGAATATC BT0487 Gene 
Knockout 
 
BT1434 3’ Up 
Sal1 
GCGGTCGACTGTAGACATGGGAATTTCTGG BT1434 Gene 
Knockout 
 
BT1434 5’ Out CTTGGCGATGTCTACAATACG BT1434 Gene 
Knockout 
 





BT1434 5’ Down 
Xbal 
GCGTCTAGAGAATAGTTCCGTAAAGATCTTCCG BT1434 Gene 
Knockout 
 













GCGTCTAGAGCGTAATCGCGATACCATGCAGCA BT3616 Gene 
Knockout 
 
BT0824 5’ Up  
Sal1 
GCGGTCGACCGCGTGTCTGGATATGATATTCCA BT0824 Gene 
Knockout 
 









BT0824 5’ Out TATCAACTTTATAAATTACAACTA BT0824 Gene 
Knockout 
 
BT0824 3’ Down 
Xbal 
GCGTCTAGACCCACAGGTGGAAGATTTCAGCCT BT0824 Gene 
Knockout 
 
BT2383 5’ Up 
Sal1 
GCGGTCGACGGAGTATTATCCCAATGTCGA BT2383 Gene 
Knockout 
 





BT2383 5’ Out TTTTTTTTCAAATGCGACAGAGAG BT2383 Gene 
Knockout 
 
BT2383 3’ Down 
Xbal 
GCGTCTAGAGGCTAAACAGGTCACCCGATA BT2383 Gene 
Knockout 
 
BT2778 5’ Up 
Sal1 
GCGGTCGACCGAAACACACTCCTCCAG BT2778 Gene 
Knockout 
 





BT2778 5’ Out AAAATTCATTCTCCATGCAGT BT2778 Gene 
Knockout 
 
BT2778 3’ Down 
Xbal 
GCGTCTAGAATTGACGATTTGATAATCAGT BT2778 Gene 
Knockout 
 
    
qPCR Primers Primer Use Reference 
16S F (Bt/Bo) ggtagtccacacagtaaacgatgaa 16S rDNA 
normalization 
Rogers et al. 
2013 
16S R (Bt/Bo) cccgtcaattcctttgagtttc 16S rDNA 
normalization 
Rogers et al. 
2013 
BT0348F tgcggcaaccaaattcaacaaa Arabinose locus 
expression 
This study 
BT0348R  accaagtgccccattcgtcaag Arabinose locus 
expression 
This study 
BT0792F ccggatgggcagaacaaga Xylose locus 
expression 
This study 
BT0792R caccgcacgagaatcacaccag Xylose locus 
expression 
This study 
BT0364F tgaatggcggtaaggtaaaagaaca Arabinan PUL 
expression 
Rogers et al. 
2013 
BT0364R cgggccggaagcgagtag Arabinan PUL 
expression 
Rogers et al. 
2013 
BT1280F tgcgcggtacaaaatccatc MOG PUL 
expression 
Rogers et al. 
2013 
BT1280R ggcggctgcggctgctc MOG PUL 
expression 
Rogers et al. 
2013 
BT1548F tgtctttcgcaatccgtcacctc pgm gene 
expression 
This study 
BT1548R cttgcgcaccatcatcccagtat pgm gene 
expression 
This study 
BT1763F tgccgcatccgcttctatct Levan PUL 
expression 
Rogers et al. 
2013 
BT1763R cgtccgtattgctcagtgttcagt Levan PUL 
expression 
Rogers et al. 
2013 
BT1986F ccccgaccgcaacctgataa rpiB gene 
expression 
This study 
BT1986R gtgggcggggcgtagtgata rpiB gene 
expression 
This study 
BT2805F tccacgccccgatataatgtagg Ribose PUL 
expression 
Glowacki et al. 
2019 
BT2805R accgtttgcaccccagaagtagtaa Ribose PUL 
expression 
Glowacki et al. 
2020 
BT3090F atgctgaatgccgcccaata Dextran PUL 
expression 






BT3090R cgagaaaaccgccggatacata Dextran PUL 
expression 
Rogers et al. 
2013 
BT3332F tgttcccggagccagtgttc Chondroitin 
sulfate PUL 
expression 
Rogers et al. 
2013 
BT3332R ttcgtccagcgttttagtatcttcttt Chondroitin 
sulfate PUL 
expression 
Rogers et al. 
2013 
BT3680F cgggaaattaaatatactgctacgaaact Arabinogalactan 
PUL expression 
Rogers et al. 
2013 
BT3680R ctgccgggtctacattggtga Arabinogalactan 
PUL expression 
Rogers et al. 
2013 
BT3702F gctattggcggggcattgg Amylopectin PUL 
expression 
Rogers et al. 
2013 
BT3702R cagcggattttggggagagttcg Amylopectin PUL 
expression 
Rogers et al. 
2013 
BT3788F aagcgtggggaaaaaggtaagg α-Mannan PUL 
expression 
Rogers et al. 
2013 
BT3788R gctaaacgcgcccaatcataac α-Mannan PUL 
expression 
Rogers et al. 
2013 
BT3946F caatcaatccggcaactcctgt rpe gene 
expression 
This study 




n PUL expression 
Rogers et al. 
2013 
BT4114R gggaagccgtctacaataaataaa Homogalacturona
n PUL expression 
Rogers et al. 
2013 
BT4164F gaaatgtaatgaatgatgcaaaaggtaga Rhamnogalacturon
an I PUL 
expression 
Rogers et al. 
2013 
BT4164R cgaaacgtccgtggaagaaagta Rhamnogalacturon
an I PUL 
expression 
Rogers et al. 
2013 
BT4660F agcccgacaaatacttccaacct Heparin sulfate 
PUL expression 
Rogers et al. 
2013 
BT4660R tgtgcggcaaagtgtatcctaaag Heparin sulfate 
PUL expression 
Rogers et al. 
2013 
BT4671F cagcgtggattggaatgtaagatgggtaa Polygalacturonate 
PUL expression 
Rogers et al. 
2013 
BT4671R gtaattcttttgcgggccgtatgtgtagtc Polygalacturonate 
PUL expression 




Table 4.2 RNAseq hits for arabinose and xylose compared to wild type Bt grown in glucose  
 
Name 






BT0032 0.196 0.045 hypothetical protein 
BT0215 N/A 14.539 iron uptake regulatory protein 
BT0348 35.501 N/A alpha-L-arabinofuranosidase 
BT0349 34.634 N/A hypothetical protein 
BT0350 16.794 N/A xylulose kinase (xylulokinase) 
BT0351 11.152 N/A hypothetical protein 
BT0352 9.899 N/A hypothetical protein 
BT0353 11.484 N/A putative sugar epimerase/aldolase 
BT0354 13.432 N/A hypothetical protein 
BT0355 15.076 N/A Na+/glucose cotransporter 





BT0525 0.153 N/A outer membrane protein, function unknown 
BT0551 0.139 N/A Asparagine synthetase 
BT0552 0.182 N/A glutamate synthase, small subunit 
BT0553 0.168 N/A glutamate synthase, large subunit 
BT0791 N/A 191.375 hypothetical protein 
BT0792 N/A 138.075 xylulose kinase (xylulokinase) 
BT0793 N/A 103.337 hypothetical protein 
BT0794 N/A 176.870 D-xylose-proton symporter (D-xylose transporter) 
BT0933 0.055 N/A hypothetical protein 
BT0970 0.188 N/A haloacid dehalogenase-like hydrolase 
BT1211 N/A 6.911 hypothetical protein 
BT1272 6.882 N/A FucR 
BT1273 33.673 N/A hypothetical protein 
BT1274 20.438 N/A hypothetical protein 
BT1275 20.804 N/A L-fuculose kinase 
BT1276 20.896 N/A hypothetical protein 
BT1277 25.673 N/A L-fucose permease 
BT1419 0.139 N/A hypothetical protein 
BT1420 0.183 N/A hypothetical protein 
BT1456 N/A 5.403 thioredoxin (TRX) 
BT1572 N/A 25.976 RNA polymerase ECF-type sigma factor 
BT1604 N/A 15.085 cytochrome c biogenesis protein ResB  
BT1605 N/A 8.053 cytochrome c biogenesis protein 
BT1757 5.371 N/A fructokinase 
BT1758 14.207 N/A glucose/galactose transporter 
BT1759 8.735 N/A levanase precursor (2,6-beta-D- fructofuranosidase) 
BT1760 10.039 N/A glycosylhydrolase 
BT1761 9.887 N/A hypothetical protein 
BT1762 10.844 N/A putative outer membrane protein, probably involved in nutrient 
binding 
BT1763 8.690 N/A putative outer membrane protein, probably involved in nutrient 
binding 
BT1765 9.210 N/A levanase precursor (2,6-beta-D- fructofuranosidase) 
BT2156 0.045 0.047 putative sugar phosphate isomerase/epimerase 
BT2157 0.045 0.043 hypothetical protein 
BT2158 0.052 0.051 putative dehydrogenases and related proteins 
BT2159 0.052 0.054 putative oxidoreductase 
BT2178 0.044 N/A hypothetical protein 
BT2301 5.044 N/A conserved protein found in conjugate transposon 
BT2490 N/A 0.037 hypothetical protein 
BT2555 0.021 N/A hypothetical protein 
BT2569 N/A 6.141 RNA polymerase ECF-type sigma factor 
BT2803 9.944 7.306 ribokinase 
BT2804 9.213 5.742 ribokinase 
BT2805 5.917 N/A putative outer membrane protein, probably involved in nutrient 
binding 
BT2806 5.517 N/A hypothetical protein 
BT2807 6.233 N/A hypothetical protein 
BT2808 6.582 N/A putative inosine-uridine preferring nucleoside hydrolase 
BT2809 8.714 5.328 putative integral membrane protein 
BT2988 N/A 0.191 hypothetical protein 
BT3009 N/A 38.513 GH3 (gentobiase) 
BT3024 0.118 0.191 putative outer membrane protein, probably involved in nutrient 
binding 
BT3025 0.158 N/A putative outer membrane protein, probably involved in nutrient 
binding 
BT3026 0.194 N/A glycosylhydrolase, putative xylanase 





BT3114 0.177 N/A beta-galactosidase 
BT3208 0.066 N/A hypothetical protein 
BT3221 0.187 0.176 hypothetical protein 
BT3222 0.189 N/A hypothetical protein 
BT3344 0.062 0.070 hypothetical protein 
BT3345 0.049 0.069 conserved hypothetical protein, putative outer membrane protein 
BT3346 0.071 0.084 putative outer membrane protein, probably involved in nutrient 
binding 
BT3347 0.085 0.088 hypothetical protein 
BT3415 N/A 7.670 hypothetical protein 
BT3537 0.163 0.196 hypothetical protein 
BT3571 4.995 9.968 hypothetical protein 
BT3572 5.262 9.262 hypothetical protein 
BT3573 N/A N/A hypothetical protein 
BT3574 N/A 6.489 hypothetical protein 
BT3614 17.203 35.446 putative oxidoreductase 
BT3615 11.803 24.525 hypothetical protein 
BT3616 10.148 17.738 fucose permease 
BT3617 N/A 8.187 sorbitol dehydrogenase 
BT3669 N/A 5.567 hypothetical protein 
BT3704 N/A 0.163 hypothetical protein 
BT4038 6.407 N/A putative outer membrane protein, probably involved in nutrient 
binding 
BT4039 5.552 N/A putative outer membrane protein, probably involved in nutrient 
binding 
BT4040 5.089 N/A putative galactose oxidase precursor 
BT4159 N/A 6.799 hypothetical protein 
BT4160 N/A 7.404 beta-galactosidase precursor 
BT4225 N/A 0.145 hypothetical protein 
BT4227 0.174 0.203 hypothetical protein 
BT4294 7.176 N/A hypothetical protein 
BT4295 10.615 N/A putative chitobiase 
BT4296 10.456 N/A hypothetical protein 
BT4297 10.132 N/A putative outer membrane protein, probably involved in nutrient 
binding 
BT4298 10.432 N/A putative outer membrane protein, probably involved in nutrient 
binding 
BT4299 11.937 N/A hypothetical protein 
BT4384 N/A 5.115 hypothetical protein 
BT4579 7.366 5.918 hypothetical protein 
BT4672 N/A 5.005 hypothetical protein 
BT4686 N/A 0.157 hypothetical protein 
BT4715 N/A 11.610 non-specific DNA-binding protein Dps 
 
Notes  
  This work is currently not submitted to a peer-reviewed journal article. However, the plan 
is to submit this work in the coming months to year after subsequent experiments are performed 
and analyzed. This work would not have been possible without helpful discussion and assistance 
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  Carbohydrate and nutrient utilization by members of gut microbiota is critical for their 
survival within the competitive gut environment. The most successful strains could be thought of 
as belonging to the most abundant bacterial phyla of the Firmicutes and the Bacteroidetes. This is 
likely due to their vast nutrient degrading abilities, allowing them to switch to a wide range of 
available nutrients. These phyla, especially members of the Bacteroidetes are also important for 
host health through the generation of short-chain fatty acids, colonization resistance, gut immune 
system maturation and barrier function, and several other functions1-4. The Bacteroides have a 
particularly large capacity for degrading host, plant (dietary), bacterial, and algal polysaccharides 
with diverse linkages and compositions through products encoded in genetic loci termed 
polysaccharide utilization loci (PULs)5-10. However, except for a few studies11-13, little is known 
about the fate of other nutrients such as monosaccharides and nucleic-acid derived substrates or 
the detailed mechanistic strategies used by Bacteroides to catabolize these substrates. Work 
presented in this dissertation offers new insights into the variety of carbohydrates that 
Bacteroides thetaiotaomicron (Bt) utilizes for growth through the identification of the Ribose 
Utilization System (Rus) PUL. This is only the second PUL described that targets a 
monosaccharide and the first to be implicated in processing of a nutrient (ribose-1-phosphate), 
formed from the actions of an upstream, genomically unlinked pathway for nucleoside 
scavenging. Importantly, this dissertation describes the actions of the Rus PUL-encoded 
ribokinases, which is the first described eubacterial ribokinase with 1’-phosphorylating abilities. 
Further, the work within this dissertation highlights the complexity of host mucosal glycan 
foraging abilities of Bt and the in vivo relevance of these systems. Lastly, this work has described 






Chapter Summary and Further Results 
  The underlying current that links the chapters of this dissertation together has been an in-
depth examination of the substrates that Bt catabolizes, and the mechanisms governing their 
utilization and regulation. The genes and products required for ribose and nucleoside metabolism 
were identified and characterized in Chapter II, a PUL-encoded, antigenic protein was identified 
that was responsive to host glycans (Chapter III), genes that likely code for regulatory proteins 
and new mechanisms of regulation were uncovered (Chapter IV), and discussed below, PUL-
encoded machinery responsible for degrading host-derived nutrients were examined. In sum, this 
work has advanced the known substrate-degrading abilities and regulatory mechanisms of Bt 
with important implications for the broader Bacteroidetes phylum, important members of the 
human gut microbiota, oral cavity, and in the environment14,15.  
  Of the characterized PULs in Bacteroides, most are patterned similar to the starch 
utilization system (Sus), which was the first PUL described16. This system contains a regulatory 
protein, (SusR), a TonB-dependent outer membrane (OM) transporter (SusC), an OM lipoprotein 
required for substrate binding (SusD), an OM glycoside hydrolase (SusG), periplasmic amylases 
(SusA and SusB), and accessory OM binding proteins (SusE/SusF)17-20. What typically denotes a 
PUL is the presence of SusC and SusD homologs, which are often referred to as SusC- or SusD-
like proteins21. The accessory proteins found in each PUL are what delineates the cognate 
substrate that is degradation. These often include OM and periplasmic glycoside hydrolases, 
sulfatases, esterases, sialidases, and regulators22,23. Additionally, PULs almost ubiquitously target 
substrates that are large and complex in both linkage and structure such as polysaccharides, 
while previously thought to be unimportant or not required for catabolism of smaller nutrients 
such as monosaccharides24. Therefore, the Rus PUL described in Chapter II that targets ribose is 
unique in many regards.  
  First and foremost, the Rus is only the second described PUL that encodes functions 
required for the utilization of a monosaccharide (ribose) (Figure 2.1C and D), with the fructan 
PUL previously being characterized for fructose utilization25. Interestingly, these systems appear 
to be patterned in similar ways, both containing a dedicated inner membrane permease and a 
sugar-specific kinase, which suggests these PULs are adapted and built around monosaccharide 
utilization. Further, both ribose and fructose are connected as sugars of the pentose phosphate 





2.2A), while ribose upregulates fructan PUL expression (Figure 2.9G). Although these two 
systems are likely connected, an in vivo competition experiment did not clearly show how these 
systems may work together (Figure 2.8G and H). Components of the fructan system are required 
for fructose growth while the cognate substrate(s) are fructose polymers such as the 
polysaccharide levan, inulin, and fructooligosaccharides25 and the SusC/D-like proteins delineate 
which fructose polysaccharide is catabolized between different isolates of the same strain and are 
required for growth on these substrates26.  
  In contrast, the RusC and RusD proteins (SusC/D homologs) within the Rus PUL are 
dispensable for growth on all ribose-containing substrates that I tested for growth (Figure 
2.7B,C,G, and S-U). Although this phenomenon has not previously been described, (SusC/D 
homologs are usually required), this may be due, in part, to not being able to identify the cognate 
ribose polymer that RusD binds and RusC imports. However, it is also conceivable that this 
system has evolved a mechanism independent of these PUL-encoded proteins, or perhaps Bt has 
a secondary system containing OM import and binding machinery (Figure 2.9G) that ribose-
containing compounds can be shuttled through. A similar mechanism has previously been 
suggested for the Sus PUL27. Although ribose and other monosaccharides can cross the OM of 
gram negative bacteria through proteins such as OmpF and related Omps28, nucleosides typically 
cross the OM through facilitated transporters such Tsx-porins29. Bt does not have a good 
homolog of these nucleoside-related transport proteins however, there are numerous 
uncharacterized OM transporters in Bt that could potentially serve this role30. Further, this 
system is unique in the sensing and catabolism of nucleosides as it requires the presence of 
ribose and the novel regulatory protein RusR (Figure 2.1C and Figure 2.6D).  
RusR is a novel regulatory protein, but not just in terms of Bt PULs or metabolism. The 
amino acid sequence coding for RusR (encoded by BT2802), does not have homology to 
previously described families of proteins or regulators. Predictive algorithms have found a helix-
turn-helix domain responsible for DNA-binding, this evidence alone is not sufficient to speculate 
if the sugar bound is ribose or the phosphorylation status of ribose that RusR recognizes or the 
mechanism of action, other than saying it is a positive acting regulator based on my results. This 
warrants further characterization through X-ray crystallography and binding assays. 
Additionally, there are likely many further uncharacterized regulatory proteins in Bt13,31, and the 





from this work was that the ribokinases phosphorylation abilities. RusK1 and RusK2 are the first 
described ribokinases in eubacteria able to generate ribose 1,5 bisphosphate (PRibP) from ribose-
1-phosphate (R1P) (Figure 2.9F). Additionally, RusK2 is the first described ribokinase able to 
phosphorylate in the 1’ position of an already 5’phosphorylated ribose (R5P). This mechanism of 
phosphorylating R1P derived from the actions of a genomically unlinked nucleoside scavenging, 
nucleoside phosphorylase (BT4554) (Figure 2.9A-C), is the first time that PUL-encoded 
functions have been documented to synergize with upstream, non-PUL encoded machinery for 
the catabolism of a nutrient. The mechanism of ribose and nucleoside utilization had important 
implications for Bt in vivo in mice fed a fiber-rich (FR) diet. Those implications being that the 
encoded ribokinases and nucleoside phosphorylases are required for successful competition on 
the FR diet when source(s) of ribose (likely nucleosides) are present.   
The original impetus for studying the Rus PUL was that this PUL with unknown function 
was upregulated in mice fed a fiber free (FF) diet or in neonate mice dependent on mothers’ milk 
for nutrition, which is also a FF condition (Figure 2.1A). This result suggested that this PUL may 
target an endogenous nutrient source as it behaved similar to PULs responsive to host-glycan 
degradation22. However, when competed against wild type Bt, it was clear that rus was required 
for a competitive advantage only in a FR-diet and not the FF-diet (Figure 2.3A-F). This effect 
was mediated by ribose or a ribose-containing source (nucleosides) from the FR diet (Figure 
2.4A-C). Further, this effect was narrowed down to the combined actions of both RusK1 and 
RusK2, but not their individual actions (Figure 2.4G and Figure 2.5A), as well as the unlinked, 
nucleoside phosphorylase, BT4554 (Figure 2.9D). Although the exact substrate mediating this 
effect in vivo was not conclusively identified, my results point to a nucleoside-containing 
nutrient. This study demonstrates the importance of studies on bacterial metabolism, as predicted 
functionality and metabolic KEGG maps of the PPP were at an incomplete view of how Bt 
processes ribose and nucleosides.  
Although the ribose results in Chapter II mostly ruled out this nutrient being important in 
an FF-diet, it is clear that the FF-diet is an important dietary condition to study as it resembles a 
Westernized diet rich in fats and simple sugars while depleted of complex dietary fibers. This 
style of dietary consumption can predispose individuals to colonization by invading pathogens2, 
worsen preexisting health conditions such as inflammatory bowel disease (ulcerative colitis)32 





directly linked the effects of a Westernized diet to actions of the gut microbiota, and although Bt 
is often a beneficial gut symbiont that degrades complex dietary fibers, it is also an efficient 
degrader of the host mucosal lining, rich in O- and N-linked glycans7,22. This ability is associated 
with the development of colitis in the context of FF diets and predisposed genetic conditions35,36. 
Bt degrades mucosal-derived glycans through PUL-encoded machinery. Many of these PULs 
encode sulfatases which act to remove the sulfate groups from highly sulfated host glycans36-38. 
Work in Chapter III, has built upon foundational knowledge of the sulfatase-dependent 
mechanism(s) and the generation of outer-membrane vesicles (OMVs) containing sulfatases and 
other mucin-degrading enzymes36,39. The intimate connection between gut bacteria and the host, 
allows the host immune system to generate a response that is either tolerogenic (Tregs) towards 
resident gut symbionts or more skewed towards CD4+ effector T cells (Teffs) when invading 
pathogens are present, or when resident bacteria perform deleterious functions towards the 
host40,41. Accordingly, the type of T cells generated can be influenced based on the nutrients 
available for degradation by the gut microbiota, as the antigens that the host senses are different 
based on what proteins the bacterium has expressed in response to nutrients. In order to test how 
the host responds to individual bacteria in a diet-dependent manner, a T cell-based assay termed, 
BθOM was developed specific for an outer membrane (OM) antigen found in OMVs from Bt 
(Bt, Bθ) (Figure 3.1 and Figure 3.2B-C).  
It was observed that upon screening a T cell hybridoma line for cells active in response to 
Bt antigens, that different in vitro growth conditions of Bt caused differential T cell activation 
levels (Figure 3.1). In vivo characterization of the T cell response revealed that BθOM T cells 
differentiate into both Tregs and Teffs (Figure 3.6A-C and Figure 3.7A-F). An important dynamic 
that is dependent on Tregs being dominant by regulating the Teffs to prevent Bt-induced colitis 
(Figure 3.7C) that was observed in vivo in Rag1-/- mice. Upon deletion of the BθOM Tregs, a 
proinflammatory state was observed (Figure 3.8A-B). The most obvious next question was what 
is the Bt-OM antigen that the BθOM T cells recognize and why is it dependent on host diet.  
I positively identified the antigen as an OM SusE/F-like lipoprotein encoded by BT4295 
by using a transposon mutagenesis library of Bt (Figure 3.10A). This was refined to a single 
peptide and was mapped to a single amino acid substitution that abrogated the T cell response to 
BT4295 (Figure 3.10 F-G and Figure 3.12B). Interestingly, BT4295 is found within one of the 





contain sulfatases, the PUL circumscribed by BT4294-4300 does not contain sulfatases, or 
hydrolytic enzymes (Figure 3.10B). Rather, it appears to be involved in the binding and import 
of a glycan, although hydrolytic or degrading function(s) cannot be ruled out as three of these 
proteins are hypothetical and contain no previously characterized conserved protein domains. In 
addition to the BT4295 antigen, the transposon approach located additional potential antigens 
(Figure 3.11B).  
Not surprisingly, due to being in the same PUL as BT4295, BT4298, a SusC-like protein 
also weakly stimulated T cells (Figure 3.10C). Intriguing are the remaining hits that correspond 
to the genes, BT1220-1223. These genes code for proteins within the PPP and perhaps this 
represents a similar phenomenon as was observed in Chapter II, with an upstream or downstream 
metabolic reliance on PUL-encoded and unlinked functions. These findings required follow up 
study of the initial observation that different in vitro growth media affects the expression of the 
BT4295 T cell antigen. Finding that the salts: K2HPO4 and NaCl and mucin O-glycans, strongly 
increased expression of BT4295 and downstream T cell activation (Figure 3.14A-D). Although 
the mechanism of how salts stimulate the expression of this glycan are unknown, it could be a 
response that Bt has developed to in vivo stresses associated with salt intake. The mucosal O-
glycan response is more expected with the observation of this system being active in FF dietary 
conditions where host polysaccharides would be used as a nutrient. Further, expression of this 
antigen was reduced or repressed in vivo when mice were provided water containing 30% w/v 
glucose (Figure 3.15C-D). This result suggests that dietary glucose can alter the expression of 
this system, however this was only performed on a standard chow diet similar to the FR diet 
which contains many plant derived polysaccharides. In the context of a FF diet, where glucose is 
already a prominent constituent and when Bt physiology shifts to catabolizing host 
polysaccharides, the same suppression may not be observed and should be further tested in 
follow-up studies.  
As Chapters II and III have demonstrated, Bt physiology is dynamic. In Chapter IV, I 
examine some of the ways in which Bt regulates and responds to different nutrients, uncovering 
how monosaccharides alter nutrient hierarchy and competitive fitness, as well as describe the 
global regulatory proteins. The characterized regulatory mechanisms in Bt are diverse, occurring 
locally within metabolic loci, globally with Crp-like mechanisms, and small RNAs42-44. These 





ECF-σ/anti-σ pair, SusR-like activators, LacI-type repressors and GntR-like transcription 
factors11,12,22,31,45-47. These mechanisms allow Bt and related Bacteroides to degrade and 
catabolize a diverse set of carbohydrate nutrients in complex mixtures48-50. However, previous 
studies have not given much focus to monosaccharides despite these substrates being monomers 
of polysaccharides, and as demonstrated in Chapter II, monosaccharides may be important in 
vivo as was the case for ribose and nucleosides.  
The results from this study showed that the monosaccharide ribose and presence of the 
genes response for its catabolism (rus) altered the in vitro transcriptional response of 
polysaccharide utilization genes for several glucose-containing polymers as well as a few other 
arabinose containing nutrients (Figure 4.1). I further confirmed that the Δrus strain competed 
worse in vitro in media containing glucose as the sole carbon source or in a rich media that had 
glucose as one of its components (Figure 4.2G-H). This result may be due to the presence of 
nucleosides or ribose in the rich media or may also serve to explain the altered hierarchy of 
glucose-based polysaccharides. Extending these findings of monosaccharides affecting the 
transcription of other genes, I examined the global response to arabinose and xylose by RNAseq 
analysis compared to glucose (Figure 4.3). Interestingly, in arabinose, Bt upregulates the PUL 
(BT4294-4299) that contains the T cell antigen BT4295 from Chapter III. This suggests that the 
hits in the PPP initially observed in the transposon screen (Figure 3.11B), may be related to 
arabinose being able to upregulate this PUL in addition to host mucin-O-glycans (MOG). 
Additionally, several previously uncharacterized genes predicted to code for orphan ECF-σ 
regulators were upregulated in both arabinose and xylose (Figure 4.3) as well as in ribose (Figure 
2.9G).  
These orphan regulators are not located adjacent to clear metabolic genes and are without 
anti-σ factors. I was unable to make deletions in the two most highly differentially regulated 
factors, BT2184 and BT2569. However, this result propelled me to make deletions in other 
orphan ECF-σ factors and orphan LacI-type regulators. Several of the LacI regulators acted as 
repressors during growth on uronic acid containing mono- and polysaccharides as well as 
rhamnose (Figure 4.6). Further, only the orphan ECF-σ, BT2492, when deleted caused growth 
defects on 12 of the polysaccharides Bt normally catabolizes (Figure 4.4). The most severe defect 
was seen for growth in MOG. It is these sulfated, host-derived polysaccharides that are the focus 






Sulfatase containing and host glycan responsive PULs are required for growth on MOG 
  Within the 88 PULs that Bt encodes, there are at least 16 known to be transcriptionally 
active towards host-derived glycans such as MOG, chondroitin sulfate (CS), heparin sulfate 
(HS), and keratin sulfate22,45. With the degradation of host mucosal glycans being a driver of 
colitis36, the importance of elucidating the function of these PULs and the machinery they 
encode is of critical importance. To this end, I’ve generated individual mutant strains lacking 
entire mucin PULs as well as a strain lacking 11 different PULs (11x mutant) containing nearly 
all of Bt’s sulfatase genes (Figure 5.1A). The methodology for the order in which PULs were 
sequentially deleted was based on several factors i) best way to delete the most sulfatases, ii) 
deletion of hydrolytic enzymes (fucosidases, sialidases, glycoside hydrolases), and iii) deletion 
of the most highly expressed PULs in vivo. I had hypothesized that deletion of successive PULs 
would lead to a step-wise decrease in the ability to grow on MOG as a sole carbon source. This is 
largely what I observed, with an initial decrease in growth at the 3x deletion (Figure 5.1C), with 
slight decreases in growth moving through to the 7x deletion strain (Figure 5.1D-G). A 
substantially larger defect was seen in the transition to the 8x deletion strain that extend to the 9x 
and 10x strains (Figure 5.1H-J). I continued the process of deleting strains by completing 
deletion of BT4240-50, yielding the 11x deletion strain (Figure 5.2A).  
The large growth defects associated with the 8x and 11x strains suggested that functions 
encoded in these individual PULs were key to MOG catabolism and led to the hypothesis that an 
individual deletion strain containing only these genes would also exhibit a strong growth defect. 
To test, I used single deletion strains and grew these in vitro on MOG as a sole carbon source, 
however none of the individual mutant strains approached the defects seen in the 8x or 11x 
deletions arguing against a model in which a single PUL is most important. Rather this result 
supports a model of step-wise degradation (Figure 5.2 B-E). Additionally, a deletion strain of the 
anaerobic sulfatase maturating enzyme (anSME or ΔChuR) was tested, as this enzyme is 
required for active sulfatases37. Interestingly, this deletion strain did not match the magnitude of 
the growth defect of the 11x deletion strain (Figure 5.2F). This result suggests that the ability to 





Figure 5.1 Sulfatase PULs code for many additional functions required for degradation and growth in MOG. 
A) Schematic of the architecture of PULs deleted individually or in succession leading to a 11x mutant strain lacking all of the 
PULs shown. Genes are sized relative to the amino acid length and color coded according to predicted function. A key of the 
predicted functionalities is included as a key at the bottom of this panel. B-J) Growth curves of wild type Bt (black curves) or the 
indicated mutant strain (red curves on 10 mg/ml MOG). The deleted PUL gene locus tag numbers are shown on each panel. All 





Figure 5.2 Individual MOG-responsive PUL deletions are not sufficient to abrogate growth. 
A-F) Growth curves of wild type Bt (black curves) or individual deletion strains lacking a single PUL or a single gene (red curves) 
on 10 mg/ml MOG. The same time scale and absorbance scale was used for all panels.  
 
I further followed up on this to ensure that orphan sulfatases not found within PULs were not 
involved in catabolism of MOG. No differences in growth compared to wild type Bt in either 
individual or a 4x deletion strain of orphan sulfatases was observed (Figure 5.3A-B). Further, 
none of the deletion PULs or orphaned sulfatases exhibited growth defects on non-MOG 
substrates such as glucose (Figure 5.3C-E).  
Lastly, in addition to MOG, host-derived CS and HS can also be used as carbon sources 
by Bt. These polysaccharides are structurally similar to those found in bacterial capsules. 
Although throughout this thesis the prospect of Bt and related Bacteroides acting to degrade 
bacterial capsules has only been mentioned in the introduction (Chapter I) and in Chapter II with 
certain bacteria putting ribose into their capsules, it is an important underexplored nutrient niche. 
In order to examine possible capsule degrading abilities in vivo, I took advantage of the 
following 1) knowledge of Bt degrading HS via PUL-encoded functions and 2) the E. coli Nissle 
1917 strain that produces a highly sulfated capsular polysaccharide termed heperonsan. This 
polysaccharide capsule is similar in structure to HS51,52. I performed an in vivo competition of 
wild type and a ΔHS PUL mutant in Bt in the presence of the E. coli Nissle strain and observed 
that in a FF diet, the capsule from this E. coli may be used as a carbon source, until heparan 






Figure 5.3 Orphan sulfatase deletions do not affect MOG growth and MOG PUL deletions grow normally on glucose. 
A-E) Wild type Bt (black line) or individual PUL or single gene deletion strains grown on MOG (A-B) or glucose (C-E). Deletion 
strains are color coded as listed in the key found within each panel.  
 
The behavior of the ΔHS PUL mutant are interesting. This strain remained stable in both the FR 
and FF diet (Figure 5.4A-B), until heparan sulfate was introduced in the water. This suggests that 
although wild type Bt can catabolize HS, there are other available nutrients that the ΔHS PUL 
strain can utilize and establish and maintain a niche.  
Figure 5.4 Heparin sulfate competition in vivo between Bt and E. coli Nissle 1917.  
A-B) Relative fecal abundance enumerated by qPCR of wild type Bt (black line), a mutant lacking the genes for heparin sulfate 
utilization (red line), and E. coli Nissle 1917 (blue line) on mice fed a fiber rich diet (A) or a fiber free diet (B).  The initial time 
point at day 0 is the inoculum abundance for both Bt strains, the E. coli strain was introduced at day 12. B) The shaded blue boxed 
region represents where water containing 0.5% w/v heparan sulfate containing water was introduced to the mice ad libitum for 4 





The combined findings of these results have allowed insight into the complex mechanisms and 
PULs that Bt uses to catabolize highly sulfated host and bacterial capsule-derived glycans. The 
findings described in this discussion, coupled with the results of the previous chapters have 
helped to expand the known PUL-encoded functions that are important for successful 
competition in vivo, and broadened the diversity of substrates that Bt degrades.  
 
Future Work 
Determination of monosaccharide nutrient utilization by Bacteroides 
  The bulk of this dissertation research has focused on nutrient strategies, mainly PUL-
encoded, that allow Bt to grow on various carbohydrates. Prior to this work, an in-depth 
mechanistic study of monosaccharide utilization had not been performed for Bt. The finding that 
ribose and nucleoside utilization occur via PUL-encoded mechanisms while requiring upstream 
hydrolase functions is an important step towards recognizing additional substrates that Bt 
degrades. In Chapter II, I observed the ribose-induced synergistic metabolism of the sugar’s 
deoxyribose, lyxose, and UDP sugars. Future work should focus on expanding the known 
repertoire of substrates that can be used as sole carbon sources by testing additional mixtures of 
carbohydrates to examine if synergism is a common mechanism that Bacteroides use. Additional 
substrates derived from anthropogenic substances such as artificial sweeteners and emulsifiers, 
and more carbohydrates from environmental derived polysaccharides of fungus and algae should 
also be investigated. Perhaps the area where the most inroads could be made towards 
understanding the metabolism and in vivo relevance will be the testing of exopolysaccharides 
and capsular polysaccharides from gut bacteria. Many PULs remain uncharacterized and these 
substrates have largely been overlooked due to issues in isolation techniques and difficulty in 
characterization of the monomers present in these polysaccharides. It is likely that the best way 
to approach this is through growth analysis and transcriptional responses in order to identify 
genes that respond to these substrates.  
Further defining of the sulfatase and fucosidase mechanisms of host glycan catabolism 
  Work from Chapter III and Chapter V demonstrate the importance of Bt PULs involved 
in degrading host mucosal glycans. Although deletion of 11 PULs in combination led to a large 





to erode the ability of Bt to degrade host polysaccharides, additional deletions in the background 
of the 11x strain will need to be performed. There are at least 3 additional host-glycan responsive 
PULs that need to be assayed: BT4294-99, (identified in Chapter III), BT3461-3507 22, and 
BT4355-59 49. The observance that additional, non-sulfatase enzymes must be required for 
growth will need to be explored through genetic deletions of fucosidases for example. The 
deletion of additional PULs in the 11x background may lead to additional enzymes that are 
important for catabolism of host glycans. Further, in vivo competitions of these strains (i.e. the 
11x deletion versus wild type) should be performed in both FR and FF diets to examine the 
impact that lacking these PULs has for different diets. Further, in vitro competitions and 
additional growth and transcriptional experiments need to be performed for the ΔHS PUL versus 
wild type Bt versus E. coli Nissle 1917. It is possible that in vivo, the E. coli strain is not 
producing the heparan containing capsule and therefore is the reason why it is not outcompeted. 
Together, these studies into host glycan degradation may one day guide the development of 
drugs to inhibit the mucosal degrading abilities by Bt and related mucosal glycan degrading 
bacteria through inhibiting enzymes. 
Defining the regulation strategies in Bt for nutrient metabolism 
  In Chapter IV I described several new regulatory proteins as well as the earlier 
description of RusR in Chapter II. In this dissertation these proteins were not characterized 
biochemically. Rather, I infer the importance of these through growth-based assays of deletion 
strains lacking genes coding for these predicted regulators. This approach coupled with 
transcriptional assays allowed me to comment on the necessity of these proteins for global 
regulation of carbohydrate nutrients, but did not provide insight into the direct mechanisms of 
these proteins. Moving forward, research will focus on purification efforts of these regulatory 
proteins and I will perform binding assays such as isothermal titration calorimetry or gel-shift 
assays to detect the ligands that these proteins recognize.  
Final Conclusions 
  The work presented in this dissertation has added to the known substrate degrading 
abilities of Bt, and this is the first in-depth mechanistic model for the utilization of a 
monosaccharide ribose and the degradation nucleosides within Bt. Further, the characterization 





hypothesize that the observed co-dependence on non-Rus PUL encoded enzymes is likely a 
common occurrence for other PULs that currently lack knowledge of the cognate substrate they 
can degrade. Further, the in vivo approaches used in the studies here, demonstrate the importance 
of using multiple diets even when predicted functionality indicates the requirement of these 
systems is restricted to specific conditions. I also observed that monosaccharides affect the 
transcription of other PULs and metabolism-related genes, which likely influences the observed 
nutrient hierarchies of Bt. This result together with the deletion strains of ΔrusR and ΔBT2492 
suggest that the mechanisms that Bt uses to switch between different carbon sources is much 
more complex and fluid than previously appreciated. This ability to rapidly change nutrient 
utilization based on the substrates present, no doubt contributes to the survival of Bt and related 
Bacteroidetes. Ultimately, the studies present in this dissertation lay the groundwork for 
additional inquiry into PULs that currently lack mechanistic studies. In the future, studies like the 
ones described here will hopefully aid in designing treatments for health disorders caused by the 
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